Pasar al contenido principal

NUEVOS MATERIALES Y SONDAS PARA EL RECONOCIMIENTO, LIBERACION DE FARMACOS, NANOMOTORES Y COMUNICACION

PID2021-126304OB-C41

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 83
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Ficin-Cyclodextrin-Based Docking Nanoarchitectonics of Self-Propelled Nanomotors for Bacterial Biofilm Eradication

  • Ziemyte, Migle
  • Diez-Sánchez, Paula
  • Ferrer, María D.
  • Mira, Alex
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Murguía, Jose R.|||0000-0001-9364-4603
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Development of bioinspired nanomotors showing effective propulsion and cargo delivery capabilities has attracted much attention in the last few years due to their potential use in biomedical applications. However, implementation of this tech-nology in realistic settings is still a barely explored field. Herein, we report the design and application of a multifunctional gated Janus platinum-mesoporous silica nanomotor constituted of a propelling element (platinum nanodendrites) and a drug-loaded nano-container (mesoporous silica nanoparticle) capped with ficin enzyme modified with beta-cyclodextrins (beta-CD). The engineered nanomotor is designed to effectively disrupt bacterial biofilms via H2O2-induced self-propelled motion, ficin hydrolysis of the extracellular polymeric matrix (EPS) of the biofilm, and controlled pH-triggered cargo (vancomycin) delivery. The effective synergic antimicrobial activity of the nanomotor is demonstrated in the elimination of Staphylococcus aureus biofilms. The nanomotor achieves 82% of EPS biomass disruption and a 96% reduction in cell viability, which contrasts with a remarkably lower reduction in biofilm elimination when the components of the nanomotors are used separately at the same concentrations. Such a large reduction in biofilm biomass in S. aureus has never been achieved previously by any conventional therapy. The strategy proposed suggests that engineered nanomotors have great potential for the elimination of biofilms., The authors acknowledge financial support from Project CIPROM/2021/007 from the Generalitat Valenciana. This research was also supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund - A way of doing Europe. This study was also part of the Advanced Materials Program (MFA/2022/053) supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This research was also funded by Universitat Politecnica de Valencia and the FISABIO Foundation, NANO-DRILL Project (UGP-19-384), and NANODONT Project (UPV-FISABIO-2020-B14). The authors gratefully acknowledge the support of the European Research Council (ERC) via the Advanced Grant (101052997, EDISON). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council . Neither the European Union nor the granting authority can be held responsible for them. M.Z. thanks for her FPU Ph.D. scholarship by the Spanish government (FPU17/01302). A.E. is also grateful for her Ph.D. grant from the Generalitat Valenciana (ACIF/2018/110). P.D. thanks Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120). V.M-C. acknowledges financial support from Project CIDE-GENT/2020/031, funded by Generalitat Valenciana. Scheme 1, (top) and Figure 3a were created with BioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Folate- and aCD47-functionalized lipid nanoparticles efficiently deliver mRNA and remodel pancreatic tumor microenvironment

  • Parés, Marta
  • Pallaruelo-Santamaría, Víctor
  • Fillat, Cristina
  • Martínez-Latorre, Javier|||0000-0001-5421-5371
  • Candela-Noguera, Vicente
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Abstract: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive and treatment-resistant malignancies, with limited efficacy to conventional treatments such as surgical resection or chemotherapy. This clinical scenario underscores the need for novel therapeutic strategies. The development of multifunctional platforms capable of targeting tumors through multiple mechanisms offers an innovative strategy to overcome this challenge. Lipid nanoparticles (LNPs) offer a versatile platform capable of efficiently delivering genetic material. Moreover, through surface functionalization it is feasible to improve LNP performance optimizing therapeutic outcomes in a single formulation. Here, we explored a dual functionalization strategy of the LNP for tumor targeting and tumor remodeling to improve treatment efficacy. LNPs were designed for delivering reporter DNA plasmid or mRNA into the PDAC cellular models Capan-2 and PANC-1. The DNA plasmid contains a pancreatic cancer-specific chimeric promoter for transcriptional specificity to PDAC cells. Besides, LNPs were functionalized with folate and an anti-CD47 antibody to both target the folate receptor in PDAC cells and block CD47-mediated immune evasion. Both pDNA and mRNA LNPs targeted PDAC cells in a dose-dependent manner, with mRNA-LNPs demonstrating more efficient transfection. Notably, LNPs functionalized with the anti-CD47 antibody increased phagocytosis in vitro, and promoted an inflammatory phenotype of M1-like macrophages in mouse Capan-2 xenografts. This combinatorial design of the formulated LNP represents an innovative therapeutic strategy and opens future perspectives in the search for effective treatments for PDAC. Keywords: Lipid nanoparticles; Immunotherapy; ACD47; Folate; Macrophages; Pancreatic cancer, This research was supported by European Union s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020- 119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovacion ¿ and by the European Regional Development Fund A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from la Caixa Foundation under agreement LCF/PR/ SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Self-propelled enzyme-controlled IR-mesoporous silica Janus nanomotor for smart delivery

  • Mayol, Beatriz
  • Pradana-López, Sandra
  • Villalonga, Anabel
  • Anillo, Carlos
  • Vilela, Diana
  • Sánchez, Alfredo
  • Martínez-Ruiz, Paloma
  • Villalonga, Reynaldo
  • García-Fernández, Alba|||0000-0002-8416-1674
  • De La Torre-Paredes, Cristina
  • Diez-Sánchez, Paula
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Here, we report the preparation of a novel Janus nanoparticle with opposite Ir and mesoporous silica nanoparticles through a partial surface masking with toposelective modification method. This nanomaterial was employed to construct an enzyme -powered nanomachine with self -propulsion properties for on -command delivery. The cargo -loaded nanoparticle was provided with a pH -sensitive gate and unit control at the mesoporous face by first attaching boronic acid residues and further immobilization of glucose oxidase through reversible boronic acid esters with the carbohydrate residues of the glycoenzyme. Addition of glucose leads to the enzymatic production of H 2 O 2 and gluconic acid, being the first compound catalytically decomposed at the Ir nanoparticle face producing O 2 and causing the nanomachine propulsion. Gluconic acid leads to a pH reduction at the nanomachine microenvironment causing the disruption of the gating mechanism with the subsequent cargo release. This work demonstrates that enzyme -mediated self -propulsion improved release efficiency being this nanomotor successfully employed for the smart release of Doxorubicin in HeLa cancer cells., Financial support from the Spanish Ministry of Economy and Competitiveness (projects CTQ2017-87954-P and PID2021-125723NB- I00) and the Spanish Ministry for Science and Innovation (project CNS2022-135255) is gratefully acknowledged. This work was also supported by PID2021-126304OB-C41 project via MCIN/AEI/10.13039/501100011033/and by the Generalitat Valenciana (CIPROM/2021/007) . Thanks to the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) . The Complutense University of Madrid and the Autonomous Community of Madrid also supported this work through the PR27/21- 015 Grant.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Spatiotemporal Communication in Artificial Cell Consortia for Dynamic Control of DNA Nanostructures

  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Ventura-Cobos, Jordi|||0000-0001-8475-9820
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Shao, Jingxin
  • Buddingh, Bastiaan C.
  • van Hest, Jan C. M.
  • Abdelmohsen, Loai K. E. A.
[EN] The spatiotemporal orchestration of cellular processes is a ubiquitous phenomenon in pluricellular organisms and bacterial communities, where sender cells secrete chemical signals that activate specific pathways in distant receivers. Despite its importance, the engineering and investigation of spatiotemporal communication in artificial cell consortia remains underexplored. In this study, we present spatiotemporal communication between cellular-scale entities acting as both senders and receivers. The transmitted signals are leveraged to elicit conformational alterations within compartmentalized DNA structures. Specifically, sender entities control and generate diffusive chemical signals, namely, variations in pH, through the conversion of biomolecular inputs. In the receiver population, compartmentalized DNA nanostructures exhibit changes in conformation, transitioning between triplex and duplex assemblies, in response to this pH variation. We demonstrate the temporal regulation of activated DNA nanostructures through the coordinated action of two antagonistic sender populations. Furthermore, we illustrate the transient distance-dependent activation of the receivers, facilitated by sender populations situated at defined spatial locations. Collectively, our findings provide novel avenues for the design of artificial cell consortia endowed with programmable spatiotemporal dynamics through chemical communication., The authors would like to acknowledge the support from the Dutch Ministry of Education, Culture, and Science (Gravitation programs 024.001.035, 024.003.013, 024.005.020 - Interactive Polymer Materials IPM, and the Spinoza premium), ERC Advanced Grant (Artisym 694120), ERC Advanced Grant Edison (101052997), the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (project PID2021-126304OB-C41), and the GVA (Project CIPROM/2021/007). A.L.-L. acknowledges support from the MSCA Cofund project oLife, which has received funding from the European Union's Horizon 2020 research and innovation program under the Grant Agreement 847675. A.L.-L. thanks the Spanish Government for his "Ramon y Cajal" Fellowship (RYC2021-034728-I), funded by MCIN/AEI/10.13039/501100011033 and by the European Union << NextGenerationEU >>/<< PRTR >>. A.L-L. also thanks the UPV for funding (Ayuda para potenciar la investigacion postdoctoral de la UPV (PAID-PD-22), Ayuda a Primeros Proyectos de Investigacion (PAID-06-22), Vicerrectorado de Investigacion de la Universitat Politecnica de Valencia (UPV)).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Exploring the Synergy between Nano-Formulated Linezolid and Polymyxin B as a Gram-Negative Effective Antibiotic Delivery System Based on Mesoporous Silica Nanoparticles

  • Otri, Ismael
  • Medaglia, Serena|||0000-0003-3537-9842
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
[EN] Antimicrobial resistance is a current silent pandemic that needs new types of antimicrobial agents different from the classic antibiotics that are known to lose efficiency over time. Encapsulation of antibiotics inside nano-delivery systems could be a promising, effective strategy that is able to delay the capability of pathogens to develop resistance mechanisms against antimicrobials. These systems can be adapted to deliver already discovered antibiotics to specific infection sites in a more successful way. Herein, mesoporous silica nanomaterials are used for an efficient delivery of a linezolid gram-positive antibiotic that acts synergistically with gram-negative antimicrobial polymyxin B. For this purpose, linezolid is encapsulated in the pores of the mesoporous silica, whose outer surface is coated with a polymyxin B membrane disruptor. The nanomaterial showed a good controlled-release performance in the presence of lipopolysaccharide, found in bacteria cell membranes, and the complete bacteria E. coli DH5. The performed studies demonstrate that when the novel formulation is near bacteria, polymyxin B interacts with the cell membrane, thereby promoting its permeation. After this step, linezolid can easily penetrate the bacteria and act with efficacy to kill the microorganism. The nano-delivery system presents a highly increased antimicrobial efficacy against gram-negative bacteria, where the use of free linezolid is not effective, with a fractional inhibitory concentration index of 0.0063 for E. coli. Moreover, enhanced toxicity against gram-positive bacteria was confirmed thanks to the combination of both antibiotics in the same nanoparticles. Although this new nanomaterial should be further studied to reach clinical practice, the obtained results pave the way to the development of new nanoformulations which could help in the fight against bacterial infections., Please additionally note that this research was supported through project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund A Way of Doing Europe. This study also forms part of the Advanced Materials Programme (MFA/2022/053) and was supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). I.O. was funded by the Erasmus Mundus Programme, Action 2, Lot 1, Syria (predoctoral fellowship). S.M. was funded by Generalitat Valenciana (Santiago Grisolía fellowship).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Metabolomic Biomarkers of Pulmonary Fibrosis in COVID-19 Patients One Year After Hospital Discharge

  • Botello-Marabotto, Marina Dolores
  • Tarraso, Julia
  • Mulet, Alba
  • Presa-Fernandez, Lucia
  • Fernandez-Fabrellas, Estrella
  • Rodriguez Portal, Jose A.
  • Ros, Jose A.
  • Lozano-Vicente, Desire
  • Signes-Costa, Jaime
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Coronavirus disease 2019 (COVID-19) global pandemic has affected more than 600 million people up to date. The symptomatology and severity of COVID-19 are very broad, and there are still concerns about the long-term sequelae that it can have on discharged patients. The development of pulmonary fibrotic sequelae after this infection is especially worrying. Our aim was to determine if there was a metabolomic signature that could predict the development of pulmonary fibrotic sequelae. It is a multicenter prospective observation subcohort based on the COVID-FIBROTIC study. A metabolomic analysis was performed by nuclear magnetic resonance (NMR) on serum samples from patients admitted with bilateral COVID-19 pneumonia collected 2 months after hospital discharge. One year after admission, clinical, functional and radiological data were collected from these same patients. Finally, 109 patients (mean age 57.68 [DS14.03], 65.13% male) were available. Fibrotic sequelae 1 year after COVID-19 disease were found in 33% of them. Based on the NMR analysis of the serum samples, it was possible to distinguish with 80.82% of sensitivity, 72.22% of specificity and 0.83 of an area under the curve (AUC) value which patients would have radiological signs of pulmonary fibrotic pattern 1 year after sample collection. According to the metabolites participating in the discriminative model and the univariate statistics, glucose, valine, and fatty acids (& boxH;CH-CH2-CH & boxH;) were suggested as potential biomarkers of the development of pulmonary fibrotic sequelae after COVID-19., This work was supported by project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe and Generalitat Valenciana (project CIPROM/2021/007) and CIBER (CB07/01/2012). There has also been the support of Institute of Health Carlos III (COV20/01209, Ministry of Science and Innovation of Spain) and grants from the Valencian Society of Pulmonology (FNCV Grant 2022 IP: Lucia Fernandez Presa; FNCV Grant Coordinated Research Project 2022 IP: Jaime Signes-Costa), U26 NMR: Biomedical Applications II platform from Nanbiosis (Research Infrastructures & Services of CIBER-BBN) and Marina Botello - Marabotto PhD grant (FPU 2020) from Spanish' government.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Nanostructured Supports for Detection of Pathogens and Biomolecules of Interest Based on Molecular Gates with Oligonucleotides

  • Aranda Sobrino, María de las Nieves
[ES] La tesis doctoral "Nanostructured supports for the detection of pathogens and biomolecules of interest based on molecular gates with oligonucleotides" se centra en el diseño de nanomateriales híbridos orgánico-inorgánicos como biosensores innovadores para la detección rápida y específica de patógenos como el virus del papiloma humano (VPH) y la bacteria Vibrio vulnificus, así como biomoléculas relevantes como miR-4732-3p, relacionado con la cardiotoxicidad en pacientes con cáncer. Los sensores desarrollados, basados en puertas moleculares en alúmina mesoporosa y validados con muestras clínicas, destacan por su alta sensibilidad, especificidad, rapidez y facilidad de uso, lo que los hace prometedores para aplicaciones en diagnóstico y monitoreo ambiental., [CA] The doctoral thesis "Nanostructured supports for the detection of pathogens and biomolecules of interest based on molecular gates with oligonucleotides" focuses on the design of organic-hybrid nanomaterialsInorganic as innovative biosensors for rapid and specific detection of pathogens such as human papillomavirus (HPV) and the bacterium Vibrio vulnificus, as well as relevant biomolecules such as miR-4732-3p, related to cardiotoxicity in cancer patients. The developed sensors, based on mesoporous alumina molecular gates and validated with clinical samples, stand out for their high sensitivity, specificity, speed and ease of use, which makes them promising for applications in diagnosis and environmental monitoring., [EN] La tesi doctoral "Nanostructured supports for the detection of pathogens and biomolecules of interest based on molecular gates with oligonucleotides" se centra en el disseny de nanomaterials híbrids orgànic-inorgànics com biosensors innovadors per a la detecció ràpida i específica de patògens com el virus del papil·loma humà (VPH) i el bacteri Vibrio vulnificus, així com biomolècules rellevants com miR-4732-3p, relacionat amb la cardiotoxicitat en pacients amb càncer. Els sensors desenrotllats, basats en portes moleculars en alúmina mesoporosa i validats amb mostres clíniques, destaquen per la seua alta sensibilitat, especificitat, rapidesa i facilitat d'ús, la qual cosa els fa prometedors per a aplicacions en diagnòstic i monitoratge ambiental., This research was supported by project PID2021-126304OB-C41 funded by MCIN/AEI and by European Regional Development Fund - A way of doing Europe. This work has received funding from the European Union’s Horizon 2020 Development of an Innovative Fluorogenic Biosensor for Direct Detection of Vibrio vulnificus, a Climate Change Biomarker research and innovation programme under grant agreement No 899708. This research was also supported by CIBER -Consorcio Centro de Investigación Biomédica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This study forms part of the Advanced Materials programme (MFA/2022/049) and was supported by MCIN with funding from European Union NextGeneration EU (PRTR-C17.I1) and by Generalitat Valenciana. The study was also supported by the grants PID2020-120619RB-I00 funded by MCIN/AEI and CIAICO/2021/293 funded by “Conselleria de Educación, Universidades y Empleo” (Generalitat Valenciana, Spain).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Strip-based lateral flow-type indicator displacement assay for gamma-hydroxybutyric acid (GHB) detection in beverages

  • Garrido-García, Eva María
  • Hernández-Sigüenza, Guillermo|||0000-0002-2075-3005
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Climent Terol, Estela
  • Rurack, Knut
  • Gaviña, Pablo
  • Parra, Margarita
[EN] The use of gamma-hydroxybutyric acid (GHB) in drug-facilitated sexual assault has increased due to its availability and high solubility in aqueous solutions and alcoholic beverages, necessitating the development of rapid methods for GHB detection. In this respect, portable testing methods for use in the field, based on lateral flow assays (LFAs) and capable of detecting trace concentrations of target analytes, are particularly attractive and hold enormous potential for the detection of illicit drugs. Using this strategy, here we report a rapid, low cost, easy-tohandle strip-based LFA for GHB analysis employing a smartphone for fluorescence readout. At molecular signalling level, the ensemble is based on a Cu2+ complex with a tetradentate ligand and the fluorescent dye coumarin 343, which indicate GHB through an indicator displacement assay (IDA) in aqueous solution. When incorporated in a LFA-based strip test this system shows a detection limit as low as 0.03 mu M for GHB in MES buffer solution and is able to detect GHB at concentrations of 0.1 mu M in soft drinks and alcoholic beverages in only 1 min., This research was funded by the Ministerio de Ciencia, Innovacion y Universidades (Spanish Government), the Agencia Estatal de Investigacion (AEI), the European Union (PID2021-126304OB-C41) (MCIU/AEI/FEDER, EU), the Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (PROMETEO CIPROM/2021/007) and the German Research Foundation (DFG; CL 761/1-19). This work was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. E. G. is grateful to the Spanish MEC for her FPU grant (FPU16/02464). G. H. thanks to Generalitat Valenciana for his pre-doctoral grant (ACIF/2021/204). V. M.-C. thanks the financial support from Generalitat Valenciana (CIDEGENT/2020/031).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Synthesis of a Pd2L4 Hydrazone Molecular Cage Through Multiple Reaction Pathways

  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
[EN] Molecular cages are preorganized molecules with a central cavity, typically formed through the reaction of their building blocks through chemical bonds. This requires, in most cases, forming and breaking reversible bonds during the cage formation reaction pathway for error correction to drive the reaction to the cage product. In this work, we focus on both Pd¿ligand and hydrazone bonds implemented in the structure of a Pd2L4 hydrazone molecular cage. As the cage contains two different types of reversible bonds, we envisaged a cage formation comparative study by performing the synthesis of the cage through three different reaction pathways involving the formation of Pd¿ ligand bonds, hydrazone bonds, or a combination of both. The three reaction pathways produce the cage with yields ranging from 73% to 79%. Despite the complexity of the reaction, the cage is formed in a high yield, even for the reaction pathway that involves the formation of 16 bonds. This research paves the way for more sophisticated cage designs through complex reaction pathways., V. M.-C. acknowledges the financial support from project CIDEGENT/2020/031 funded by the Generalitat Valenciana, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R. M.-M. acknowledges the financial support from project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033 and FEDER A way to make Europe.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Detection and Elimination of Senescent Cells with a Self-Assembled Senescence-Associated ß-Galactosidase-Activatable Nanophotosensitizer

  • Chu, Jacky C. H.
  • Xiong, Junlong
  • Wong, C.T.T.
  • Wang, S.
  • Tam, D.Y.
  • Ng, Dennis K. P.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Senescent cells have become an important therapeutic target for many age-related dysfunctions and diseases. We report herein a novel nanophotosensitizing system that is responsive to the senescence-associated ß-galactosidase (ß-gal) for selective detection and elimination of these cells. It involves a dimeric zinc(II) phthalocyanine linked to a ß-galactose unit via a self-immolative linker. This compound can self-assemble in aqueous media, forming stable nanoscale particles in which the phthalocyanine units are stacked and self-quenched for fluorescence emission and singlet oxygen production. Upon internalization into senescent HeLa cells, these nanoparticles interact with the overproduced senescence-associated ß-gal inside the cells to trigger the disassembly process through enzymatic cleavage of the glycosidic bonds, followed by self-immolation to release the photoactive monomeric phthalocyanine units. These senescent cells can then be lit up with fluorescence and eliminated through the photodynamic action upon light irradiation with a half-maximal inhibitory concentration of 0.06 ¿M., This work was supported by a General Research Fund from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 14307518). We also acknowledge financial support from Project PID2021- 126304OB-C41, funded by MCIN/AEI/10.13039/501100011033, by the European Regional Development Fund; A way of doing Europe, and Project CIPROM/2021/007, funded by Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of a novel near-infrared fluorescent probe based on nile blue for the detection of leucine aminopeptidase as a cancer biomarker.

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Azorín-Soriano, David
  • García-Fleitas, Jessie
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Soler-Beatty, Jennifer
  • Blandez, Juan F.
[EN] We report herein the design and synthesis of a near-infrared fluorescent probe (NB¿SO3-Leu) derived from the Nile Blue (NB) fluorophore scaffold, modified with sulfonic groups to improve solubility and biocompatibility. The mechanism of action of the NB-SO3-Leu probe was successfully validated in the presence of leucine aminopeptidase (LAP), a widely known cancer biomarker. The fluorescence signal of NB-SO3-Leu, which was initially low, increased 4-fold after incubation with the LAP enzyme after 15 min. In addition, the NB-SO3-Leu probe was validated in vitro in 4T1 (mouse mammary carcinoma cells), HeLa (human cervical cancer cells), and SK-Mel-103 (human melanoma cells) with high endogenous LAP levels. This work aims to advance in the development of a new generation of reliable and sensitive cancer detection methods., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/ 501100011033/and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). Thank the financial support from the FEDER found of European Union (IDIFEDER/2021/044). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. ¿ J. F. B. thanks to his postdoctoral fellowship APOSTD from Generalitat Valenciana (CIAPOS/2021/198).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In-depth study of factors affecting the formation of MCM-41-type mesoporous silica nanoparticles

  • Candela-Noguera, Vicente
  • Alfonso-Navarro, María
  • Amorós, Pedro
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mesoporous silica nanoparticles (MSN), especially MCM-41 type, have been broadly studied and used in different applications such as catalysis, nanomedicine and environmental science. One of the most advantageous properties of these materials is their easy and tunable synthesis. Nevertheless, in spite of the efforts made by researchers in the last decades, there is still no complete understanding of the mechanism and factors affecting the formation of MCM-41 type MSN, and some parameters are disregarded in the reported synthesis protocols. Considering that the fine-tuning of the parameters affecting nanoparticle synthesis is the basis for obtaining welldefined nanodevices with advanced complex functionalities, an in-depth study of the factors affecting the formation of MCM-41 type MSN is carried out in this work. We analyzed the first stages of MSN formation, namely the silica-surfactant templating and nanoparticle nucleation and growth, and found that hydrolysis and condensation rates play a central role in nanoparticle formation. Furthermore, we found that some disregarded parameters in the MCM-41 type synthesis, such as the stirring strength or the surfactant addition rate, modulate nucleation and growth, influencing the hydrolysis and condensation rates. Finally, we studied the aging and the evolution of the MSN by analyzing the consolidation of the silica framework over time. Therefore, we further elucidate some points about the mechanism and factors affecting the formation of mesoporous silica, which brings us closer to obtaining reproducible, homogeneous and tailored-made MCM-41 type MSN., Vicente Candela-Noguera thanks the Spanish Government for his fellowship (FPU15/02753) . This research was supported by projects PID2021-126304OB-C41, PID2021-126304OB-C43 and PID2021- 128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This study also forms part of the Advanced Materials programme (MFA/2022/049 and MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . The authors also thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Tear metabolomics for the diagnosis of primary open-angle glaucoma

  • Botello-Marabotto, Marina Dolores
  • Pinazo-Duran, M. Dolores
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Primary Open-Angle Glaucoma (POAG) is the most prevalent glaucoma type, and the leading cause of irreversible visual impairment and blindness worldwide. Identification of early POAG biomarkers is of enormous value, as there is not an effective treatment for the glaucomatous optic nerve degeneration (OND). In this pilot study, a metabolomic analysis, by using proton (1H) nuclear magnetic resonance (NMR) spectroscopy was conducted in tears, in order to determine the changes of specific metabolites in the initial glaucoma eyes and to discover potential diagnostic biomarkers. A classification model, based on the metabolomic fingerprint in tears was generated as a non-invasive tool to support the preclinical and clinical POAG diagnosis. 1H NMR spectra were acquired from 30 tear samples corresponding to the POAG group (n = 11) and the control group (n = 19). Data were analysed by multivariate statistics (partial least squares-discriminant analysis: PLS-DA) to determine a model capable of differentiating between groups. The whole data set was split into calibration (65%)/validation (35%), to test the performance and the ability for glaucoma discrimination. The calculated PLS-DA model showed an area under the curve (AUC) of 1, as well as a sensitivity of 100% and a specificity of 83.3% to distinguish POAG group versus control group tear data. This model included 11 metabolites, potential biomarkers of the disease. When comparing the study groups, a decrease in the tear concentration of phenylalanine, phenylacetate, leucine, n-acetylated compounds, formic acid, and uridine, was found in the POAG group. Moreover, an increase in the tear concentration of taurine, glycine, urea, glucose, and unsaturated fatty acids was observed in the POAG group. These results highlight the potential of tear metabolomics by 1H NMR spectroscopy as a non-invasive approach to support early POAG diagnosis and in order to prevent visual loss., This research was supported, in part by: 1) project PID2021- 126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe, 2) Generalitat Valenciana (CIPROM/2021/007), 3) Universitat Politecnica de Valencia and FISABIO through the POLISABIO Research Program (PI2022_02), 4) General Sub-Directorate of Networks and Cooperative Research Centers of the Carlos III Health Institute, Spanish Ministry of Economy, Industry and Competitiveness, and by the European Program FEDER, to the Spanish Research Network of Prevention, Early Detection, Treatment and Rehabilitation of Ophthalmic Pathology (OFTARED: RD16/0008/002), 5) Spanish Ministry of Science and Innovation program Cooperative Research Networks Oriented to Health Results (RIC-ORS), to the Spanish Research Net of Inflammation and immunopathology of organs and systems REI RICORS, of the Carlos III Health Institute (RD21/0002/0032) and the European Program FEDER Next Generation EU. 6) CIBER -Consorcio Centro de Investigacion Bio-medica en Red- (CB07/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. U26 NMR: Biomedical Applications II platform from Nanbiosis (Research Infrastructures & Services of CIBER- BBN) is also gratefully acknowledged. Finally, M. Botello Marabotto acknowledges Spanish Government for her PhD grant (FPU20/05279).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Caballos-Gómez, María Isabel
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Aranda-Sobrino, María Nieves
  • Calbuig, Eva
  • Gómez-Ruiz, María Dolores
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Climent Terol, Estela
[EN] We describe herein a sensor containing nanoporous anodic alumina (NAA) as sensing platform to identify SARSCOV-2 RNA using a gating mechanism. The system is based on NAA that contains a fluorescent dye (Rhodamine B; RhB) and is capped with an oligonucleotide sequence that hybridize specifically a region of SARS-CoV-2 genome. In the presence of RNA from SARS-COV-2 virus, the oligonucleotide of the surface is displaced, uncapping the pores, and producing a delivery of RhB. The detection of the virus is achieved measuring the fluorescence of the fluorophore. The nanosensor demonstrates to be highly sensitive and selective in aqueous buffers and in biological media, having a limit of detection (LOD) of 50 ± 30 copies mL-1 of SARS-CoV-2 RNA extracted from patients. Moreover, preliminary results using 18 real nasopharyngeal swab samples indicate the potential of the system to differentiate between infected and non-infected patients. Compared to the conventional RT-PCR method, in our system there is no need for sample pretreatment or RNA isolation, providing diagnostic outcomes within 60 mins while maintaining a high level of reliability, This study was sponsored by the Spanish Government (projects PID2021-126304OB-C41 (DOROTHY), PID2021-128141OB-C22 (ANTIVIBEM), and PID2021-122875OB-100 (MCUI/AEI/ FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/ 2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Polit`ecnica de Val`encia&#8722; Instituto de Investigacion ¿ Sanitaria La Fe (IISLaFe) (SARS-COV-2-SEEKER and VISION-COV projects). This research project has received funding from the European Union s HORIZON-CL4- 2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor th e granting authority can be held responsible for them. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Also, the project has received funding from the European Union s HORIZON-CL4-2022 research and innovation programme under grant agreement ID 101093042, PHOTONGATE project. A.L.P. thanks the Ministerio de Universidades for his predoctoral grant (FPU20/05297). E. C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086). Scheme 1 was done with BioRender.com. The Medicaments Research Ethics Committee, CEIm of University and Polytechnic La Fe Hospital of Valencia (2021-012-1) approved the use of samples from human patients.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

ß-Galactosidase-Triggered Photodynamic Elimination of Senescent Cells with a Boron Dipyrromethene-Based Photosensitizer

  • Chu, Jacky C. H.
  • Escriche-Navarro, Blanca
  • Xiong, Junlong
  • Ng, Dennis K. P.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Senescence is a cellular response having physiological and reparative functions to preserve tissue homeostasis and suppress tumor growth. However, the accumulation of senescent cells would cause deleterious effects that lead to age-related dysfunctions and cancer progression. Hence, selective detection and elimination of senescent cells are crucial yet remain a challenge. A beta-galactosidase (beta-gal)-activated boron dipyrromethene (BODIPY)-based photosensitizer (compound 1) is reported here that can selectively detect and eradicate senescent cells. It contains a galactose moiety connected to a pyridinium BODIPY via a self-immolative nitrophenylene linker, of which the photoactivity is effectively quenched. Upon interactions with the senescence-associated beta-gal, it undergoes enzymatic hydrolysis followed by self-immolation, leading to the release of an activated BODIPY moiety by which the fluorescence emission and singlet oxygen generation are restored. The ability of 1 to detect and eliminate senescent cells is demonstrated in vitro and in vivo, using SK-Mel-103 tumor-bearing mice treated with senescence-inducing therapy. The results demonstrate that 1 can be selectively activated in senescent cells to trigger a robust senolytic effect upon irradiation. This study breaks new ground in the design and application of new senolytic agents based on photodynamic therapy.; A tailor-made photosensitizer based on boron dipyrromethene conjugated with a galactose moiety through a self-immolative linker has been designed and synthesized. It exhibits a selective response toward the senescence-associated beta-galactosidase, rendering it an efficient theranostic behavior for detection and photodynamic elimination of senescent cells in vitro and in vivo. image, J.C.H.C., B.E.N., and J.X. contributed equally to this work. This work was supported by a General Research Fund from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. 14307518). The authors also acknowledge the financial support from Project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe and Project CIPROM/2021/007 funded by Generalitat Valenciana. Parts of the Table of Contents graphic and Figure 1A were created with BioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bi-Functional Topospecific Nanoparticles to Promote Immune-Tumor Cell Engagement as A New Immunotherapeutic Strategy

  • Ortuño-Bernal, Alba Amparo
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lucena-Sánchez, Elena
  • Pradana-López, Sandra
  • Jiménez-Alduán, Nelia
  • Diez-Sánchez, Paula
[EN] Cancer immunotherapy has emerged as a promising alternative approach, enabling the body's immune system to fight cancer. Cytotoxic T cells play a pivotal role in recognizing and eliminating tumor cells, and their effectiveness relies on establishing a physical interaction and efficient communication with cancer cells. However, this communication is often disrupted by immune escape mechanisms, allowing cancer progression. A versatile nanoplatform is developed to restore cellular connection using Janus mesoporous silica-Au nanoparticle (J-pHLIP-PD1), including specific binding sites on opposite faces for simultaneous binding to cancer cells and immune cells. The two differential surfaces on the nanoparticle allow orthogonal functionalization with the anti-PD-1 antibody that interacts with the PD-1 receptor in cytotoxic T cells on the gold face and the pH Low Insertion Peptide (pHLIP), which undergoes specific insertion into the tumor cell membrane on the silica face. J-pHLIP-PD1 nanoparticles effectively bind the surface of tumor cells and capture T cells, facilitating the formation of immune synapse-like structures that lead to reduced cancer cell viability in vitro, associated with immunogenic cell death signatures. The therapeutic potential of J-pHLIP-PD1 is also demonstrated in an in vivo metastatic melanoma model, where treatment with J-pHLIP-PD1 produces a significant decrease in metastatic burden and increases T cell presence. The Janus nanosystem represents an attractive platform that expands the toolbox of immune-engaging strategies, offering a flexible alternative to conventional immunotherapies that link immune and tumor cells, restoring cell-cell communication for cancer elimination., A. Ortuno-Bernal, S. Clara-Trujillo and E. Lucena-Sanchez have con-tributed equally to this work. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDI-SON). The authors thank the Spanish Government, project PID2021-126304OB-C41 by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund-A way of doing Europe. This studywas also supported by the Generalitat Valenciana (project PROMETEOCIPROM/2021/007). This study forms part of the Advanced Materials pro-gram (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was also supported by CIBER -Consorcio Centro deInvestigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.G-F. thanks the financial support from FC AECC (IDEAS246782GARC). E.L.-S is grateful for herFPU fellowship funded by MINECO (FPU18/06539). F.J.H thanks MIUfor his FPU grant (FPU20/06021). A.O.B acknowledges support from apredoctoral fellowship funded by the Generalitat Valenciana (GVA, Grant No.CIACIF/2023/320). Samples included in this study were provided bythe Biobanco La Fe (B.0000723) and they were processed following stan-dard operating procedures with the appropriate approval of the Ethics andScientific Committees. Graphical images and schemes were created withBioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted detection of Mycobacterium tuberculosis MPT64 antigen using an antibody-coated nanoporous anodic alumina biosensor: A novel approach for tuberculosis screening

  • Caballos, Isabel
  • Climent Terol, Estela
  • Gil-Brusola, Ana
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
[EN] Tuberculosis (TB) is a chronic condition caused by Mycobacterium tuberculosis. According to WHO's Global Tuberculosis Report 2024, TB has again become the leading cause of death from a single infectious agent, surpassing COVID-19 in 2023 and 2024 in terms of infectious disease deaths. Due to its high infectivity and serious effects, timely diagnosis and treatment are crucial for controlling its spread. This study presents a fluorogenic biosensor for detecting M. tuberculosis MPT64 antigen using gated nanoporous anodic alumina (NAA). NAA material is loaded with rhodamine B and capped with an antibody against MPT64 protein. The presence of MPT64 induces antibody displacement due to the specific recognition and subsequent release of rhodamine B to the medium that is detected by fluorescence measurement. The biosensor is physicochemically characterized by scanning electron microscopy and X-ray spectroscopy. The biosensor achieves a limit of detection (LOD) of 1.32 nM (0.032 mg L-1) for MPT64 protein and demonstrated high selectivity through testing against various antigens from other viral pathogens and bacterial species. The efficacy of the biosensor is further validated with grown mycobacteria from clinical samples. The developed approach offers three key aspects: (i) selective detection of active TB by targeting the secreted MPT64 protein using gated nanomaterials; (ii) a rapid response (60 min); and (iii) a cost-effective design suitable for resource-limited settings. This biosensor shows great potential as a tool for the clinical diagnosis of active tuberculosis., We thank PID2024-155683OB-C41 and PID2021-126304OB-C41 from the Ministerio de Ciencia, Innovacion y Universidades and AEI/10.13039/501100011033 (co-financed by the European Regional Development Fund) , and CIPROM/2021/007 (to R. M.-M.) from the Generalitat Valenciana. This research was also supported by CIBER, Instituto de Salud Carlos III (group CB07/01/2012) . I.-C. thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008) . We thank electron microscopy service of UPV for their support. R.M.M. thanks to the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. E. C. thanks the Instituto de Salud Carlos III for funding the proyects Miguel Servet 2023 CP23/00086 and PI24_01239, both co-funded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Gated Nanosensor for Sulphate-Reducing Bacteria Detection

  • López-Palacios, Alba|||0000-0002-4397-277X
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Moreno Trigos, Mª Yolanda|||0000-0003-3688-5157
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Ponz-Carcelén, Román
  • Pedro-Monzonís, María
[EN] Desulfovibrio vulgaris is an anaerobic microorganism belonging to the group of sulphate-reducing bacteria (SRB). SRB form biofilms on metal surfaces in water supply networks, producing a microbiologically influenced corrosion (MIC). This process produces the deterioration of metal surfaces, leading to high economic costs and different environmental safety and health problems related to its chemical treatment. For that reason, rapid and accurate detection methods of SRB are needed. In this work, a new detection system for Desulfovibrio has been developed using gated nanoporous materials. The probe is based on hybrid nanoporous alumina films encapsulating a fluorescent molecule (rhodamine B), whose release is controlled by an oligonucleotide gate. Upon exposure to Desulfovibrio's genomic material, a movement of the oligonucleotide gatekeeper happens, resulting in the selective delivery of the entrapped rhodamine B. The developed material shows high selectivity and sensitivity for detecting Desulfovibrio DNA in aqueous buffer and biological media. The implementation of this technology for the detection of Desulfovibrio as a tool for monitoring water supply networks is innovative and allows real-time in situ monitoring, making it possible to detect the growth of Desulfovibrio inside of pipes at an early stage and perform timely interventions to reverse it., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-A way of doing Europe. The work was also supported by Generalitat Valenciana (CIPROM/2021/007), Agencia Valenciana de la Innovacio (INNEST/2021/169, Universitat Politecnica de Valencia; INNEST/2021/174, Global Omnium) and is susceptible to be co-founded by European Union. This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.L. thanks to the Ministerio de Universidades for her predoctoral grant (FPU20/05297). A.M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bacteriophage-Gated Optical Sensor for Bacteria Detection

  • Aslan, Busra Canan
  • Ekiz, Esra
  • Tayyarcan, Emine Kubra
  • Boyaci, Ismail Hakki
  • Gumustas, Aysen
  • Yildirim, Ender
  • Tamer, Ugur
  • Evren, Ebru
  • Ahi, Elcin Ezgi
  • Caglayan, Mehmet Gokhan
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Bacterial infections significantly impact public health, and the growing threat of antimicrobial resistance underscores the urgent need for rapid and accessible diagnostic tools. This study presents a novel bacteriophage-gated sensor for the selective detection of Escherichia coli. The sensor utilizes sulforhodamine B as a fluorescent reporter dye encapsulated in mesoporous silica particles, with bacteriophages acting as gatekeepers. Upon interaction with E. coli, the bacteriophages detach from the silica surface, releasing the dye and producing a measurable fluorescence signal. The sensor demonstrated high sensitivity for E. coli detection, with a detection limit of 101 CFU/mL achieved within 5 min. Integrated into a Point-of-Care Testing device, the system aligns with ASSURED criteria, offering affordability, sensitivity, specificity, and ease of use. The fluorescence response is detectable even by the naked eye using a simple LED lamp, enabling nonprofessional operation. Validation with real water samples confirmed the sensor's accuracy, with results consistent with standard culture-based methods. This bacteriophage-gated sensor provides a low-cost, rapid, and reliable tool for bacterial detection with potential applications in environmental monitoring and clinical diagnostics., The Scientific and Technological Research Council of Turkiye (TUBITAK) is gratefully acknowledged for financial support (project number: 123Z557). The authors thank Cankaya University, Ankara, Turkey, for the manufacturing of the cartridge. We also thank project PID2021-126304OB-C41 from MCIN/AEI/10.13039/501100011033 and FEDER-A way of doing Europe, as well as CIPROM/2021/007 from Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Anthracene-Modified Nanoporous Silica Nanoparticles for ATP Detection and Salivary Diagnostics in Parkinson&apos, s Disease

  • Ahi, E.E.
  • Climent Terol, Estela
  • Beyret, Cansu
  • Caglayan, Mehmet Gokhan
  • Coban, Burak
  • Yilmaz, Rezzak
  • Durmus, Mahmut
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] ATP is an essential biological molecule, and abnormal levels are linked to various diseases. In this study, we developed an optical sensor array consisting of an anthracene-modified MCM-41 mesoporous nanoparticle-based hybrid organic-inorganic material to detect ATP in a TRIS-HCl buffer (pH 7). To create the sensor, we synthesized MCM-41 silica nanoparticles and functionalized them with aminoanthracene and imidazolium-anthracene groups. The fluorescence responses of the optical sensor array were recorded and analyzed by using a pattern recognition protocol, specifically linear discriminant analysis, to distinguish between ATP, ADP, AMP, and potential interferents. Quantitative regression analysis of ATP in TRIS-HCl was performed using artificial neural networks, which yielded an acceptable error rate of 7.8%. The sensor array was also evaluated for discrimination of Parkinson's disease (PD) from healthy controls, based on pattern recognition of ATP-related analytes in saliva samples from 24 patients with PD and 23 healthy controls. The results showed that the MCM-41 mesoporous silica nanoparticle-based sensor array can discriminate PD by pattern recognition with 73.7% sensitivity and 83.3% specificity., The diagnostic part of this study is supported by the Ankara University Scientific Research Projects Coordination Office (TSA-2023-2648 and TSA-2025-3825). V.M.-C. acknowledges financial support from the Project CIDEGENT/2020/031 funded by the Generalitat Valenciana, Project ESGENT/2024/ 001 funded by the Generalitat Valenciana, project PID2024- 157188OB-I00 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the European Union s Horizon EUROPE research and innovation program under grant agreement no. 101093042, project PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/ 501100011033 and FEDER A way to make Europe, and project PROMETEO CIPROM/2021/007 funded by Generalitat Valenciana. E.C. thanks the Instituto de Salud Carlos III for founding the projects Miguel Servet 2023 CP23/00086 and PI24_01239, both cofunded by the European Union.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines

  • Esteve-Sánchez, Yoel|||0000-0002-6845-1110
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aznar, Elena|||0000-0003-0361-3876
  • Tormo-Mas, M.A.
  • Peman, Javier
  • Eva Calbuig
  • Gomez, Maria Dolores
  • Climent Terol, Estela
[EN] Methods to detect naturally infected individuals, especially during or after a pandemic, are valuable in populations with a high rate of vaccination. Having in mind that after the COVID-19 pandemic people has been vaccinated against the virus by Spike protein (S)-based vaccines, we present in this paper a novel nanosensor based on gated nanoporous anodic alumina (NAA) material to detect naturally infected individuals in populations with high rates of vaccination. The nanosensor developed is based on a protein-capped nanomaterial for the identification of IgG antibodies that can detect nucleocapsid protein (N) of SARS-CoV-2. The NAA material has been loaded with an indicator (Rhodamine B (RhB)) and the pores of the material have been blocked with SARS-CoV-2 nucleocapsid protein (N) attached to a specific aptamer. In presence of antibodies against this antigen, the pores are uncapped, triggering the dye release and a fluorescent signal as a result. The biosensor has been tested in vitro and simulated serum for IgG detection, proving a detection limit of 1 mu g/mL. Moreover, specificity assays with N proteins from other coronaviruses have proved the robustness and efficacy of this nanosensor. Finally, the system has been tested on samples from patients that contained SARS-CoV-2 antibodies, demonstrating its potential for the discrimination of individuals that have been vaccinated or infected by SARS-CoV-2 virus., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2021-122875OB-100 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This work was also funded by the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007) , Santander and CRUE Supera COVID-19 Fund (DIACOVID project) , the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects) . R.M thanks to the European Union's Horizon EUROPE Research and Innovation Program (grant agreement No 101093042) . Y.E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Politecnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.r E.-S. acknowledges the Ministerio de Universidades for his predoctoral grant (FPU20/05297) . E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) . Scheme 1 done with BioRender.com . The use of clinical samples from patients was approved by the Drug Research Ethics Committee, CEIm of Hospital Universitari i Polite`cnic ` cnic La Fe of Valencia (2021-012-1) . In all cases was obtained an informed oral consent from all participants or next of kin prior to the research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Nanoparticle-Mediated Tumor Microenvironment Remodeling Favors the Communication with the Immune Cells for Tumor Killing

  • Lucena-Sánchez, Elena
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Melanoma is one of the most common types of skin cancer with a bad prognosis and limited treatment options in advanced stages. Immunotherapy has changed the landscape of oncology. Cancer cells can activate various mechanisms to suppress immune responses, such as the immunological checkpoint programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1), whose blockage reactivates immune killing of melanoma cells. Moreover, exposure to inhibitory cytokines such as transforming growth factor-beta (TGF-¿) induces T regulatory cell differentiation, which promotes cancer immunosuppression. These advances provided exciting outcomes in the clinical treatment of melanoma, however, there are still limitations, and a combination of several treatments is usually needed. Based on the above, inhibition of the TGF-¿ production and the PD-1/PD-L1 checkpoint may be a feasible strategy to increase T cell infiltration and cytotoxicity and thus overcome tumor immune escape. Here, mesoporous silica nanoparticles loaded with a PD-L1 inhibitor (JQ1, a thienotriazolodiazepine and a potent bromodomain family inhibitor) and capped with polyethyleneimine and a small interfering RNA targeting TGF-¿ are reported. An efficient PD-L1 downregulation and TGF-¿ silencing are achieved using the nanoparticles, along with the promotion of cancer death. This system demonstrates to be a specific and innovative therapeutic approach for the treatment of melanoma., The authors thank the Spanish Government (Project Nos. PID2021-126304OB-C41, (MCUI/FEDER, EU)) and the Generalitat Valenciana (Project No. PROMETEO CIPROM/2021/007). This work was also supported by the CIBER -Consorcio Centro de Investigación Biomédica en Red (Grant No. CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. E.L.-S. is grateful for her FPU fellowship funded by the MINECO (Grant No. FPU18/06539). F.J.H. thanks MIU for his FPU grant (Grant No. FPU20/06021). Graphical images and schemes were created with BioRender.com.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Overcoming Antifungal Resistance: A Histatin 5-Gated Nanodevice for On-Demand Surfactant Delivery against Infections

  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Sanz-Álvarez, Víctor|||0009-0004-7967-6552
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • de Boer, Leonie
  • Zaat, Sebastian A. J.
  • Diez-Sánchez, Paula
[EN] The escalating incidence of fungal infections, coupled with the emergence of antifungal resistance, represents a formidable global public health challenge. is a common opportunistic fungus that causes life-threatening, widespread candidiasis, especially in immunocompromised patients. Conventional antifungals, including azoles, echinocandins, and polyenes, have some drawbacks, such as host toxicity and the rapid appearance of resistant fungal strains. To overcome these limitations, we engineered a stimuli-responsive gated antimicrobial nanoparticle using mesoporous silica nanoparticles, functionalized with the antimicrobial peptide histatin 5 (Hst5) and loaded with the surfactant (3-(methyl)-1-tetradecylimidazolium) [C14MIM]+. The nanoparticles exhibit potent antimicrobial activity against , with minimum inhibitory concentration values comparable to current clinical antifungals. Crucially, the nanodevice exhibits a dual mechanism of action, causing membrane disruption and inducing reactive oxygen species generation, which effectively hinders the development of resistance. Furthermore, the nanoparticles display strong synergistic interactions with conventional antifungals, significantly enhancing their efficacy. In addition to its planktonic activity, the system effectively inhibits biofilm formation and demonstrates high biocompatibility with human dermal cell lines. Based on these results, the nanodevice is successfully incorporated into a wound dressing matrix, demonstrating its promising translational potential for the topical treatment of cutaneous candidiasis., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41, and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & centerdot;I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER, Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). F.J.H. thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Miguel Servet" (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

SBA-15 mesoporous particles with adsorbed cresol red dye and functionalized with 3-aminopropyl groups: Materials properties and dye release studies

  • vara Fabjan, E.
  • Cerc Koro ec, R.
  • ifrer, K.
  • Sever kapin, A.
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Research in the field of sensing has focused on tailoring the responsiveness of materials through the variation in materials properties achieved via functionalization of the mesoporous matrix. pH indicator dyes capable of protonation/deprotonation reactions are known to display different forms, resulting in changes in colour. This research focused on the preparation of mesoporous substrates SBA-15 with integrated pH indicator dye o-cresolsulphonephtalein (cresol red) grafted with (3-aminopropy)trimethoxysilane (gaining functionalized-SBA-15 material) in order to gain a colour change response following release of the dye. UV-Vis reflectance and absorbance spectra were used to evaluate forms of cresol red. The textural properties, including specific surface area, pore size distribution and pore volume were evaluated using nitrogen sorption, and XRD analysis was conducted to evaluate crystallinity of the material and pore ordering. The presence of 3-aminopropyl groups was determined by thermal decomposition using TGA¿DSC/MS. The functionalized SBA-15 materials loaded with cresol red mostly retained ordering of the pores and showed a slight reduction in surface area. Functionalization changed the surface properties of the material. In the non-functionalized SBA-15, cresol red was present in both double (H2L) and single (HL¿) protonated forms, whereas in the functionalized SBA-15 the deprotonated L2¿form prevailed. Through desorption experiments cresol red was successfully desorbed from selected sample to different media. The change of colour caused by alterations in the form of the dye once released from the mesoporous silica material into the medium was confirmed. The form of cresol red released was determined by the pH of the medium., We acknowledge the financial support from the Slovenian Research and Innovation Agency through core research Programmes No. P2 0273 and No. P1 0134. This research was also supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A renal clearable fluorogenic probe for in vivo ß-galactosidase activity detection during aging and senolysis

  • Rojas-Vázquez, Sara
  • Lozano-Torres, Beatriz
  • Galiana, Irene
  • Perez-Villalba, Ana
  • Martí-Rodrigo, Pablo
  • Palop, M. José
  • Domínguez, Marcia
  • Orzaez, Mar
  • Blandez, Juan F.
  • Fariñas, Isabel
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Accumulation of senescent cells with age leads to tissue dysfunction and related diseases. Their detection in vivo still constitutes a challenge in aging research. We describe the generation of a fluorogenic probe (sulfonic-Cy7Gal) based on a galactose derivative, to serve as substrate for beta-galactosidase, conjugated to a Cy7 fluorophore modified with sulfonic groups to enhance its ability to diffuse. When administered to male or female mice, beta-galactosidase cleaves the O-glycosidic bond, releasing the fluorophore that is ultimately excreted by the kidneys and can be measured in urine. The intensity of the recovered fluorophore reliably reflects an experimentally controlled load of cellular senescence and correlates with age-associated anxiety during aging and senolytic treatment. Interestingly, our findings with the probe indicate that the effects of senolysis are temporary if the treatment is discontinued. Our strategy may serve as a basis for developing fluorogenic platforms designed for easy longitudinal monitoring of enzymatic activities in biofluids. In vivo detection of cell senescence remains a challenge in aging research. This work introduces a novel fluorogenic probe for beta-Gal activity that is excreted in urine, providing a simple diagnosis method to estimate the systemic load of senescent cells during aging and senolytic interventions., We acknowledge the support of the Servicio Central de Soporte a la Investigacion Experimental of the Universitat de Valencia (SCSIE-UVEG). We are grateful to Biorender.com for the illustrations of mice used in the temporal scheme of the senolytic treatment in Figs. 5 and 6 (agreement number: IX264V4WHR). We thank Dr. D. Munoz-Espin for providing us with siRNAs for knock-down experiments and Dr. S. Gil for his assistance in NMR analysis. Work in the laboratory of R. M.-M was supported by grants from the Spanish Government (PID2021-126304OB-C41) and the Generalitat Valenciana (PROMETEO CIPROM/2021/007). Work in the laboratory of I.F. was supported by grants from the Spanish Government (PID2020-117937GB-I00, RED2018-102723-T, and CIBERNED CB06/05/ 0086) and Generalitat Valenciana (PROMETEO/2021/028). We also acknowledge the financial support from the Spanish Government (SAF2017-84689-R project MINECO/AEI/FEDER, UE) and the Generalitat Valenciana (project PROMETEO/2019/065) to M. O. A. P. V. was also founded by CITSAM (2021-283-001). S. R.-V. (FPU 16/03714) and B. L.-T. (FPU15/02707) were recipients of FPU predoctoral contracts from the Spanish Ministerio de Educacion; P. M-R. was the recipient of a predoctoral contract (LCF/BQ/DE18/11670015) from Fundacio la Caixa; J. F. B. was the recipient of a postdoctoral contract (PAID-10-17) of the Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Montoya-Méndez. Isabel |||0009-0003-7755-4853
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Due to the heterogeneity of the senescent phenotype and the lack of a universal biomarker of senescence, the targeting of senescent cells is still an unresolved challenge, and the elimination of senescent cells using specific drugs (senolytics) is still limited in clinical use due to the off-target effects and associated toxicities of current therapeutic strategies. In this study, the induction of senescence in human melanoma cells by palbociclib is found to lead to a senescent phenotype characterized by overexpression of the membrane protein dipeptidyl peptidase 4 (DPP4), previously identified only in ageing contexts. Based on this discovery, a nanoparticle targeting DPP4 overexpression in the senescent surfaceome is designed, synthesized, and characterized to target senescent cancer cells. The nanoparticle based on mesoporous silica is loaded with the senolytic navitoclax, coated with disulfide-containing poly(ethylene glycol) to generate a redox-sensitive gatekeeper (S-S-PEG), and functionalized with an antibody against the DPP4 protein. The ability of the nanoparticles to effectively detect and eliminate senescent cells was confirmed in vitro and in vivo using a mouse model of palbociclib-induced senescent in melanoma. The DPP4-targeted nanoparticle effectively reduces tumor growth and selectively removes senescent cells. Taken together, this study highlights the potential of surfaceome-targeted nanoparticles, as a clinically relevant strategy for improving senolytic therapies., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe and by the ERC Advanced Grant Edison (101052997) . This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was supported by CIBER (CB06/01/2012) , Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Human Papilloma Virus DNA Detection in Clinical Samples Using Fluorogenic Probes Based on Oligonucleotide Gated Nanoporous Anodic Alumina Films

  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aranda, M. Nieves
  • Tormo-Mas, María Ángeles
  • Peman, Javier
  • Prieto Rodríguez, Mireya
  • Picornell, Carlos
[EN] In this work, fluorogenic probes based on oligonucleotide capped nanoporous anodic alumina films are developed for specific and sensitive detection of human papilloma virus (HPV) DNA. The probe consists of anodic alumina nanoporous films loaded with the fluorophore rhodamine B (RhB) and capped with oligonucleotides bearing specific base sequences complementary to genetic material of different high-risk (hr) HPV types. Synthesis protocol is optimized for scale up production of sensors with high reproducibility. The sensors' surfaces are characterized by scanning electron microscopy (HR-FESEM) and atomic force microscopy (AFM) and their atomic composition is determined by energy dispersive X-ray spectroscopy (EDXS). Oligonucleotide molecules onto nanoporous films block the pores and avoid diffusion of RhB to the liquid phase. Pore opening is produced when specific DNA of HPV is present in the medium, resulting in RhB delivery, that is detected by fluorescence measurements. The sensing assay is optimized for reliable fluorescence signal reading. Nine different sensors are synthesized for specific detection of 14 different hr-HPV types in clinical samples with very high sensitivity (100%) and high selectivity (93-100%), allowing rapid screening of virus infections with very high negative predictive values (100%)., The authors gratefully acknowledge financial support projects for PID2021-126304OB-C41 and PDI2021-122875OB-100 funded by MCIN/AEI /10.13039/501100011033 / FEDER, UE, project DTS18/00090 from Instituto de Salud Carlos III and FEDER and Generalitat Valenciana (Project PROMETEO CIPROM/2021/007). This work was also supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. The authors thank UPV electron microscopy service for technical support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Aptamer-Capped Nanoporous Anodic Alumina for SARS-CoV-2 Spike Protein Detection

  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Aranda, María Nieves
  • Pla, Luis
  • Santiago Felipe, Sara
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Gómez-Ruiz, María Dolores
  • Calbuig, Eva
  • Sánchez-Sendra, Beatriz
  • Francés-Gómez, Clara
  • Geller, Ron
[EN] The COVID-19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS-CoV-2, the virus responsible for COVID-19, is crucial. Here, a biosensor based on oligonucleotide-gated nanomaterials for the specific detection of SARS-CoV-2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS-CoV-2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS-CoV-2 S-proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5 center dot 10(3) PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID-19., This study was supported by the Spanish Government (projects PID2021-126304OB-C41, and PID2021-122875OB-100 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Politecnica de Valencia-Instituto de Investigacion Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects), and by the European Commission -NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) to Ron Geller. The project leading to this application has received funding from the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. Isabel Caballos thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008). Alba Lopez-Palacios thanks the Ministerio de Universidades for her predoctoral grant (FPU20/05297). Ron Geller holds a Ramon y Cajal fellowship from the Spanish Ministerio de Economia y Competitividad (RYC-2015-17517). Figure 1 done with BioRender.com. The use of samples from human subjects was approved by the Medicaments Research Ethics Commmittee, CEIm of Hospital Universitari i Politecnic La Fe (no. 2021-012-1). Informed written consent was obtained from all participants or next of kin prior to the research.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Biosafety of mesoporous silica nanoparticles, towards clinical translation

  • Lérida-Viso, Araceli
  • Estepa-Fernández, Alejandra
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mesoporous silica nanoparticles (MSNs) have attracted the attention of chemists, who have developed numerous systems for the encapsulation of a plethora of molecules, allowing the use of mesoporous silica nanoparticles for biomedical applications. MSNs have been extensively studied for their use in nanomedicine, in applications such as drug delivery, diagnosis, and bioimaging, demonstrating significant in vivo efficacy in different preclinical models. Nevertheless, for the transition of MSNs into clinical trials, it is imperative to understand the characteristics that make MSNs effective and safe. The biosafety properties of MSNs in vivo are greatly influenced by their physicochemical characteristics such as particle shape, size, surface modification, and silica framework. In this review, we compile the most relevant and recent progress in the literature up to the present by analyzing the contributions on biodistribution, biodegradability, and clearance of MSNs. Furthermore, the ongoing clinical trials and the potential challenges related to the administration of silica materials for advanced therapeutics are discussed. This approach aims to provide a solid overview of the state-of-the-art in this field and to encourage the translation of MSNs to the clinic., This work was supported by project PID2021-126304OB-C41 funded by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe and the Generalitat Valenciana (PROMETEO CIPROM/2021/007). A.E-F. is grateful to the Spanish Government for her Ph.D. grant (FPU17/05454), A.L-V. is grateful to the Instituto de Salud Carlos III for her Ph.D. i-PFIS grant (IFI17/00039). V.M.-C acknowledges the financial support from Project CIDEGENT/2020/031 funded by Generalitat Valenciana and Project PID2020-113256RA-I00 funded by MCIN/AEI/10.13039/50110001 1033. The authors thank the use of BioRender.com for the design of the figures in the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Test Strips Based on Gated Nanoporous Anodic Alumina for the Rapid and Accurate Detection of Pseudomonas aeruginosa in Clinical Samples

  • Torres-Mesado, Andrea
  • Patricia Bernabé-Quispe
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Climent Terol, Estela
  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Pseudomonas aeruginosa is a high-priority pathogen responsible for up to 23% of infections in intensive care units, yet current diagnostic methods remain hindered by multiday delays or high technical complexity. In this study, we report a rapid and highly sensitive biosensor based on nanoporous anodic alumina (NAA) capped with a specific oligonucleotide molecular gate targeting the phzA2 gene. The S3 biosensor achieved a limit of detection (LOD) of 0.153 ng mu L-1 for genomic DNA and an exceptional 28 CFU mL(-1) for direct bacterial detection without the need for prior DNA extraction. Validation in 63 clinical urine samples demonstrated a sensitivity of 91.67% and a specificity of 94.87% (AUC: 0.961, p-value < 0.0001). Furthermore, the sensor was integrated into Lateral Flow Assay (LFA), enabling the discrimination of positive and negative clinical samples in only 1 min with 100% specificity and 90.9% sensitivity. These results, combined with a one-year stability at 4 degrees C, position this gated-nanodevice as a robust and low-cost tool for Point-of-care (POC) diagnosis of P. aeruginosa infections., This research was funded by projects PID2024-155683OB-C41, PID2021-126304OB-C41, PID2021-122875OB-I00, and TED2021-132114B-100, supported by MCIN/AEI/10.13039/501100011033, the European Regional Development Fund, the European Union (NextGenerationEU/PRTR), and the Generalitat Valenciana (CIPROM/2021/007). This study is part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from the European Union's NextGenerationEU (PRTR-C17. I1) and by the Generalitat Valenciana. The project was also funded by Ayuntamiento de Valencia (SPI2024-096) and Instituto de Salud Carlos III (PI24/01239), cofunded by the European Union. In the same way, A.T. would like to thank the INVESTIGO program of the Ministry of Innovation, Universities, Research, and Digital Society of the Valencian Community for offering this research opportunity (INVEST/2023/443). To conclude, A.T. is grateful to the Asociacion Espanola Contra el Cancer for her 2024 predoctoral fellowship (PRDVA246577TORR (2024-0590-1)), which enabled this research. E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086), cofounded by the European Union. The authors thank Electron Microscopy Service at UPV for support. Funding for open access charge: CRUE-Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Efficient removal of ofloxacin antibiotic from aqueous solution via CuCo-modified Al-MCM-41: an experimental and theoretical study

  • Farrokhnia, Maryam
  • Dianat, M. J.
  • Abdollahi, L.
  • Ghasemi, Atefeh
  • Karimi, S.
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] We explore herein the efficient removal of ofloxacin (OFL), a prevalent fluoroquinolone antibiotic, from aqueous solutions utilizing CuCo-modified Al-MCM-41 as an innovative adsorbent. Through a combination of experimental and theoretical methodologies, the adsorbents were characterized, and their performance in OFL adsorption was analyzed. Characterization techniques, including XRD, N2 adsorption-desorption, FTIR, SEM, and EDS, confirmed the successful incorporation of copper and cobalt into the mesoporous structure of Al-MCM-41, enhancing the material's adsorption capacity compared to monometallic systems. Adsorption studies revealed that the optimal Cu : Co ratio (7 : 3) achieved 90.77% removal efficiency at neutral pH. Kinetic modeling identified a two-stage process best described by a pseudo-second-order (PSO) model, while equilibrium data conformed to the Langmuir, Freundlich, and Temkin isotherm. Density functional theory (DFT) studies provided insights into the adsorption mechanism, revealing synergistic effects of Cu and Co on OFL interaction and electronic property modulation of the adsorbent. A removal efficiency of 588 mg g-1 for OFL demonstrated the strong feasibility of this adsorbent for wastewater treatments. This cost-effective, scalable adsorbent offers a sustainable solution for wastewater treatment, reducing antibiotic pollution, combating resistance, and supporting cleaner water resources-key goals in sustainable resource management., R. M. M. thanks the project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. R. M. M. also thanks the Generalitat Valenciana (project CIPROM/2021/007) for support. S. K. wishes to acknowledge the financial support of the Persian Gulf University Research Council in conducting the present study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

  • Garrido-Cano, Iris
  • Adam-Artigues, Anna
  • Lameirinhas, Ana
  • Blandez, Juan F.
  • Lluch, Ana
  • Bermejo, Begoña
  • Cejalvo, Juan Miguel
  • Eroles, Pilar
  • Candela-Noguera, Vicente
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Despite advancesin breast cancer treatment, it remainsthe leadingcause of cancer-related death in women worldwide. In this context,microRNAs have emerged as potential therapeutic targets but stillpresent some limitations for in vivo applications.Particularly, miR-200c-3p is a well-known tumor suppressor microRNAthat inhibits tumor progression and metastasis in breast cancer throughdownregulating ZEB1 and ZEB2. Basedon the above, we describe the design and validation of a nanodeviceusing mesoporous silica nanoparticles for miR-200c-3p delivery forbreast cancer treatment. We demonstrate the biocompatibility of thesynthesized nanodevices as well as their ability to escape from endosomes/lysosomesand inhibit tumorigenesis, invasion, migration, and proliferationof tumor cells in vitro. Moreover, tumor targetingand effective delivery of miR-200c-3p from the nanoparticles in vivo are confirmed in an orthotopic breast cancer mousemodel, and the therapeutic efficacy is also evidenced by a decreasein tumor size and lung metastasis, while showing no signs of toxicity.Overall, our results provide evidence that miR-200c-3p-loaded nanoparticlesare a potential strategy for breast cancer therapy and a safe andeffective system for tumor-targeted delivery of microRNAs., This research was supported by project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund A way of doing Europe. Also, this study forms part of the Advanced Materials program (MFA/2022/049) and was supported by MCIN with funding from European Union NextGeneration EU(PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was also supported by CIBER Consorcio Centro de Investigación Biomédica en Red CIBER-BBN(CB07/01/2012), CIBERONC(CB16/12/00481), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This work was also supported by Spanish Government and cofinanced by FEDER Funds (PI18/01219, PI21/01351) .I.G.-C. was funded by Margarita Salas post doctoral grant (European Union-Nextgeneration EU). A.A.-A. and A.L. were funded by Asociación Española Contra el Cancer.J.F.B. was funded by Instituto de Salud Carlos III and the European Social Fund for the financial support 'Sara Borrell' (CD19/00038). V.C.-N. was funded by Ministerio de Ciencia e Innovacio¿n (FPU grant), and J.M.C. was funded by Sociedad Española de Oncología Médica (Río Hortega-SEOM)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Pd2L4 Metal-Organic Cages with Perfluoroalkyl Edges: Ligand Design and Synthesis

  • Fiorini, Guillermo Luciano|||0000-0003-0992-9812
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Pairault, Noel
  • Vicent, Cristian
  • McClenaghan, Nathan
[EN] Molecular cages are versatile supramolecular architectures with applications in guest encapsulation, catalysis, and sensing. This study reports the first Pd2L4 cage where vertices are bridged by-(CF2)n-chains. Cage synthesis is achieved by the self-assembly of a ligand comprising a perfluorinated alkyl chain grafted with terminal pyridines and Pd(II). While the synthesis with a ligand comprising alpha,omega-monosubstituted pyridines partially produces the desired cage, the further design of two ligands with methoxy groups at the meta or para positions relative to the N-atom greatly enhances the coordination strength between the metal centre and the pyridine group. The para-substituted ligand quantitatively yields the most stable Pd2L4 cage. These findings highlight the influence of electronic effects on coordination-driven self-assembly and provide a pathway for designing robust and functional metal-organic cages containing perfluorinated edges. Additionally, we performed host-guest experiments that show a good affinity with environmentally concerning contaminant perfluorooctanoic acid. In summary, we developed Pd2L4 metal-organic cages with perfluoroalkyl edges that show good stability and promising host-guest properties., V.M.-C. acknowledges the financial support from projects ESGENT/2024/001 and CIDEGENT/2020/031 both funded by the Generalitat Valenciana, Project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/501100011033, and Project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033, and the European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the fi nancial support from Project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033/and European Regional Development Fund (FEDER) A Way to Make Europe. This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. G.F. is grateful to the Generalitat Valenciana for Subvenciones para la contratacion de personal investigador de caracter predoctoral (ACIF) grant (CIACIF/2022/112) . NMR spectra were registered at the U26 facility of Infraestructuras Cientificas y Tecnicas Singulares (ICTS) "Infraestructura Integrada de Produccion y Caracterizacion de Nanomateriales, Biomateriales y Sistemas en Biomedicina (NANBIOSIS)."
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Natural antimicrobials synergistically coupled with nanomotors: An innovative strategy for biofilm eradication

  • Medaglia, Serena|||0000-0003-3537-9842
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Reyes-Torres, Miguel|||0000-0003-4751-2698
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marin-Ferrandis, Lucia
  • Amorós, Pedro
  • Marcos, MD
  • Diez-Sánchez, Paula
[EN] Biofilms are one of the most important problems occurring in industrial environments, especially in food industry. The possibility of foodborne disease outbreaks as a result of biofilm-food cross-contamination is a distinct concern, along with the substantial costs associated with food spoilage and biofilm control. Besides, despite daily cleaning and disinfection, many bacteria grow in machines and surfaces in food processing plants, some of them forming biofilms. A promising procedure for disinfection and biofilm elimination could be the use of hybrid antimicrobial nanomaterials endowed with motion (i.e., nanomotors). Herein, we report Janus nanoparticles based on the conjunction of platinum and mesoporous silica nanoparticles, functionalized with a derivative of a natural antimicrobial compound, vanillin. The engineered nanomotors combine H2O2-triggered self-propulsion with the antimicrobial activity of vanillin, allowing enhanced physical penetration into the 3D matrix formed by the exopolymeric substances generated in monospecies (Staphylococcus aureus) and multispecies (S. aureus and Escherichia coli) biofilms and the subsequent elimination of pathogenic cells., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia Innovacion) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101,052,997, EDISON) . This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032) , supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17 & sdot;I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149) . A<acute accent>.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021) . M.R.-T. thanks MIU for his FPU grant (FPU21/03142) . A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020) . P.D.thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and "Miguel Servet" (CP24/00043) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Synergistic antimicrobial photodynamic therapy using gated mesoporous silica nanoparticles containing curcumin and polymyxin B

  • Medaglia, Serena|||0000-0003-3537-9842
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Aznar, Elena|||0000-0003-0361-3876
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Otri, Ismael
[EN] Photodynamic Therapy is a therapy based on combining a non-toxic compound, known as photosensitizer (PS), and irradiation with light of the appropriate wavelength to excite the PS molecule. The photon absorption by the PS leads to reactive oxygen species generation and a subsequent oxidative burst that causes cell damage and death. In this work, we report an antimicrobial nanodevice that uses the activity of curcumin (Cur) as a PS for antimicrobial Photodynamic Therapy (aPDT), based on mesoporous silica nanoparticles in which the action of the classical antibiotic PMB is synergistically combined with the aPDT properties of curcumin to combat bacteria. The synergistic effect of the designed gated device in combination with irradiation with blue LED light (470 nm) is evaluated against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus epidermidis. The results show that the nanodevice exhibits a noteworthy antibacterial activity against these microorganisms, a much more significant effect than free Cur and PMB at equivalent concentrations. Thus, 0.1 mu g/mL of MSNs-Cur-PMB eliminates a bacterial concentration of about 105 CFU/mL of E. coli, while 1 mu g/mL of MSNs-Cur-PMB is required for P. aeruginosa and S. epidermidis. In addition, antibiofilm activity against the selected bacteria was also tested. We found that 0.1 mg/mL of MSNs-Cur-PMB inhibited 99 % biofilm formation for E. coli, and 1 mg/mL of MSNs-CurPMB achieved 90 % and 100 % inhibition of biofilm formation for S. epidermidis and P. aeruginosa, respectively., This research was funded by the Spanish Government (projects PID2021-126304OB-C41 and PID2021-128141OB-C22, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion) and the Generalitat Valenciana, Spain (CIPROM/2021/ 007). This study forms part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from Eu ropean Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study forms part of the AGROALNEXT programme (AGROALNEXT/2022/032) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Gen eralitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolía fellowship (GRISOLIAP/2018/149). I.O. thanks Erasmus Mun dus Programme, Action 2, Lot 1, Syria, for his predoctoral fellowship. A. B. thanks the Ministerio de Universidades (Spanish Government) for her Beatriz Galindo contract (BG20/00020).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Glucose-Fueled Gated Nanomotors: Enhancing In Vivo Anticancer Efficacy via Deep Drug Penetration into Tumors

  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lucena-Sánchez, Elena
  • Pradana-López, Sandra
  • Sanz-Álvarez, Víctor
  • Garrido-Cano, Iris
  • Torres-Ruiz, Sandra
  • Cejalvo, Juan Miguel
  • Diez-Sánchez, Paula
[EN] Bioinspired nano/micromotors with drug delivery capabilities are emerging tools with the promising potential to treat numerous diseases. However, some major challenges must be overcome before reaching real biomedical applications. Above all, it is necessary to design engines that employ biocompatible and bioavailable fuels to induce efficient propulsion in biological environments. In addition, ideal nanomotors should also be capable of delivering the cargo on-command using selected stimuli. To tackle these challenges, we herein present the design and evaluation (both in vitro and in vivo) of a glucose-driven gated Janus nanomotor that performs on-demand anticancer drug delivery to treat solid tumors. The motor's nanoarchitectonics is based on the anisotropic conjunction of catalytic platinum nanodendrites (PtNds) and a mesoporous silica nanoparticle (acting as a nanocontainer for anticancer drug doxorubicin) capped with enzyme glucose oxidase (GOx). Autonomous nanomotor movement is achieved thanks to two catalytic components, GOx and PtNds, in a hybrid cascade reaction: GOx transforms glucose to give H2O2 that is subsequently catalyzed by PtNds into H2O and O2. Besides, gatekeeper moieties (GOx) respond to the presence of intracellular proteases, which induces doxorubicin delivery. Biological experiments with the nanomotor are carried out in cancer cell cultures, three-dimensional (3D) tumor models (spheroids), in vivo and in patient-derived organoids (PDOs). A strong anticancer effect is found and attributed to the synergistic combination glucose-induced propulsion, controlled drug delivery, elimination of glucose (by GOx), ROS production (H2O2 generation by GOx) and hypoxia reduction (O2 generated by PtNds). Taken together, this study advances the engineering of endogenously fueled nanomotors for in vivo operation and provides insights into the application of active particles in cancer therapy toward clinical application., The authors acknowledge the financial support from Project PROMETEO 2018/024 from the Generalitat Valenciana, Project RTI2018-100910-B-C41 and PID2021-126304OB-C41 funded by MCIN/AEI and FEDER, Project MFA/2022/049 from Advanced Materials program funding by European Union NextGenerationEU (PRTR-C17.I1) and the Generalitat Valenciana and the European Research Council (ERC) via Advanced Grant (101052997, EDISON). Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. A.E. thanks the Generalitat Valenciana for her PhD grant (ACIF/2018/110). F.J.H. thanks MIU for his FPU grant (FPU20/06021). E.L.-S. is also grateful for her FPU fellowship funded by MINECO (FPU18/06539). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support "Sara Borrell" (CD20/00120) and Scientific Foundation of the Spanish Association Against Cancer (AECC) for her postdoctoral grant (INVES246470DIEZ). S.P.-L. thanks Investigo program of the Spanish Government funded by NextGenerationEU from the European Union. V.S.-A. thanks MIU for his FPI grant (PRE2022-103714), J.J.E.-M. thanks the AECC Scientific Foundation for his PhD grant (PRDVA21651ESTE). I.G.-C. was funded by Margarita Salas postdoctoral grant (European Union-Next generation EU). J.M.C. was funded by Sociedad Espanola de Oncologia Medica (Juan Rodes-SEOM). The authors are especially thankful to the associations Amunt Contra el Cancer, La Venuseta, Corazon Solidario Contra el Cancer, Mou-te Per Elles, and Asociacion Las Triples. Scheme A and Figures A-i,B-i, A-i, A, A, and A were created with BioRender.com https://BioRender.com/xs7c89a
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Nanodevice-Mediated Immune Cell Recruitment: Targeting Senescent Cells via MMP-3-Responsive CXCL12-Coated Nanoparticles

  • Escriche-Navarro, Blanca
  • Labernadie, Anna
  • Garrido-García, Eva María
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Senescent cells are involved in age-related disorders in different organs and are therapeutic targets for fibrotic and chronic pathologies. Immune-modulating agents, able to enhance senescent cell detection and elimination by endogenous immune cells, have emerged as pharmacological strategies. We report herein a nanoparticle for immune cell-mediated senolytic therapy designed to recruit immune cells in response to specific enzymatic matrix metalloproteinase-3 (MMP-3) activity in the senescence-associated secretory phenotype. For this, mesoporous silica nanoparticles (MSNs) are coated with a peptide substrate of the metalloproteinase MMP-3, and the peptide is decorated with chemokine CXCL12 that enhances immune cell recruitment (NPs@CXCL12). Controlled release studies confirmed the progressive and specific release of CXCL12 in the presence of MMP-3. The ability of immune cell recruitment in response to a senescent microenvironment (senescent WI-38 fibroblasts) is confirmed by Transwell migration assays with green fluorescent Jurkat T-cells, showing NPs@CXCL12 has an enhanced chemotaxis effect toward senescent cells compared to free CXCL12 (2-fold). Moreover, the cytotoxic capacity of human primary natural killer (NK) cells over senescent WI-38 is also confirmed, and their migration trajectories in response to NPs@CXCL12 or free CXCL12 are monitored by using a microfluidic device. Results confirm the ability of NPs@CXCL12 to generate a chemotactic gradient able to attract NK cells. When compared with free CXCL12, the NPs@CXCL12 system showed a reduction of up to 15.56% in the population of NK cells migrating toward free CXCL12 under competitive conditions. This study demonstrates the potential of designing nanoparticles to recruit immune cells under specific responses to eliminate senescent cells. Results confirm that NPs@CXCL12 can effectively establish a chemotactic gradient to attract NK cells., This research was supported by projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by the European Regional Development FundyA way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012), Instituto de Salud Carlos III, and Ministerio de Ciencia e Innovacion. A.L. is grateful to the RYC2020/029736/I grant and PID2021-125212OA-I00 project funded by MCIN. B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project "IFI19/00026", cofunded by the European Union and the company Senolytic Therapeutics S.L. for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Finite Element Models of Gold Nanoparticles and Their Suspensions for Photothermal Effect Calculation

  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Ibáñez Civera, Francisco Javier|||0000-0002-1035-2662
  • Masot Peris, Rafael|||0000-0002-1114-649X
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] (1) Background: The ability of metal nanoparticles to carry other molecules and their electromagnetic interactions can be used for localized drug release or to heat malignant tissue, as in the case of photothermal treatments. Plasmonics can be used to calculate their absorption and electric field enhancement, which can be further used to predict the outcome of photothermal experiments. In this study, we model the nanoparticle geometry in a Finite Element Model calculus environment to calculate the effects that occur as a response to placing it in an optical, electromagnetic field, and also a model of the experimental procedure to measure the temperature rise while irradiating a suspension of nanoparticles. (2) Methods: Finite Element Method numerical models using the COMSOL interface for geometry and mesh generation and iterative solving discretized Maxwell's equations; (3) Results: Absorption and scattering cross-section spectrums were obtained for NanoRods and NanoStars, also varying their geometry as a parameter, along with electric field enhancement in their surroundings; temperature curves were calculated and measured as an outcome of the irradiation of different concentration suspensions; (4) Conclusions: The results obtained are comparable with the bibliography and experimental measurements., This research was funded by the Spanish State Research Agency project numbers RTI2018-100910-B-C43-AR, PID2021-126304OB-C44 and PID2021-126304OB-C41, Generalitat Valenciana project PROMETEO CIPROM/2021/007, Instituto de Salud Carlos III-CIBER-BBN: Safe N Medtech and Smart-4-Fabry Projects (European Union s H2020 Framework Programme (H2020/2014-2020), grant agreement 814607) and the Spanish Ministry of Science and Innovation with the predoctoral grants number FPU17/03800 and FPU17/03239 to J.M.T.-H. and J.M.T., respectively. Funding for open access charge: Universitat Politècnica de València.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Preserving Heritage Spaces by a Tea Tree Oil-Loaded Silica Microparticles System for Air Purification

  • Tassi, Anna Laura
  • Cebriá-Mendoza, María Concepción
  • Pinna, Daniela
  • Santiglia, Alessia
  • Santagostini, Laura
  • Guglielmi, Vittoria
  • Bosch-Roig, Pilar|||0000-0003-2019-399X
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Featured Application This research aims to develop a cost-effective and easy-to-use technology for improving indoor air quality through the reduction of fungal and bacterial contamination. While the primary objective of the project is the conservation of cultural heritage, the proposed tool also has broader applications as a passive air purification system for residential and occupational settings, contributing to healthier indoor environments by lowering harmful microbial loads.Abstract Airborne fungi and bacteria pose a severe challenge for conservators, as they can settle on artistic surfaces, leading to chemical, physical and aesthetic degradation of artworks. A new air-cleaning system has been developed to reduce indoor airborne microorganisms by leveraging the antimicrobial potential of Tea Tree (Melaleuca alternifolia) Essential Oil (TTEO) encapsulated within the pores of MCM-41 mesoporous silica microparticles (MCM-TTEO), thereby extending its antimicrobial activity and enhancing its efficacy. Experimental data showed a progressive release of TTEO from the MCM-TTEO system during the 5 weeks monitoring. The release rate was quite linear in the first week, reaching about 16.2%, before plateauing at approximately 30% in the next weeks. A comparison of the performances of the MCM-TTEO system with those of the non-encapsulated ('free') TTEO was performed using a comprehensive air quality monitoring approach, which tracked temperature, relative humidity, microbial loads and particulate matter. Results demonstrate that the MCM-TTEO system maintained higher biocidal activity over the 5-week study period than the free EO. Furthermore, the biocidal efficacy increased when the MCM-TTEO system was used in direct contact with microorganisms. These promising findings highlight the potential for exploring different combinations of the two components in both passive and active configurations, including the development of air filtration systems., Erasmus + Placement 2023/2024 Scholarship funded A.L.T. staying in Valencia and the Santos Juanes Project funds the lab fungible material. This research was funded by the Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2024-155683OB-C41 and PID2024-162542OB-I00), MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion and the Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Fluorogenic Biosensor for Direct Detection of Vibrio vulnificus, a Climate Change Biomarker

  • Aranda-Sobrino, María Nieves
  • Carmona-Salido, Héctor
  • Sanjuán, Eva
  • Amaro, Carmen
  • Caballos-Gómez, María Isabel
  • López-Palacios, Alba|||0000-0002-4397-277X
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
[EN] Vibrio vulnificus, a marine pathogen and climate change biomarker, poses serious risks to human and animal health through seafood consumption and seawater exposure. Rapid detection methods are urgently needed for both vibriosis diagnosis and surveillance in warming coastal waters. We report a fluorogenic biosensor based on nanoporous anodic alumina loaded with rhodamine B and capped with an oligonucleotide probe targeting a unique sequence of the vvhA cytolysin gene, specific to V. vulnificus. In the presence of the target DNA, the probe is displaced, pores open, and the fluorophore is released, generating a measurable signal. The biosensor exhibited high sensitivity and selectivity across diverse matrices, including fish mucus and serum, human serum, sterilized brackish water, and-critically-unprocessed natural lake and seawater samples, without DNA extraction or amplification. Detection limits ranged between 10 & sup2; and 5 & times; 10 & sup2; CFU mL(-)& sup1;, comparable in sensitivity to state-of-the-art qPCR assays. The biosensor outperformed conventional approaches in speed, simplicity, and cost-effectiveness, while maintaining accuracy. These findings underscore the potential of this platform for integrated One Health applications, bridging environmental monitoring with rapid diagnosis of vibriosis in humans and animals.Preliminary results from this study were previously made available as a preprint in SSRN (DOI: https://ssrn.com/abstract=5032822)., Ministerio de Ciencia, Innovación y Universidades (MICIU) and the Agencia Estatal de Investigación (AEI/10.13039/501100011033), with co&#8208; funding from the European Regional Development Fund (ERDF), European Union, Grant/Award Numbers: PID2020&#8208;120619RB&#8208;I00, PID2024&#8208;162627OB&#8208;I00, PID2021&#8208;126304OB&#8208;C41, PID2024&#8208;155683OB&#8208;C41; Generalitat Valenciana (Spain), Grant/Award Numbers: CIAICO/2021/293, CIAICO/2024/236; Spanish Ministry of Science and Innovation (MCIN) with funding from the European Union European Union NextGenerationEU (PRTR&#8208;C17.I1) and the Generalitat Valenciana (GVA&#8208;THINKINAZUL/2021/027; Principal Investigators: Carmen Amaro and B. Fouz, Universitat de València); Instituto de Salud Carlos III, Grant/Award Number: CIBER ConsorcioCentrodeInvestigaciónBiomédicaenRed(CB06/01/2012)
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Photothermic Release of Curcumin for Antimicrobial Photodynamic Therapy

  • Trigo-Gutierrez, Jeffersson K.
  • G. O. Mima, Ewerton
  • Medaglia, Serena|||0000-0003-3537-9842
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Drug delivery systems (DDS) are promising tools to enhance antimicrobial Photodynamic Therapy (aPDT) by improving the targeted delivery and controlled release of photosensitizers. In this study, we introduce a light-responsive DDS based on curcumin-loaded mesoporous silica nanoparticles featuring a gold nanostar core and paraffin capping, designed specifically for near-infrared (NIR)-triggered photothermal release. This multicomponent nanoplatform uniquely combines photothermal activation with light-controlled drug delivery for antimicrobial applications. The synthesized nanoparticles exhibited a mean diameter below 500 nm, a polydispersity index of 0.154, and a surface charge of ¿21.9 mV. Upon NIR irradiation at 1200 J/ cm2 , curcumin release was approximately 90%. In planktonic bacterial cultures, aPDT mediated by this system led to reductions of 3.16 log10 and 2.18 log10 in colony-forming units (CFUs) for Staphylococcus aureus and Pseudomonas aeruginosa, respectively. For bacterial biofilms, a higher curcumin concentration (1000 ¿g/mL) resulted in CFU reductions of 2.16 log10 and 1.77 log10 for S. aureus and P. aeruginosa, respectively. This study demonstrated a NIR-activated nanocarrier for the controlled release of curcumin and effective inactivation of both planktonic and biofilm-associated bacteria offering a new approach to improve the precision and efficacy of aPDT., J.K.T.-G. received a PhD sandwich scholarship from the Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES-PrInt-Unesp Program, process #88887.3636622/2019-00). E.G.O.M. was funded by SPRINT FAPESP 2019/08884-1, RIDC 13/07276-1, CNPq/INCT 14/50857-8. This research was also supported through projects PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund A Way of Doing Europe and by the Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Systematic study of the implications of calcination and solvent extraction of the surfactant in MCM-41-type mesoporous silica nanoparticles

  • Candela-Noguera, Vicente
  • Aznar, Elena|||0000-0003-0361-3876
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Amorós, Pedro
[EN] Mesoporous silica nanoparticles (MSN) have been growing in recent years in a broad range of applications, such as nanomedicine, catalysis, and gas storage. For the preparation of MSN, especially in nanomedicine applications, the extraction of the surfactant template, generally 1-hexadecyltrimethylammonium bromide (CTAB), is required. Several methods to remove the surfactant from MNS have been reported in the literature, such as calcination, solvent extraction, and dialysis. Depending on the method employed, the materials obtained have different properties; however, a systematic study that compares the use of different surfactant extraction methods and their implications in the final characteristics of the MSN has not been reported. Hence, the aim of this work is to study the effect of surfactant removal on MSN by calcination at different temperatures (400 degrees C, 450 degrees C, 500 degrees C and 550 degrees C) or by extraction with HCl/ethanol or NH 4 NO 3 /ethanol. The final materials are fully characterised by different techniques. The study performed shows the removal efficiency when the different methods are used, and their effect on silica condensation degree, mesoporosity, cytotoxicity, and degradation rate. The results allow for obtaining a deeper knowledge of the surfactant removal processes., V.C.-N. thanks the Spanish Government for his fellowship (FPU15/02753) . This research was supported by projects PID2021-126304OB-C41, PID2021-126304OB-C43 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-Away of doing Europe. This study also forms part of the Advanced Materials programme (MFA/2022/049 and MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB07/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. The authors also thank the Electron Microscopy Service at UPV and SCSIE at UV for support. NMR was registered at the U26 facility of ICTS "NANBIOSIS" at the Universitat of Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Covalent organic frameworks as nanocarriers of tailored BODIPY for phototheragnostic applications

  • Jimenez-Duro, Miguel
  • Soler-Beatty, Jennifer
  • Martinez-Fernandez, Marcos
  • Avellanal-Zaballa, Edurne
  • Martinez, Jose I.
  • Ortiz, Maria J.
  • Duran-Sampedro, Gonzalo
  • Banuelos, Jorge
  • Segura, Jose L.
  • Soriano-Teruel, Paula
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Grafting fluorophores and photosensitizers onto nanocarriers is recognized as an effective strategy for fluorescent bioimaging and photodynamic therapy. This approach enhances targeted drug delivery to tumor sites, while improving the biocompatibility and stability of poorly water-soluble bioprobes, thereby reducing side effects. Among the available organic dyes and nanoparticles, BODIPY and COF stand out as a compatible pair for this purpose. To leverage the COF-BODIPY scaffold as a photoactive platform for biomedical applications, we have optimized their integration. To this aim, first, BODIPY units were functionalized to enable strong binding to specific sites of the COF via click chemistry, positioning the BODIPY within the pores of the COF. Following this approach, BODIPY derivatives photoactive across different spectral regions (from the green to the red window) were straightforwardly grafted onto the COF. The structural and photophysical properties of these nanomaterials were thoroughly characterized. Notably, the COF bearing styrylated and iodinated BODIPY was especially appealing due to its dual photonic performance, enabling both singlet oxygen generation and red fluorescence under long-wavelength excitation. Upon its cellular uptake by human melanoma cells, this dyed nanoparticle selectively stained lysosomes, and at the same time triggered a cytotoxic response to induce cell death under illumination with red light, thus being a suitable candidate for theragnostic purposes., This research was supported by projects: TED2021-129886B-C43 granted by MCIN/AEI/10.13039/501100011033 and the European Union NextGeneration EU/PRTR; PID2021-128141OB-C22 and PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe; PID2022-138908NB-C33 and PID2024-157648-NB-C22 granted by MICIU/AEI/10.13039/501100011033 and FEDER, UE. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) and Gobierno Vasco (IT1639-22). The work was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. L. S. acknowledges the MICIIN for the REDES project "RED2022-134503-T". P. M. S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). J. I. M. acknowledges funding from Spanish MCIN (Grants PID2023-149077OB-C31, TED2021-12941A-I00 and PLEC2021-007906 funded by MCIN/AEI/10.13039/501100011033 and by the "European Union NextGenerationEU/PRTR"), and Comunidad de Madrid (Grant TEC-2024/TEC-459). The Severo Ochoa Centres of Excellence program through Grant CEX2024-001445-S is also acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In Situ-Forming Gels Loaded with Stimuli-Responsive Gated Mesoporous Silica Nanoparticles for Local Sustained Drug Delivery

  • De La Torre, Cristina
  • Coll, Carmen
  • Ultimo, Amelia
  • Ruiz-Hernández, Eduardo
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] A novel combination of in situ-forming hydrogels of hyaluronic acid with gated mesoporous materials was developed to design depots for local sustained release of chemotherapeutics. The depot consists of a hyaluronic-based gel loaded with redox-responsive mesoporous silica nanoparticles loaded with safranin O or doxorubicin and capped with polyethylene glycol chains containing a disulfide bond. The nanoparticles are able to deliver the payload in the presence of the reducing agent, glutathione (GSH), that promotes the cleavage of the disulfide bonds and the consequent pore opening and cargo delivery. Release studies and cellular assays demonstrated that the depot can successfully liberate the nanoparticles to the media and, subsequently, that the nanoparticles are internalized into the cells where the high concentration of GSH induces cargo delivery. When the nanoparticles were loaded with doxorubicin, a significant reduction in cell viability was observed. Our research opens the way to the development of new depots that enhance the local controlled release of chemotherapeutics by combining the tunable properties of hyaluronic gels with a wide range of gated materials., This research was funded by the Wellcome Trust Institutional Strategic Support Fund, the European Research Council under Grant Agreement No. 758887, and the European Union's Horizon 2020 research and Innovation program under Grant Agreement No. 952259 (NANOFACTS). We also thank the Spanish Government (projects PID2021-126304OB-C41 and PDI2021-122875OB-100) and the Generalitat Valenciana (project PROMETEO CIPROM/2021/007) for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Quorum sensing communication between lipid-based artificial cells

  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Buddingh, Bastiaan C.
  • van Hest, J.C.M.
  • Abdelmohsen, L.K.E.
[EN] Population behavior based on quorum sensing communication is a key property of living microorganisms. Here, we show quorum sensing behavior in an artificial cell population consisting of giant lipid vesicles loaded with sender-receiver machinery (enzymes and responsive biomolecules). Our system allows the examination of the collective output based on cell density, fuel concentration and proximity, which are important factors controlling natural quorum sensing behavior., The authors acknowledge funding from the Dutch Ministry ofEducation, Culture and Science(Gravitation program 024.001.035and Spinoza premium), ERC Advanced Grant Artisym (694120), ERCAdvanced Grant Edison (101052997); the Spanish Ministry ofScience and Innovation, AEI, and FEDER-EU (project PID2021-126304OB-C41), and the GVA (Project CIPROM/2021/007). A. L.-L.thanks the MSCA Cofund project oLife (847675), which has receivedfunding from the EU's Horizon 2020 research and innovationprogram; and the Spanish Ministry of Universities for his MariaZambrano fellowship funded by Next Generation EU from theEuropean Union. Dr W. Altenburg is thanked for supplying GFP.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Models of Chemical Communication for Micro/Nanoparticles

  • Ventura-Cobos, Jordi|||0000-0001-8475-9820
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Abdelmohsen, L.K.E.
  • van Hest, J.C.M.
[EN] Engineering chemical communication between micro/ nanosystems (via the exchange of chemical messengers) is receiving increasing attention from the scientific community. Although a number of micro- and nanodevices (e.g., drug carriers, sensors, and artificial cells) have been developed in the last decades, engineering communication at the micro/nanoscale is a recent emergent topic. In fact, most of the studies in this research area have been published within the last 10 years. Inspired by nature¿where information is exchanged by means of molecules¿the development of chemical communication strategies holds wide implications as it may provide breakthroughs in many areas including nanotechnology, artificial cell research, biomedicine, biotechnology, and ICT. Published examples rely on nanotechnology and synthetic biology for the creation of micro- and nanodevices that can communicate. Communication enables the construction of new complex systems capable of performing advanced coordinated tasks that go beyond those carried out by individual entities. In addition, the possibility to communicate between synthetic and living systems can further advance our understanding of biochemical processes and provide completely new tailored therapeutic and diagnostic strategies, ways to tune cellular behavior, and new biotechnological tools. In this Account, we summarize advances by our laboratories (and others) in the engineering of chemical communication of micro- and nanoparticles. This Account is structured to provide researchers from different fields with general strategies and common ground for the rational design of future communication networks at the micro/nanoscale. First, we cover the basis of and describe enabling technologies to engineer particles with communication capabilities. Next, we rationalize general models of chemical communication. These models vary from simple linear communication (transmission of information between two points) to more complex pathways such as interactive communication and multicomponent communication (involving several entities). Using illustrative experimental designs, we demonstrate the realization of these models which involve communication not only between engineered micro/ nanoparticles but also between particles and living systems. Finally, we discuss the current state of the topic and the future challenges to be addressed., The authors acknowledge funding from the Dutch Ministry of Education, Culture and Science (Gravitation program 024.005.020 and Spinoza premium), ERC Advanced Grant Artisym (694120), ERC Advanced Grant Edison (101052997); the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (project PID2021-126304OB-C41), and the GVA (Project CIPROM/2021/007). A.L.-L. thanks the Spanish Government for his Ramón y Cajal Fellowship (RYC2021-034728-I), funded by MCIN/AEI/10.13039/501100011033 and by the European Union &#8810;NextGenerationEU&#8811;/&#8810;PRTR&#8811;. A.L-L. also thanks the UPV for funding (Ayuda para potenciar la investigación postdoctoral de la UPV (PAID-PD-22), Ayuda a Primeros Proyectos de Investigación (PAID-06-22), Vicerrectorado de Investigación de la Universitat Politecnica &#768; de Valencia &#768; (UPV)).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Molecular Cages as Probes in Indicator Displacement Assays: The Case of Scopolamine Detection

  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Garrido-García, Eva María
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Climent Terol, Estela
  • Vicent, Cristian
[EN] A study of the Pd-based molecular cage C1 host-guest properties against fluorescein and the drug scopolamine is reported. C1 forms an interpenetrated structure C12 in the presence of >= 40% water in H2O/DMSO solvent mixtures. The presence of fluorescein (FL) induces the disassembly of the C12 structure to form the [FL2 subset of C1] complex. Moreover, the addition of scopolamine (SCOP, a drug typically involved in drug-facilitated sexual assaults) to [FL2 subset of C1] results in fluorescein release and the formation of [SCOP subset of C12], obtaining a fluorescence signal proportional to the concentration of scopolamine with a limit of detection as low as 59.4 mu g mL-1. A good selectivity for scopolamine against other drugs such as MDMA, cocaine, GBL, and ketamine is observed. This is the first scopolamine detection method described to date using a molecular cage and one of the very few examples of the use of cages in indicator displacement assays. Similar concepts could be applied to the design of other molecular cage-based sensors for the detection of target analytes., V.M.-C. acknowledges the financial support from projects ESGENT/2024/001 and CIDEGENT/2020/031, both funded by the Generalitat Valenciana, Project PID2024-157188OB-I00 funded by MICIU/AEI/10.13039/501100011033 y FEDER A way to make Europe, Project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/501100011033, and Project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.- M. acknowledges the financial support from Project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana, project PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/501100011033 y FEDER A way to make Europe, and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033/and FEDER A way to make Europe. This research was supported by CIBER Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. E.C. thanks the Instituto de Salud Carlos III (Miguel Servet 2023 CP23/00086) and E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant (UP2021-036). The authors would like to acknowledge the Rigel computing system of the Universitat Politecnica de Valencia for providing the computational resources necessary for this study. The authors thank the U26 facility of ICTS "NANBIOSIS" and the nuclear magnetic resonance facility of Fundacion de la Comunidad Valenciana Centro de Investigacion Principe Felipe (CIPF) for NMR experiments. The authors thank "Servei Central d'Instrumentacio Cientifica (SCIC)" at Universitat Jaume I for mass spectrometry measurements.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Targeted Delivery of the Pan-Inflammasome Inhibitor MM01 as an Alternative Approach to Acute Lung Injury Therapy

  • García-Fernández, Alba|||0000-0002-8416-1674
  • Garrido-García, Eva María
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Sancho, Mónica
  • Bisbal, Viviana
  • Orzáez, Mar
[EN] Acute lung injury (ALI) is a severe pulmonary disorder responsible for high percentage of mortality and morbidity in intensive care unit patients. Current treatments are ineffective, so the development of efficient and specific therapies is an unmet medical need. The activation of NLPR3 inflammasome during ALI produces the release of proinflammatory factors and pyroptosis, a proinflammatory form of cell death that contributes to lung damage spreading. Herein, it is demonstrated that modulating inflammasome activation through inhibition of ASC oligomerization by the recently described MM01 compound can be an alternative pharmacotherapy against ALI. Besides, the added efficacy of using a drug delivery nanosystem designed to target the inflamed lungs is determined. The MM01 drug is incorporated into mesoporous silica nanoparticles capped with a peptide (TNFR-MM01-MSNs) to target tumor necrosis factor receptor-1 (TNFR-1) to proinflammatory macrophages. The prepared nanoparticles can deliver the cargo in a controlled manner after the preferential uptake by proinflammatory macrophages and exhibit anti-inflammatory activity. Finally, the therapeutic effect of MM01 free or nanoparticulated to inhibit inflammatory response and lung injury is successfully demonstrated in lipopolysaccharide-mouse model of ALI. The results suggest the potential of pan-inflammasome inhibitors as candidates for ALI therapy and the use of nanoparticles for targeted lung delivery., This research was supported by Project Nos. PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2020-115048RB-I00 funded by MCIN/AEI/10.13039/501100011033 and by European Regional Development Fund - A way of doing Europe. The authors also thank Generalitat Valenciana (PROMETEO Project CIPROM/2021/007 and PROMETEO 2019/065) for support. E.G. is grateful to the Spanish MIU and European Union-Next Generation EU for her "Margarita Salas" postdoctoral grant (UP2021-036). The authors would also like to thank Animal Facilities from Centro de Investigacion Principe Felipe for its support in the animal research and procedures, and I. Borred and J. Forteza from Instituto Valenciano de Patologia for its technical support in the histopathology analysis. The authors thank for the use of Biorender.com in the figures and graphical abstract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Development of Rapid Detection Tests for SARS-CoV-2 and other Pathogens based on Materials with Molecular Gates

  • Caballos-Gómez, María Isabel
[ES] La presente tesis doctoral titulada "Development of rapid detection tests for SARS-CoV-2 and other pathogens based on materials with molecular gates" se centra en el desarrollo de materiales avanzados de detección, diseñados para la identificación rápida de patógenos como SARS-CoV-2, Xylella fastidiosa y Mycobacterium tuberculosis. Para lograr este objetivo general, la investigación se estructura en cuatro metas específicas, las cuales se desarrollan a lo largo de los capítulos de esta tesis. En el primer capítulo, se presenta el desarrollo de un sistema de detección basado en el soporte de alúmina anódica nanoporosa (NAA) combinado con puertas moleculares de ADN complementario para la detección del ADN genómico de Xylella fastidiosa. Este sistema aprovecha estas hebras como agente de bloqueo de los poros de la NAA, lo que permite una detección específica de este patógeno de gran relevancia en ecología y agricultura. En el segundo capítulo se explora la creación de un sistema basado en materiales de alúmina con anticuerpos como puertas moleculares para la detección de Mycobacterium tuberculosis, el patógeno responsable de la tuberculosis. Este dispositivo busca brindar una detección específica mediante la implementación de anticuerpos que actúan como agentes de bloqueo de los poros a la vez que elemento reconocedor en el sistema. El tercer capítulo, aborda el diseño, síntesis y evaluación de los sistemas de NAA funcionalizados con aptámeros para la detección temprana de SARS-CoV-2. El proyecto de investigación se enfoca en obtener una alta sensibilidad y selectividad para identificar el virus, dado su impacto en la salud pública y la importancia de su detección temprana para controlar la propagación del COVID-19. Por último, el cuarto capítulo se desarrolló un novedoso sistema de detección para material genético de SARS-CoV-2, combinando el sistema CRISPR-Cas con el soporte de NAA funcionalizado con ADN de cadena simple. Esta metodología integró la especificidad de CRISPR-Cas con la amplificación de señal de los materiales de NAA, logrando detectar secuencias de oligonucleótidos específicos con alta precisión. Todos los capítulos profundizan en la síntesis y caracterización de estos materiales con puertas moleculares, que se han diseñado para detectar biomoléculas de diferente naturaleza como pueden ser proteínas o secuencias específicas de ADN. Además, se estudian las dinámicas de liberación del indicador encapsulado en los poros en presencia de sus respectivos analitos e interferentes, lo cual es crucial para evaluar la eficiencia y viabilidad práctica de los materiales en aplicaciones reales. Los estudios demuestran cómo la interacción entre el analito y la puerta molecular desplaza a esta última dando lugar a la liberación controlada del colorante, funcionando como una señal medible que confirma la presencia del patógeno. Estos avances en el diseño de sistemas de detección con puertas moleculares representan un importante progreso en los campos de reconocimiento y diagnóstico, ofreciendo métodos rápidos, altamente sensibles, selectivos y adaptables a la detección de un amplio rango de patógenos de importancia en la actualidad., [CA] La present tesi doctoral titulada "Development of rapid detection tests for SARS-CoV-2 and other pathogens based on materials with molecular gates" se centra en el desenvolupament de materials avançats de detecció, dissenyats per a la identificació ràpida de patògens com SARS-CoV-2, Xylella fastidiosa i Mycobacterium tuberculosis. Per a assolir aquest objectiu general, la investigació s'estructura en quatre metes específiques, les quals es desenvolupen al llarg dels capítols d'aquesta tesi. En el primer capítol, es presenta el desenvolupament d'un sistema de detecció basat en el suport d'alúmina anòdica nanoporosa (NAA) combinat amb portes moleculars d'ADN complementari per a la detecció de l'ADN genòmic de Xylella fastidiosa. Aquest sistema aprofita aquestes cadenes com a agent de bloqueig dels porus de la NAA, la qual cosa permet una detecció específica d'aquest patogen de gran rellevància en ecologia i agricultura. En el segon capítol s'explora la creació d'un sistema basat en materials d'alúmina amb anticossos com a portes moleculars per a la detecció de Mycobacterium tuberculosis, el patogen responsable de la tuberculosi. Aquest dispositiu busca proporcionar una detecció específica mitjançant la implementació d'anticossos que actuen com a agents de bloqueig i reconeixement en el sistema. El tercer capítol aborda el disseny, síntesi i avaluació dels sistemes de NAA funcionalitzats amb aptàmers per a la detecció primerenca de SARS-CoV-2. El projecte de recerca se centra en obtindre una alta sensibilitat i selectivitat per a identificar el virus, donat el seu impacte en la salut pública i la importància de la seua detecció primerenca per a controlar la propagació de la COVID-19. Finalment, el quart capítol desenvolupa un innovador sistema de detecció per a material genètic de SARS-CoV-2, combinant el sistema CRISPR-Cas amb el suport de NAA funcionalitzat amb ADN de cadena simple. Aquesta metodologia integra l'especificitat de CRISPR-Cas amb l'amplificació de senyal dels materials de NAA, aconseguint detectar seqüències específiques d'oligonucleòtids amb alta precisió. Tots els capítols profunditzen en la síntesi i caracterització d'aquests materials amb portes moleculars, que s'han dissenyat per a detectar diferents tipus d'analits, des de cèl·lules i proteïnes fins a seqüències específiques d'ADN. A més, s'estudien les dinàmiques d'alliberament de l'indicador encapsulat en els porus en presència dels seus respectius analits, la qual cosa és crucial per a avaluar l'eficiència i viabilitat pràctica dels materials en aplicacions reals. Els estudis demostren com la interacció entre l'analit i la porta molecular desplaça aquesta última, donant lloc a l'alliberament controlat del colorant i funcionant com un senyal mesurable que confirma la presència del patogen. Aquests avanços en el disseny de sistemes de detecció amb portes moleculars representen un important progrés en els camps del reconeixement i diagnòstic, oferint mètodes ràpids, altament sensibles, selectius i adaptables per a la detecció d'un ampli rang de patògens d'importància actual., [EN] This doctoral thesis, titled "Development of rapid detection tests for SARS-CoV-2 and other pathogens based on materials with molecular gates," focuses on the development of advanced detection materials, designed for the rapid identification of pathogens such as SARS-CoV-2, Xylella fastidiosa, and Mycobacterium tuberculosis. To achieve this aim, the research is structured into four specific goals, which are developed throughout the chapters of this thesis. The first chapter presents the development of a detection system based on nanoporous anodic alumina (NAA) combined with complementary DNA molecular gates to detect the genomic DNA of Xylella fastidiosa. This system leverages these DNA strands as pore-blocking agents in the NAA, allowing a specific detection of this pathogen, which is highly relevant in ecology and agriculture. The second chapter explores the development of a system based on alumina materials with antibodies as molecular gates to recognize Mycobacterium tuberculosis, the pathogen responsible for tuberculosis. This device aims to provide specific detection by implementing antibodies that act as blocking and recognition agents in the system. The third chapter addresses the design, synthesis, and evaluation of NAA systems functionalized with aptamers for the early detection of SARS-CoV-2. This research project focuses on achieving high sensitivity and selectivity to identify the virus, given its impact on public health and the importance of early detection to control the spread of COVID-19. Finally, the fourth chapter develops an innovative detection system for SARS-CoV-2 genetic material, combining the CRISPR-Cas system with an NAA support functionalized with single-stranded DNA. This methodology integrates the specificity of CRISPR-Cas with the signal amplification of NAA materials, achieving highly precise detection of specific oligonucleotide sequences. All chapters explore the synthesis and characterization of these gated materials, designed to detect analytes from different nature, from proteins to specific DNA sequences. In addition, the dynamics of the encapsulated indicator release within the pores are studied in the presence of their respective analytes, which is crucial for evaluating the efficiency and practical feasibility of these materials in real-world applications. The studies demonstrate how the interaction between the analyte and the molecular gate displaces the latter, resulting in the controlled release of the dye, acting as a measurable signal that confirms the presence of the pathogen. These advances in the design of detection systems with molecular gates represent a significant step forward in the fields of recognition and diagnostics, offering rapid, highly sensitive, selective, and adaptable methods for detecting a wide range of pathogens of current importance., This research was supported by MCIN/AEI projects PID2021-126304OB-C41 and PID2020-113256RA-I00 funded by MCIN/AEI and by European Regional Development Fund - A way of doing Europe. Also, it is supported by project PDC2022-133576-C21 funded by MCIN/AEI and by European Union Next GenerationEU/ PRTR. Also, this study forms part of the Advanced Materials programme (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). The project leading to this application has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899708. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). The work was also supported by Agència Valenciana de la Innovació (INNVA2-2021-2) and is susceptible to be co-founded by European Union. Part of the equipment used to develop this work was supported by Generalitat Valenciana (IDIFEDER/2021/044) and is susceptible to be co-founded through the Operational Programme of the European Regional Development Fund. I.C. thanks to Instituto de Salud Carlos III her postdoctoral fellowship (IFI21/0008). BioRender.com was used for the elaboration of some of the figures. The authors want to thank the Electron Microscopy Service at the UPV for support. This research was supported by CIBER - Consorcio Centro de Investigación Biomédica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A navitoclax-loaded nanodevice targeting matrix metalloproteinase-3 for the selective elimination of senescent cells

  • Escriche-Navarro, Blanca
  • Garrido-García, Eva María
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence is implicated in the occurrence and progression of multiple age-related disorders. In this context, the selective elimination of senescent cells, senolysis, has emerged as an effective therapeu- tic strategy. However, the heterogeneous senescent phenotype hinders the discovery of a universal and robust senescence biomarker that limits the effective of senolytic with off-target toxic effects. Therefore, the development of more selective strategies represents a promising approach to increase the specificity of senolytic therapy. In this study, we have developed an innovative nanodevice for the selective elimi- nation of senescent cells (SCs) based on the specific enzymatic activity of the senescent secretome. The results revealed that when senescence is induced in proliferating WI-38 by ionizing radiation (IR), the cells secrete high levels of matrix metalloproteinase-3 (MMP-3). Based on this result, mesoporous silica nanoparticles (MSNs) were loaded with the senolytic navitoclax (Nav) and coated with a specific peptide which is substrate of MMP-3 (NPs(Nav)@MMP-3). Studies in cells confirmed the preferential release of cargo in IR-induced senescent cells compared to proliferating cells, depending on MMP-3 levels. More- over, treatment with NPs(Nav)@MMP-3 induced a selective decrease in the viability of SCs as well as a protective effect on non-proliferating cells. These results demonstrate the potential use of NPs to develop enhanced senolytic therapies based on specific enzymatic activity in the senescent microenvironment, with potential clinical relevance., This research was supported by projects PID2021-126304OBC41 and PID2021-128141OB-C22 funded by MCIN/ AEI /10.13039/501100011033/ and by European Regional Development Fund - A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER (CB06/01/2012), Instituto de Salud Carlos III and Ministerio de Ciencia e Innovación. This work was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). B.E-N. is grateful to the Instituto de Salud Carlos III (ISCIII) for the grant through the project IFI19/00026 , co-funded by the European Union and the company Senolytic Therapeutics S.L for the support. E.G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her Margarita Salas postdoctoral grant (UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

New advanced anti-tumor therapies based on hybrid mesoporous nanodevices

  • Lucena Sánchez, Elena
[ES] La presente tesis doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el diseño, síntesis, caracterización y evaluación de nuevos nanodispositivos híbridos orgánico-inorgánicos. En concreto, se han desarrollado nanopartículas de sílice mesoporosas (MSNs) y nanopartículas Janus combinando MSNs con platino y con oro con el objetivo de mejorar los tratamientos anti-tumorales. El primer capítulo es una introducción general que incluye una visión global del contexto en el que se enmarca la investigación realizada. En particular, se incluye información básica sobre los diferentes tipos de nanopartículas empleados en esta tesis doctoral, así como la descripción de la enfermedad del cáncer y la aplicación de los nanomateriales como terapia. A continuación, en el segundo capítulo, se presentan los objetivos generales y específicos de esta tesis doctoral. Los capítulos tercero y cuarto describen dos estrategias terapéuticas basadas en el desarrollo de nanopartículas con movimiento para mejorar la terapia antitumoral. Concretamente, en el primer capítulo experimental se presenta un nanodispositivo autopropulsado para la liberación controlada de fármacos en respuesta al glutatión (GSH) intracelular. Éste se basa en nanopartículas tipo Janus compuestas por sílice mesoporosa y oro, funcionalizadas en la parte del oro con la enzima catalasa, cargadas con doxorrubicina y con cadenas de oligo(etilenglicol) (S-S-PEG) unidas por puentes disulfuro en la cara de la sílice. Una vez sintetizado y caracterizado el dispositivo, se confirmó su movimiento y se demostró el funcionamiento de la puerta molecular. Finalmente, la internalización celular y la liberación de doxorrubicina se estudiaron en cultivos celulares. Motivados por los resultados anteriores, en el cuarto capítulo se describe un nuevo nanomotor diseñado como tratamiento antitumoral y similar al anterior. En este caso, la nanopartícula Janus desarrollada está compuesta por una nanopartícula de sílice mesoporosa junto con una de platino, cargada con doxorrubicina y cubierta con S-S-PEG. Al igual que en el trabajo anterior, se consigue la autopropulsión del dispositivo. Además, se obtuvo el perfil cinético de liberación del cargo en respuesta a estímulos y se confirmó su aplicación en cultivos celulares. Los capítulos cinco y seis se centran en una estrategia terapéutica nueva que consiste en potenciar la acción del sistema inmune sobre el tumor para conseguir su eliminación. En el primero de estos capítulos experimentales, se utilizaron nanopartículas MSNs cargadas con el fármaco JQ-1 y un siRNA frente al factor de crecimiento transformante ßeta (TGF-ß) como inmunoterapia. Una vez sintetizadas y caracterizadas, se confirmó la capacidad de estas nanopartículas para llevar a cabo la liberación de los cargos, junto con la disminución en la expresión de PD-L1 y en la producción de TGF-ß. Por último, se confirmó su aplicabilidad al ser capaces de inducir la eliminación de células de melanoma por el sistema inmune. De acuerdo con el último capítulo experimental, se describe un nuevo enfoque inmunoterapéutico basado en la comunicación química. En este caso, empleamos una nanopartícula Janus de oro y sílice funcionalizada con un péptido llamado pHLIP en la cara de sílice y el anticuerpo contra el receptor PD-1 unido a la cara de oro (J-pHLIP-PD1). La membrana de la célula tumoral es decorada por este nanodispositivo y gracias a la exposición del anticuerpo PD-1, se consiguió atrapar a los linfocitos T circulantes, desencadenando la eliminación de células tumorales por el sistema inmunitario. Además, estos resultados se confirmaron en un modelo metastásico B16-F10-Luc con una reducción de nódulos metastáticos. Finalmente, en el capítulo séptimo y octavo, se aborda la discusión general y las conclusiones derivadas de los estudios experimentales presentados en esta tesis doctoral., [CA] Aquesta tesi doctoral titulada "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" se centra en el disseny, síntesi, caracterització i avaluació de nous nanodispositius híbrids orgànic-inorgànics. En concret, s'han desenvolupat nanopartícules de sílice mesoporoses (MSNs) i nanopartícules Janus combinant MSNs amb platí i amb or per al tractament antitumoral. El primer capítol és una introducció general que inclou una visió global del context on s'emmarca la recerca realitzada. En particular, es presenta informació bàsica sobre les nanopartícules emprades en aquesta tesi doctoral, així com la descripció de la malaltia del càncer i l'aplicació dels nanomaterials com a teràpia. A continuació, al segon capítol, es presenten els objectius generals i específics d'aquesta tesi doctoral. Els capítols tercer i quart descriuen dues estratègies terapèutiques basades en el desenvolupmanet de nanopartícules amb moviment per aconseguir una millora de la terapia antitumoral. Concretament, al primer capítol experimental es presenta un nanodispositiu autopropulsat per a l'alliberament controlat de fàrmacs en resposta al glutatió (GSH) intracel·lular. Aquest es basa en nanopartícules tipus Janus compostes per sílice mesoporosa i or, funcionalitzades a la part de l'or amb l'enzim catalasa, carregades amb doxorrubicina i amb cadenes d'oligo(etilenglicol) (SS-PEG) unides per ponts disulfur a la cara de la sílice. Una vegada sintetitzat i caracteritzat el dispositiu, es va confirmar la seua capacitat de moviment i es va demostrar el funcionament correcte de la porta molecular. Finalment, la internalització cel·lular i l'alliberament de doxorrubicina es van estudiar en cultius cel·lulars. Motivats pels resultats anteriors, al quart capítol es descriu un nanomotor nou dissenyat com a tractament antitumoral i similar a l'anterior. En aquest cas, la nanopartícula Janus desenvolupada està composta per una nanopartícula de sílice mesoporosa juntament amb una de platí, carregada amb doxorrubicina i coberta amb S-S-PEG. Igual que en el treball anterior, s'aconsegueix autopropulsió del dispositiu. A més, es va obtenir el perfil cinètic d'alliberament del càrrec en resposta a estímuls i se'n va confirmar l'aplicació en cultius cel·lulars. Els capítols cinc i sis se centren en una estratègia terapèutica nova que consisteix a potenciar l'acció del sistema immune sobre el tumor per aconseguir-ne l'eliminació. Al primer d'aquests capítols experimentals, es van utilitzar nanopartícules MSNs carregades amb el fàrmac JQ-1 i un siRNA davant del factor de creixement transformant ßeta (TGF-ß) com a immunoteràpia. Un cop sintetitzades i caracteritzades, es va confirmar la capacitat d'aquestes nanopartícules per dur a terme l'alliberament dels càrrecs, juntament amb la disminució de l'expressió de PD-L1 i de la producció de TGF-ß. Finalment, se'n va confirmar l'aplicabilitat en ser capaços d'induir l'eliminació de cèl·lules de melanoma pel sistema immune. D'acord amb el darrer capítol experimental, es descriu un nou enfocament immunoterapèutic basat en la comunicació química. En aquest cas, fem servir una nanopartícula Janus d'or i sílice funcionalitzada amb un pèptid anomenat pHLIP a la cara de sílice i l'anticòs contra el receptor PD-1 unit a la cara d'or (J-pHLIP-PD1). La membrana de la cèl·lula tumoral és decorada per aquest nanodispositiu i gràcies a l'exposició de l'anticòs PD-1, es va aconseguir atrapar els limfòcits T circulants, desencadenant l'eliminació de cèl·lules tumorals pel sistema immunitari. A més, aquests resultats es van confirmar en un model metastàtic B16-F10-Luc amb una reducció de nòduls metastàtics. Finalment, al capítol setè i vuitè, s'aborda la discussió general i les conclusions derivades dels estudis experimentals presentats en aquesta tesi doctoral., [EN] The present PhD thesis entitled "New advanced anti-tumor therapies based on hybrid mesoporous nanodevices" focuses on the design, synthesis, characterization, and evaluation of new hybrid organic-inorganic nanodevices. We have developed mesoporous silica nanoparticles (MSNs) and Janus platinum-MSN and gold-MSN nanoparticles for tumor treatment. The first chapter is a general introduction that includes an overview of the context related to the research developed in this thesis. In particular, it includes basic information about different nanoparticles used in this doctoral thesis along with the description of cancer disease characteristics and the application of nanomaterials as therapy. Next, in the second chapter, the general and specific objectives of this Ph.D. thesis are presented. The third and fourth chapters describe two nanotechnology-based therapeutic strategies based on the development of nanomotors to improve cancer therapy. Specifically, the first experimental chapter presents a self-moving nanodevice for controlled drug release in response to intracellular glutathione (GSH). It is based on Janus gold-mesoporous silica nanoparticles functionalized with the enzyme catalase in the gold face, loaded with doxorubicin and capped with disulfide-linked oligo(ethylene glycol) (S-S-PEG) chains on the silica face. Once synthesized and characterized, the nanosystem motion was confirmed and the proper gating mechanism of the nanodevice was proven. Finally, the cellular uptake and doxorubicin release capacity have been demonstrated in cell cultures. Encouraged by the above results, chapter four describes a similar nanomotor design for antitumor therapy. In this case, the nanoparticle developed is composed of a Janus platinum-mesoporous silica nanoparticle, loaded with doxorubicin, and capped with S-S-PEG. As well as in the previous work, self-propulsion of the nanoparticles was achieved. Moreover, the stimuli-responsive cargo release kinetic profile was obtained and its application was confirmed in cell cultures. Chapters five and six focus on a new therapeutic strategy, empowering the immune system action on tumors to reach tumor cell death. In the first of these experimental chapters, JQ-1 and transforming growth factor-beta (TGF-ß) siRNA-loaded nanoparticles were used as efficient tumor immunotherapy. Once synthesized and characterized, the efficient cargo delivery was accomplished along with the programmed death-ligand 1 (PD-L1) downregulation and TGF-ß silencing. Lastly, its application was confirmed by triggering a specific immunogenic removal of tumor cells in melanoma cells. In chapter six, the development of a new communication-based immunotherapeutic approach is reported. In this case, we employ Janus gold-MSN functionalized with a peptide called pHLIP onto silica face and anti-PD-1 antibody bound to gold face (J-pHLIP-PD1). Tumor cell membrane is decorated by this nanodevice, leaving exposed on the surface PD-1 antibody which catches circulating T lymphocytes. It triggers immune system-induced-tumor leveling. Moreover, J-pHLIP-PD1 treatment-associated reduction of metastatic burden was also proven. Finally, in the seventh and eighth chapter, the general discussion and conclusions derived from the presented experimental studies of this Ph.D. thesis are exposed., The authors thank the Spanish Government (Projects MAT2015-64139-C4-1, AGL2015-70235-C2-2-R, CTQ2014-58989-P, CTQ2015-71936-REDT and CTQ2017-87954-P) and the Generalitat Valencia (PROMETEO/2018/024) for support. The Comunidad de Madrid (IND2017/BMD-7642) is also gratefully acknowledged. The authors thank the Spanish Government (project PID2021-126304OB-C41, (MCUI/FEDER, EU)) and the Generalitat Valenciana (project PROMETEO CIPROM/2021/007). E.L-S is grateful for her FPU fellowship funded by MINECO (FPU18/06539). This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). This study forms part of the Advanced Materials program (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. This work was supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON) and by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chitosan nanoparticles-encapsulated cannabis extracts and their antimicrobial potential against skin pathogens

  • Skala, Tomas
  • Frankova, Adela
  • Tauchen, Jan
  • Kahankova, Zdenka
  • Hubka, Vít
  • Kloucek, Pavel
  • Ventura-Cobos, Jordi|||0000-0001-8475-9820
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
[EN] Cannabis compounds are well-known for their therapeutic applications in the treatment of various health issues. These substances, mainly cannabinoids, are known for their antimicrobial properties and ability to interact with various cells through endocannabinoid receptors. However, the limitations of cannabis extract, particularly its viscosity, stickiness, and low bioavailability when applied topically, limit its use in dermatology. To enhance topical applications for treating bacterial infections and dermatophytosis, cannabis extracts were encapsulated in chitosan nanoparticles, an easily accessible and cost-effective. Cannabis extracts were prepared from three cannabis strains differing in content of major cannabinoids, namely Chocolope (THCA-A), Jonas 1 (CBDA), and Hemp G (CBGA), and subsequently were encapsulated in chitosan nanoparticles. The resulting particles were characterized, and antimicrobial and cytotoxic activity was evaluated. The mean size of particles ranged from 89.1 +/- 24.8 nm for empty nanoparticles to 355.6 +/- 101.6 nm for particles containing Hemp G extract. Considering the extract:chitosan ratio (1:10 w/w, 1:20 w/w respectively) and the encapsulation efficiency (EE) range from 44.65 +/- 4.39% to 94.44 +/- 0.93%, total amount of extracts encapsulated in chitosan nanoparticles ranged from 2.96 +/- 0.05 to 5.61 +/- 0.19% in 1 g of chitosan nanopowder. Most significant antimicrobial effect was observed against the fungi Nannizzia fulva CCF 6025, where the MIC80 of the pure extract from Jonas 1 variety was 256 mu g/mL while the encapsulated extract in chitosan nanoparticles (1:10 w/w extract:chitosan ratio) inhibited growth at a concentration of 256 mu g/mL of nanoparticles (corresponding to 13.05 +/- 0.13 mu g/mL of extract). Overall, encapsulation reduced the amount of extract required to inhibit the growth of pathogenic microorganisms by up to several times, notably in case of dermatophytes, compared to non-encapsulated extracts. Encapsulation also reduced the cytotoxic effects of the extracts on human keratinocytes. Furthermore, pure high-THCA-A extract and encapsulated extract in chitosan nanoparticles slightly increased cell viability after 72 h exposure in low concentrations compared to control. These results may suggest the chitosan nanoparticles-encapsulated formulations as a suitable topical delivery form of cannabis extracts, offering a possible adjunctive treatment of dermatophytosis and wound healing., The author(s) declare that financial support was received for the research and/or publication of this article. The work used facilities provided by the METROFOOD-CZ Research Infrastructure (https://metrofood.cz), supported by the Ministry of Education, Youth and Sports of the Czech Republic (Project No. LM2023064). This research was supported by SGS project No. SV23-18-21310 and TACR Sigma -DC2 TQ03000678. The authors would like to acknowledge the support from the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (projects PID2021-128141OB-C22 and PID2021-126304OB-C41). AM-A thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). AL-L thanks the Spanish Government for his "Ramon y Cajal" Fellowship (RYC2021-034728-I).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chemical characterization and encapsulation of &lt, i&gt, Ganoderma pfeifferi&lt, /i&gt, extract with cytotoxic properties

  • Stastny, Jan
  • Skala, Tomas
  • Marsik, P.
  • Lerida-Viso, Araceli
  • Matejka, Jaroslav
  • Mascellani Bergo, Anna
  • Marcos, María Dolores
  • Jablonsky, Ivan
  • Kloucek, Pavel
  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Mushrooms of the genus Ganoderma are known for diverse biological activities, demonstrated both traditionally and experimentally. Their secondary metabolites have shown cytotoxic potential across different cancer cell lines. Besides exploration of the most active components in different species or genotypes, new formulation techniques are in development. In recent years, there has been a growing interest in the use of nanomaterials because of significant potential for pharmacology applications as substance carriers. Applying nanoparticles may enhance the medicinal effect of the mushroom substances. This study investigated the cytotoxic properties of Ganoderma species methanolic extracts against the HeLa cancer cell line. Notably, the extract obtained from Ganoderma pfeifferi demonstrated the highest activity and was further used for encapsulation within synthesized mesoporous silica nanoparticles MCM-41. Subsequently, the cytotoxic effect of the loaded MCM-41 to the free form of extract was compared. The obtained results indicate successful encapsulation, and similar activity comparing encapsulated form to free extracts (IC50 16.6 mu g/mL and 20.5 mu g/mL, respectively). In addition, the four unique compounds were identified as applanoxidic acid A, applanoxidic acid G, ganoderone A, and ganoderone B in the G. pfeifferi. This study is an essential prerequisite for further steps like nanoparticle functionalization for sustained or on-command delivery of these natural extracts., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded by the National Agency for Agricultural Research of the Ministry of Agriculture of the Czech Republic under project number QK1910209; by the Research Infrastructure METROFOOD-CZ supported by the Ministry of Education, Youth, and Sports of the Czech Republic under project number LM2023064). This research was supported by projects PID 2021-126304OB-C41 and PID 2021- 128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund- A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. A.M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). AB. thanks the MCIN for her BG20/00020 contract.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Antimicrobial Surfaces: Stainless Steel Functionalized with the Essential Oil Component Vanillin

  • Medaglia, Serena|||0000-0003-3537-9842
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Villaescusa Alonso, Luis Angel|||0000-0002-2720-3217
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Morella-Aucejo, Angela
  • Ruiz Rico, María
  • Martínez-Manez, Ramón
[EN] Pathogenic microorganisms can adhere to solid surfaces, leading to the formation of biofilms, thus building a physical barrier hindering the penetration and diffusion of antimicrobial compounds. In this context, the use of natural antimicrobial compounds, such as essential oil components, as substitutes for common synthetic antimicrobials in the fight to prevent antimicrobial resistance is explored. As stainless steel is one of the most widely used surfaces in different industries, we have developed an innovative antimicrobial treatment for stainless steel surfaces based on a multi-step functionalization process, in which the stainless steel surface is coated with a silica layer to which a vanillin derivative is covalently attached. The surface was analyzed by microscopy studies, indicating the correct immobilization on the surfaces. Antimicrobial studies (viability and bacterial adhesion assays) were performed against the bacteria Staphylococcus epidermidis, which is one of the most frequent causes of nosocomial infections. The results of the microbiological studies showed that vanillin-functionalized stainless steel surfaces reduce the bacteria viability by 100% and the biofilm formation on the stainless steel surface by 75% compared with non-functionalized surfaces, highlighting the contact-killing and adhesion resistance properties of the developed surface. Additional cycles using the functionalized surfaces showed good maintenance of the antimicrobial coating efficacy. Moreover, the surfaces coated with an intermediate silica layer demonstrated much greater antimicrobial activity than surfaces in which the active molecule was directly functionalized on the stainless steel surface., This research was supported by the projects PID2021-126304OB-C41 and PID2021-128141OB-C22, funded by the MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund-A way of doing Europe. This study was also supported by the Generalitat Valenciana (CIPROM/2021/007). This research was supported by the CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. This study formed part of the Advanced Materials program (MFA/2022/053) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This study formed part of the AGROALNEXT program (AGROALNEXT/2022/032) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This study formed part of the THINKINAZUL program (THINKINAZUL/2021/004) and was supported by the MCIN, with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by the Generalitat Valenciana. This research was also supported by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 814607 (SAFE-N-MEDTECH project). S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149). & Aacute;.M.-A. thanks the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). A.B. thanks the MCIN for her BG20/00020 contract and her PAID-PD-22 project funded by the UPV.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

B-Galactosidase-Activatable Nile Blue-Based NIR Senoprobe for the Real-Time Detection of Cellular Senescence

  • Lozano-Torres, Beatriz
  • Blandez, Juan F.
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence is a stable cell cycle arrest in response to stress or other damage stimuli to maintain tissue homeostasis. However, the accumulation of senescent cells can lead to the progression of various senescence-related disorders. In this paper, we describe the development of a ß-galactosidase-activatable near-infrared (NIR) senoprobe, NBGal, for the detection of senescent cells based on the use of the FDA-approved Nile blue (NB) fluorophore. NBGal was validated in chemotherapeutic- induced senescence cancer models in vitro using SK-Mel 103 and 4T1 cell lines. In vivo monitoring of cellular senescence was evaluated in orthotopic triple-negative breast cancer-bearing mice treated with palbociclib to induce senescence. In all cases, NBGal exhibited a selective tracking of senescent cells mainly ascribed to the overexpressed ß-galactosidase enzyme responsible for hydrolyzing the NBGal probe generating the highly emissive NB fluorophore. In this way, NBGal has proven to be a qualitative, rapid, and minimally invasive probe that allows the direct detection of senescent cells in vivo., The authors acknowledge financial support from the Spanish Government (PID2021-126304OB-C41) and the Generalitat Valenciana (PROMETEO CIPROM/2021/007). This work was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. B.L.-T. is grateful to the Spanish Ministry of Economy for their Ph.D. grants (FPU15/02707). J.F.-B. thanks to his postdoctoral fellowship Sara Borrell from ISCIII (CD19/00038).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Copper-cobalt peroxide nanoparticles: a biomimetic cascade reaction for enhanced Fenton-like therapy at physiologically relevant pH

  • Farrokhnia, Maryam
  • Manoochehri, Hamed
  • Shirkani, Mina
  • Karimi, Sadegh
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Traditional Fenton-like reactions, commonly employed in chemodynamic therapy (CDT) for cancer treatment, face limitations due to the mildly acidic tumor microenvironment (TME) and scarce H2O2 availability. Aiming to overcome these hurdles, we report herein the preparation of copper-cobalt peroxide (CCp) nanoparticles, a novel catalyst that enables a pH-activated, self-supplying H2O2-mediated cascade reaction. In the slightly acidic TME (pH 6.5-7.0), CCp nanoparticles degrade, generating H2O2in situ. This intrinsic H2O2 production eliminates the need for external H2O2 sources and enables activation in a significantly higher pH range. Simultaneously, released Cu and Co ions, primarily in lower oxidation states, synergistically drive a catalytic loop for sustained hydroxyl radical ((OH)-O-center dot) production. The non-ferrous bimetallic approach exhibits exquisite pH sensitivity and self-sufficiency, surpassing traditional Fenton reactions. Comparative studies highlight CCp's superior performance against copper-based bimetallic peroxides containing Fe and Ce, confirming the synergistic power of Cu-Co pairing. In vitro experiments demonstrate that the synthesized CCp-NPs exhibit greater toxicity toward breast cancer cells (4T1) than towards non-cancerous cells, showcasing their therapeutic potential. Furthermore, CCp-NPs outperform other nanoparticles in inhibiting cancer cell proliferation, colony formation, and migration. Density Functional Theory (DFT) calculations suggest that Co doping enhances CCp's ability to participate in Fenton reactions. Overall, this work is pioneering in relation to the design of a new class of smart nanoparticles for CDT. The combination of self-generated H2O2, high pH activation, and synergistic metal effects in CCp opens the door for next-generation cancer theranostic nanoparticles with unprecedented efficiency and precision, minimizing side effects., RMM thanks the project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/ and by the European Regional Development Fund - A way of doing Europe. RMM also thanks the Generalitat Valenciana (CIPROM/2021/007) for support. HM and MF would like to thank the Deputy of Research and Technology of Bushehr University of Medical Sciences, Iran, for supporting this research project. SK wishes to acknowledge the financial support of the Persian Gulf University Research Council in conducting the present study.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Remarkable enhancement of cinnamaldehyde antimicrobial activity encapsulated in capped mesoporous nanoparticles: A new &quot, nanokiller&quot, approach in the era of antimicrobial resistance

  • Morella-Aucejo, Ángela|||0000-0002-6357-949X
  • Medaglia, Serena|||0000-0003-3537-9842
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Ruiz Rico, María
[EN] Combating antimicrobial resistance is one of the biggest health challenges because of the ineffectiveness of standard biocide treatments. This challenge could be approached using natural products, which have demonstrated powerful therapeutics against multidrug-resistant microbes. In the present work, a nanodevice consisting of mesoporous silica nanoparticles loaded with an essential oil component (cinnamaldehyde) and functionalized with the polypeptide epsilon-poly- L -lysine is developed and used as an antimicrobial agent. In the presence of the corresponding stimuli (i.e., exogenous proteolytic enzymes from bacteria or fungi), the polypeptide is hydrolyzed, and the cinnamaldehyde delivery is enhanced. The nanodevice's release mechanism and efficacy are evaluated in vitro against the pathogenic microorganisms Escherichia coli , Staphylococcus aureus , and Candida albicans . The results demonstrate that the new device increases the delivery of the cinnamaldehyde via a biocontrolled uncapping mechanism triggered by proteolytic enzymes. Moreover, the nanodevice notably improves the antimicrobial efficacy of cinnamaldehyde when compared to the free compound, ca. 52-fold for E. coli , ca. 60fold for S. aureus , and ca. 7-fold for C. albicans . The enhancement of the antimicrobial activity of the essential oil component is attributed to the decrease of its volatility due to its encapsulation in the porous silica matrix and the increase of its local concentration when released due to the presence of microorganisms., This research was supported by projects PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012) , Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. This work was also funded by the Generalitat Valenciana and Agencia Valenciana de la Innovacion (MCIN) (INNEST/2021/169 project) and is susceptible to be co-founded by the European Union. <acute accent> A. M.-A. thanks to the Universitat Politecnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22) . A.B. thanks the MCIN for her BG20/00020 contract and her PAID-PD-22 project funded by UPV.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A NIR fluorescent probe for the detection of renal damage based on overrepresentation of alanine aminopeptidase enzyme

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Meyer, Kathleen
  • Blandez, Juan F.
  • Serrano, Manuel
[EN] Kidney damage generates changes at the phenotypic and genotypic levels that allow its monitoring using different biomarkers in blood, urine or serum. Among these biomarkers, kidney failure causes the urine overrepresentation of the alanine aminopeptidase (APN) enzyme. Here, we describe the design of a molecular probe (NB-ALA) based on the Nile Blue fluorophore (NB), which can detect the APN enzyme in urine by simple fluorometric measurements., The authors thank the Spanish Government (PID2021-126304OB-C41) and the Generalitat Valenciana (PROMETEO CIPROM/2021/007) for support and acknowledge the financial support from the FEDER fund of the European Union (IDIFE-DER/2021/044). This work was also supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. M. D.-R. is grateful for his predoctoral fellowship Grisolias to the Genelalitat Valenciana (GRISOLIAP/2019/144). J. F. B. is thankful for his postdoctoral fellowship Sara Borrell from ISCIII (CD19/00038).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Smartphone-assisted lateral flow nanosensor for the selective detection of GHB in urine

  • Garrido-García, Eva María
  • Hernández-Sigüenza, Guillermo|||0000-0002-2075-3005
  • Mollá-Guerola, Lara|||0009-0009-2387-9816
  • López-Lima, Rocío|||0009-0007-8121-8085
  • Ortiz-Gómez, Eduardo|||0009-0005-5778-9158
  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Climent Terol, Estela
  • Gaviña, Pablo
[EN] We report a rapid test strip based on mesoporous silica nanoparticles functionalized with a specific GABA(B) receptor agonist to selectively detect gamma-hydroxybutyric acid (GHB) in urine samples. The sensing mechanism involves rhodamine B-loaded MCM-41 silica nanoparticles whose pores are capped with a GABA-derived ligand (baclofen) acting as a gatekeeper via supramolecular interactions with the GABA(B) receptor protein. In the presence of GHB, competitive binding produces GABA(B) receptor protein displacement, leading to pore opening and fluorophore release, which is detected via fluorescence readout. The nanosensor demonstrated high sensitivity, with a limit of detection (LOD) of 168 mu M in buffer solution and 41 mu M in diluted urine. Selectivity assays showed highly specific sensor response over common drugs such as cocaine, morphine, MDMA, heroin, scopolamine, 1,4-butenediol (1,4-BD), gamma-aminobutyric acid (GABA), and gamma-butyrolactone (GBL). The sensing material was also incorporated into a lateral flow assay (LFA) platform with a smartphone-assisted fluorescence readout, providing a rapid, portable, and low-cost analysis of GHB. The resulting test strip exhibited high sensitivity, with a LOD of 0.28 mu M in diluted urine, which is low enough to clearly distinguish between physiological endogenous GHB levels (similar to 96 mu M) and exogenous intake within only 1 min, a crucial requirement in forensic and clinical toxicology. This portable, cost-effective method holds strong potential for on-site forensic and clinical GHB screening., This work was financially supported by the Universitat Politecnica de Valencia (PAID-06-23) and by the Spanish Ministry of Science and Innovation through projects PID2021-126304OB-C41 and PID2024-155683OB-C41 (MICIU/AEI/10.13039/501100011033), co-funded by the European Regional Development Fund (FEDER, "A Way of Making Europe"). This study also forms part of the Advanced Materials Program (MFA/2022/053) and was supported by MCIN with funding from the European Union-Next Generation EU (PRTR-C17.I1) and by Generalitat Valenciana. This study was also supported by Generalitat Valenciana (CIPROM/2021/007). E. G. is grateful to the Spanish MIU and European Union-Next Regeneration EU for her "Margarita Salas" postdoctoral grant(UP2021-036).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Requirements of Constrictive Binding and Dynamic Systems on Molecular Cages for Drug Delivery

  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
[EN] Molecular cages have promising host¿guest properties for drug delivery applications. Specifically, guest¿cage complexes can be used for the on-command release of encapsulated guest molecules in response to specific stimuli. This research explores both the dynamic and constrictive binding guest¿cage systems for drug encapsulation and release in biological environments. In dynamic systems, the guest rapidly passes in-and-out through the portals of the cage, enabling drug delivery in vitro but facing limitations in vivo due to dilution effects that result in guest release. These challenges are addressed by constrictive binding systems, where the guest is trapped in a ¿gate-closed¿ state within the cage. In these systems, the on-command release is triggered by a ¿gate opening¿ event, which lowers the guest¿out energy barrier. A full guest release is achieved when the gate opening reduces the cage¿guest affinity, making constrictive binding systems more effective for controlled drug delivery. As a result, this study shows that guest¿cage complexes have suitable properties for drug delivery in biological contexts., V.M.-C. acknowledges the financial support from project CIDEGENT/2020/031 funded by the Generalitat Valenciana, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033, and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the financial support from project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033 and FEDER A way to make Europe.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fibroblast Activation Protein Alpha-Targeted Nanoparticles for Tumor Microenvironment Remodeling and Antitumor Therapy in Triple-Negative Breast Cancer

  • Lameirinhas, Ana
  • Diez-Sánchez, Paula
  • Ágreda-Roca, Anna
  • Torres-Ruiz, Sandra
  • Sánchez-Serrano, Paloma
  • Tapia, Marta
  • Lluch, Ana
  • Bermejo, Begoña
  • Cejalvo, Juan Miguel
  • Eroles, Pilar
  • Garrido-Cano, Iris
  • Hicke-García, Francisco Javier|||0000-0002-8419-0467
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Triple-negative breast cancer (TNBC) remains a highly aggressive subtype with limited treatment options and poor prognosis. While most therapies target tumor cells, the tumor microenvironment (TME), particularly cancer-associated fibroblasts (CAFs), plays a key role in tumor progression, therapy resistance, and immune suppression.We developed NP-FAP-DOX, a mesoporous silica nanoparticle-based nanodevice loaded with doxorubicin and functionalized with a fibroblast activation protein alpha (FAP-alpha) ligand peptide for selective binding to FAP-alpha-positive CAFs. FAP-alpha targeting ability and cytotoxic effect were assessed in TNBC cells, patient-derived CAFs, and patient-derived organoids (PDOs). In vivo efficacy was evaluated in the murine orthotopic TNBC 4T1 allograft model, assessing tumor growth inhibition, toxicity, CAFs depletion, extracellular matrix degradation, apoptosis induction, and TME-associated cellular and stromal changes. NP-FAP-DOX exhibited controlled drug release, selective binding to FAP-alpha, and cytotoxicity in TNBC cells, patient-derived CAFs, and PDOs. In vivo, NP-FAP-DOX reduced tumor growth, depleted CAFs, degraded the extracellular matrix, induced apoptosis, increased lymphocyte infiltration, and decreased M2-like macrophages. Compared with free doxorubicin, NP-FAP-DOX enhanced therapeutic efficacy while reducing cardiotoxicity and systemic side effects. These findings highlight NP-FAP-DOX as a promising nanomedicine strategy for TNBC, integrating tumor inhibition, TME remodeling, and immune activation, with strong potential for clinical translation., This work was supported by the Spanish Government and cofinanced by FEDER Funds (AES Program, grants PI21/01351; CIBERONC, Biomedical Research Networking Centre for Cancer CB16/12/00481), by projects PID2021-126304OB-C41 and PID2024-155683OB-C41 from MCIN/AEI /10.13039/501100011033/ and FEDER-A way of doing Europe, and also by Universitat Politecnica de Valencia (PAID-06-23, Primeros Proyectos de Investigacion). The authors are also grateful for the Advanced Materials program (MFA/2022/049) supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Project CIPROM/2021/007 from Generalitat Valenciana and CIBER-BBN, Biomedical Research Networking Centre for Bioengineering, Biomaterials and Nanomedicine (CB06/01/2012). A.L. and A.A.-R. were funded by predoctoral grants from the Scientific Foundation of the Spanish Association Against Cancer. P.D. was also funded by a postdoctoral grant from the Scientific Foundation of the Spanish Association Against Cancer (INVES246470DIEZ). F.J.H. was funded by Ministerio de Universidades (FPU20/06021). S.T.-R. was funded by Conselleria d'Educacio, Investigacio, Cultura i Esport, Generalitat Valenciana (ACIF/2019/119). I.G.-C. was funded by Margarita Salas postdoctoral grant (European Union-Next generation EU). M.T. and J.M.C. were funded by Sociedad Espanola de Oncologia Medica (Rio Hortega-SEOM). The funders had no role in the study design, data collection, analysis, interpretation, or manuscript preparation.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

In Vivo Study of Osseointegrable Bone Calcium Phosphate (CaP) Implants Coated with a Vanillin Derivative

  • Medaglia, Serena|||0000-0003-3537-9842
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Bernabe-Quispe, Patricia
  • Tomás-Chenoll, Julia
  • Cebriá-Mendoza, María Concepción
  • Tormo-Mas, Maria Angeles
  • Primo Capella, Victor
  • Peris-Serra, José-Luis
[EN] Background/Objectives: Orthopaedic infections associated with implant surgery remain a major public health concern, often caused by bacterial colonization of implant surfaces. Staphylococcus epidermidis is among the most common pathogens involved. Developing antimicrobial bone implants that prevent infection without compromising bone regeneration is therefore essential. This study investigates the antimicrobial and osteointegrative performance of calcium phosphate (CaP) materials functionalized with vanillin, an essential oil component with known antimicrobial properties. Methods: Commercial CaP regenerative materials were covalently coated with vanillin. Antibacterial activity was evaluated against Staphylococcus epidermidis RP62A using viability assays. In vivo osseointegration was assessed in New Zealand female rabbits implanted with vanillin-coated and uncoated CaP scaffolds. Results: Vanillin-functionalized CaP scaffolds exhibited strong bactericidal activity at 24 h and bacteriostatic effects at 48 h at a concentration of 10 mg/mL. In vivo analyses showed no significant differences in osseointegration between vanillin-coated implants and control CaP materials. Conclusions: Vanillin-functionalized CaP materials maintain a high safety profile without impairing bone integration, supporting their potential use in clinical applications., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, PID2021-122875OB-100, PID2024-155683OB-C41 and PID2024-162542OB-I00 funded by MCIN/AEI/10.13039/501100011033/ and by European Regional Development Fund-a way of funding Europe. Also, this study forms part of the Advanced Materials programme (MFA/2022/053) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. The study was also supported by Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB06/01/2012) and MICRO-STOP project, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. All figures done with BioRender.com. S.M. thanks the Generalitat Valenciana for her Grisolia fellowship (GRISOLIAP/2018/149). M.C-M thanks the Generalitat Valenciana for the postdoctoral contract (INVEST/2022/381). Part of the equipment used to develop this work was supported by Generalitat Valenciana (IDIFEDER/2021/044) and is susceptible to be co-founded through the Operational Programme of the European Regional Development Fund. The authors also thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles

  • Barguilla, Irene
  • Oliver, Patrick
  • Annangi, Balasubramanyan
  • Diez-Sánchez, Paula
  • Marcos, R.
  • Hernández, A.
  • Candela-Noguera, Vicente
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos Martínez, María Dolores|||0000-0001-7079-8589
[EN] Mesoporous silica nanoparticles (MSNs) are amongst the most used nanoparticles in biomedicine. However, the potentially toxic effects of MSNs have not yet been fully evaluated, being a controversial matter in research. In this study, bare MSNs, PEGylated MSNs (MSNs-PEG), and galacto-oligosaccharide-functionalized MSNs (MSNs-GAL) are synthesized and characterized to assess their genotoxicity and transforming ability on human lung epithelial BEAS-2B cells in short- (48 h) and long-term (8 weeks) exposure scenarios. Initial short-term treatments show a dose-dependent increase in genotoxicity for MSNs-PEG-treated cells but not oxidative DNA damage for MSNs, MSNs-PEG, or for MSNs-GAL. In addition, after 8 weeks of continuous exposure, neither induced genotoxic nor oxidative DNA is observed. Nevertheless, long-term treatment with MSNsPEG and MSNs-GAL, but not bare MSNs, induces cell transformation features, as evidenced by the cell¿s enhanced ability to grow independently of anchorage, to migrate, and to invade. Further, the secretome from cells treated with MSNs and MSNs-GAL, but not MSNs-PEG, shows certain tumor-promoting abilities, increasing the number and size of HeLa cell colonies formed in the indirect soft-agar assay. These results show that MSNs, specifically the functionalized ones, provoke some measurable adverse effects linked to tumorigenesis. These effects are in the order of other nanomaterials, such as carbon nanotubes or cerium dioxide nanoparticles, but they are lower than those provoked by some approved drugs, such as doxorubicin or dexamethasone., This work was supported by PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2020-116789RB-C43 funded by MCIN/AEI/10.13039/501100011033/, by the European Regional Development Fund "A way of doing Europe", by Generalitat Valenciana (CIPROM/2021/007), and by the Generalitat de Catalunya (2021-SGR-00731). The work was also supported by CIBER "Consorcio Centro de Investigación Biomédica en Red" (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. This study forms part of the Advanced Materials programme (MFA/2022/049) and was supported by MCIN with funding from European Union NextGenerationEU (PRTR-C17.I1) and from Generalitat Valenciana. This project has also received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 965196. Alba Hernández was granted an ICREA ACADEMIA award. Vicente Candela-Noguera thanks the Spanish Government for his fellowship (FPU15/02753). Paula Díez thanks the Generalitat Valenciana for her contract APOSTD/2020/153 and thanks the Instituto de Salud Carlos III and the European Social Fund for the financial support `Sara Borrell¿, CD20/00120. The authors thank the Electron Microscopy Service at UPV for support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Remodeling the tumor immune microenvironment with lipid nanoparticles

  • Martínez-Latorre, Javier|||0000-0001-5421-5371
[ES] Esta tesis doctoral, titulada "Remodelación del microambiente inmunitario tumoral con nanopartículas lipídicas", explora el desarrollo de nuevas estrategias inmunoterapéuticas contra el cáncer, tanto a nivel terapéutico como de métodos de administración. En concreto, el trabajo investiga enfoques alternativos y relativamente poco explorados, como las inmunoterapias basadas en macrófagos y la inmunoterapia mediada por antígenos exógenos, que tratan de superar las principales limitaciones de las modalidades inmunoterapéuticas actuales. Paralelamente, la tesis evalúa las nanopartículas lipídicas (LNP) como sistemas de administración de genes no virales para la inmunoterapia. El primer capítulo experimental describe el desarrollo de una novedosa plataforma LNP para la inmunoterapia basada en macrófagos. Las LNP cargadas con ADN plasmídico o ARNm de luciferasa se funcionalizaron con ácido fólico (FA) para dirigirse a las células cancerosas pancreáticas que expresan el receptor de folato y con un anticuerpo anti-CD47 (aCD47) para bloquear la evasión inmunitaria mediada por CD47. Los resultados demuestran una transfección eficaz de las células de cáncer de páncreas, con las LNP cargadas con ARNm superando a las formulaciones basadas en plásmidos. Además, la funcionalización con FA mejoró la captación dirigida de LNP in vitro y la funcionalización con aCD47 restauró la fagocitosis de las células tumorales por los macrófagos in vitro. Los experimentos in vivo en modelos de xenoinjertos Capan-2 de ratón con LNP-ARNm-FA-aCD47 demostraron la expresión in vivo de luciferasa y promovieron un cambio hacia un fenotipo de macrófagos proinflamatorio M1 dentro del microambiente tumoral. En conjunto, estos resultados presentan una plataforma LNP optimizada, capaz de inmunomodular los macrófagos asociados a tumores. El segundo capítulo experimental presenta una novedosa inmunoterapia mediada por antígenos exógenos basada en el epítopo alpha-Gal (galactosa-alpha-1,3-galactosa). El epítopo alpha-Gal es altamente inmunogénico en humanos y provoca fuertes respuestas debido a anticuerpos preexistentes. Se desarrollaron LNP que codifican el ARNm de la alpha-1,3-galactosiltransferasa (alpha-GT) para permitir la biosíntesis endógena de alpha-Gal en la superficie de las células tumorales. El tratamiento con estas LNP indujo con éxito la expresión de alpha-Gal en líneas celulares cancerosas murinas y humanas y promovió el reclutamiento de anticuerpos anti-alpha-Gal humanos naturales hacia las células tumorales. Estos resultados identifican a la LNP alpha como una plataforma inmunoterapéutica prometedora que aprovecha la inmunidad humoral preexistente. El tercer capítulo experimental describe una novedosa inmunoterapia mediada por antígenos exógenos basada en la proteína hemaglutinina (H) del virus del sarampión. La proteína H es un antígeno altamente inmunogénico en humanos debido a la vacunación generalizada contra el virus del sarampión. Se formularon LNP que codifican la proteína H y se demostró que transfectan eficazmente tanto cultivos celulares cancerosos bidimensionales como esferoides tumorales tridimensionales. Además, la administración in vivo de LNP H en ratones vacunados contra el sarampión con tumores de melanoma B16-BL6 dio lugar a una disminución significativa del crecimiento tumoral. Este efecto terapéutico está asociado con una fuerte infiltración intratumoral de linfocitos T citotóxicos CD8+, un cambio en la proporción de células T CD8/CD4 y la producción ex vivo de citocinas proinflamatorias tras la reactivación del antígeno, características distintivas de una potente respuesta inmunitaria mediada por células T CD8+. En conjunto, estos resultados ponen de relieve el potencial de LNP H como nueva estrategia para mejorar la inmunogenicidad tumoral y provocar fuertes respuestas inmunitarias antitumorales., [EN] This doctoral thesis, entitled "Remodeling the Tumor Immune Microenvironment with Lipid Nanoparticles", explores the development of novel cancer immunotherapeutic strategies at both the therapeutic and delivery levels. Specifically, the work investigates alternative and comparatively underexplored approaches, including macrophage-based immunotherapies and exogenous antigen-mediated immunotherapy, which seek to overcome key limitations of current immunotherapeutic modalities. In parallel, the thesis evaluates lipid nanoparticles (LNPs) as non-viral gene delivery systems for immunotherapy. The first experimental chapter describes the development of a novel LNP platform for macrophage-based immunotherapy. LNPs loaded with either luciferase-encoding plasmid DNA or mRNA were functionalized with folic acid (FA) for targeting folate receptor-expressing pancreatic cancer cells and with an anti-CD47 antibody (aCD47) to block CD47-mediated immune evasion. The results demonstrate efficient transfection of pancreatic cancer cells, with mRNA-loaded LNPs outperforming plasmid-based formulations. Moreover, the functionalization with FA enhanced targeted uptake of LNPs in vitro and aCD47 functionalization restored the phagocytosis of tumor cells by macrophages in vitro. In vivo experiments in mouse Capan-2 xenograft models with LNP-mRNA-FA-aCD47 demonstrated in vivo expression of luciferase and promoted a shift to a pro-inflammatory, M1-like macrophage phenotype within the tumor microenvironment. Together, these results present an optimized LNP platform capable of immunomodulating tumor-associated macrophages. The second experimental chapter presents a novel exogenous antigen-mediated immunotherapy based on the alpha-Gal epitope (galactose-alpha-1,3-galactose). alpha-Gal epitope is highly immunogenic in humans and elicits strong pre-existing antibody responses. LNPs encoding alpha-1,3-galactosyltransferase (alpha-GT) mRNA were developed to enable endogenous alpha-Gal biosynthesis on tumor cell surfaces. Treatment with these LNPs successfully induced alpha-Gal expression in both murine and human cancer cell lines and promoted the recruitment of naturally occurring human anti-alpha-Gal antibodies to tumor cells. These results identify LNP alpha as a promising immunotherapeutic platform that exploits pre-existing humoral immunity. The third experimental chapter describes a novel exogenous antigen-mediated immunotherapy based on the hemagglutinin (H) protein of the measles virus. H protein is a highly immunogenic antigen in humans due to widespread vaccination against measles virus. LNPs encoding H protein were formulated and shown to efficiently transfect both two-dimensional cancer cell cultures and three-dimensional tumor spheroids. Moreover, in vivo administration of H-expressing LNPs in measles-vaccinated mice bearing B16-BL6 melanoma tumors resulted in significant tumor growth delay. This therapeutic effect is associated with robust intratumoral infiltration of CD8+ cytotoxic T lymphocytes, a shift in the CD8/CD4 T cell ratio, and ex vivo production of pro-inflammatory cytokines upon antigen recall, hallmarks of a potent CD8+ T cell-mediated immune response. Together, these results highlight the potential of LNP H as a novel strategy to enhance tumor immunogenicity and elicit strong antitumor immune responses. We hope that the results obtained in this doctoral thesis will demonstrate the versatility of LNP-based platforms and support the development of innovative cancer immunotherapies that leverage alternative immunotherapeutic strategies, such as macrophage-based approaches and exogenous antigen-mediated immunotherapy., [CA] Esta tesi doctoral, titulada «Remodelació del microambient immunitari tumoral amb nanopartícules lipídiques», explora el desenvolupament de noves estratègies immunoterapèutiques contra el càncer, tant a nivell terapèutic com de mètodes d'administració. En concret, el treball investiga enfocaments alternatius i relativament poc explorats, com les immunoteràpies basades en macròfags i la immunoteràpia mediada per antígens exògens, que tracten de superar les principals limitacions de les modalitats immunoterapèutiques actuals. Paral·lelament, la tesi avalua les nanopartícules lipídiques (LNP) com a sistemes d'administració de gens no virals per a la immunoteràpia. El primer capítol experimental descriu el desenvolupament d'una nova plataforma LNP per a la immunoteràpia basada en macròfags. Les LNP carregades amb ADN plasmídic o ARNm de luciferasa es van funcionalitzar amb àcid fòlic (FA) per a dirigir-se a les cèl·lules canceroses pancreàtiques que expressen el receptor de folat i amb un anticòs anti-CD47 (aCD47) per a bloquejar l'evasió immunitària mediada per CD47. Els resultats demostren una transfecció eficaç de les cèl·lules de càncer de pàncrees, amb les LNP carregades amb ARNm superant a les formulacions basades en plasmidis. A més, la funcionalització amb FA va millorar la captació dirigida de LNP in vitro i la funcionalització amb aCD47 va restaurar la fagocitosi de les cèl·lules tumorals pels macròfags in vitro. Els experiments in vivo en models de xenotrasplantament Capan-2 de ratolí amb LNP-ARNm-FA-aCD47 van demostrar l'expressió in vivo de luciferasa i van promoure un canvi cap a un fenotip de macròfags proinflamatori M1 dins del microambient tumoral. En conjunt, aquests resultats presenten una plataforma LNP optimitzada, capaç de immunomodular els macròfags associats a tumors. El segon capítol experimental presenta una nova immunoteràpia mediada per antígens exògens basada en el epítop alpha-Gal (galactosa-¿-1,3-galactosa). El epítop alpha-Gal és altament immunogènic en humans i provoca fortes respostes a causa d'anticossos preexistents. Es van desenvolupar LNP que codifiquen el ARNm de la ¿-1,3-galactosiltransferasa (¿-GT) per a permetre la biosíntesi endògena de ¿-Gal en la superfície de les cèl·lules tumorals. El tractament amb estes LNP va induir amb èxit l'expressió de ¿-Gal en línies cel·lulars canceroses murines i humanes i va promoure el reclutament d'anticossos anti-¿-Gal humans naturals cap a les cèl·lules tumorals. Estos resultats identifiquen a la LNP alpha com una plataforma immunoterapèutica prometedora que aprofita la immunitat humoral preexistent. El tercer capítol experimental descriu una nova immunoteràpia mediada per antígens exògens basada en la proteïna hemaglutinina (H) del virus de la xarampió. La proteïna H és un antigen altament immunogènic en humans a causa de la vacunació generalitzada contra el virus de la pallola. Es van formular LNP que codifiquen la proteïna H i es va demostrar que transfecten eficaçment tant cultius cel·lulars cancerosos bidimensionals com esferoides tumorals tridimensionals. A més, l'administració in vivo de LNP H en ratolins vacunats contra la pallola amb tumors de melanoma B16-BL6 va donar lloc a una disminució significativa del creixement tumoral. Aquest efecte terapèutic està associat amb una forta infiltració intratumoral de limfòcits T citotòxics CD8+, un canvi en la proporció de cèl·lules T CD8/CD4 i la producció ex vivo de citocines proinflamatòries després de la reactivació de l'antigen, característiques distintives d'una potent resposta immunitària mediada per cèl·lules T CD8+. En conjunt, aquests resultats posen en relleu el potencial de LNP H com a nova estratègia per millorar la immunogenicitat tumoral i provocar fortes respostes immunitàries antitumorals. Esperem que els resultats obtinguts en aquesta tesi doctoral demostren la versatilitat de les plataformes basades en LNP i recolzen el desenvolupament d'immunoteràpies innovadores contra el càncer., This research was supported by European Union’s Horizon 2020 research and innovation programme under grant agreement No 899708 (ULISES). The work has also received funding from projects PID2020-119692RB-C22, PID2023-146637OB-C22, PID2021-128141OBC22, PID2021-126304OB-C41 and PID2024-155683OB-C41 funded by MCIN-Ministerio de Ciencia e Innovación and by the European Regional Development Fund—A way of doing Europe. This study was also supported by the ERC Advanced Grant Edison (101052997), the Generalitat Valenciana (CIPROM/2021/007) and CIBER (CB06/01/2012) and (RD21/0017/0012) Instituto de Salud Carlos III, the Generalitat de Catalunya (SGR21/01169). The research leading to these results has also received funding from “la Caixa” Foundation under agreement LCF/PR/SP23/52950009. The Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Research Council. Neither the European Union nor the granting authority can be held responsible for them. J.M-L. is grateful to the Spanish MECD for his FPU grant (FPU19/06219). PM.S-T. is grateful to the Generalitat Valenciana for a postdoctoral Investigo contract (INVEST/2023/443). We also acknowledge the support of CERCA Programme/Generalitat de Catalunya.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Nitroreductase-responsive gated mesoporous silica nanocarriers for hypoxia-targeted drug delivery

  • Barros, Mariana
  • Sáez José A.
  • Arroyo, Pau
  • Ros-Lis, J. Vicente
  • Garrido, M. Dolores
  • Terencio, M. Carmen
  • Montesinos, M. Carmen
  • Gaviña, Pablo
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Hypoxia, i.e., low oxygen concentration at the tissue level, is a common feature of most solid tumors, and is responsible for their enhanced aggressiveness and resistance to chemotherapy, radiotherapy and photodynamic therapy. Hypoxic microenvironments are also characterized by the overexpression of various reductase enzymes such as nitroreductases. Herein, we report a hypoxia-responsive hybrid nanomaterial consisting of mesoporous silica nanoparticles, loaded with the chemotherapy drug doxorubicin, and functionalized on their surface with a self-immolative gatekeeper responsive to nitroreductases, for the controlled release of the cargo. Thus, under bioreductive conditions, elicited by the presence of nitroreductase and NADH, the reduction of the nitroaromatic containing molecular gate induces a self-immolative elimination leading to the disintegration of the gatekeeper and the delivery of the doxorubicin from inside the pores. The nitroreductase-responsive nanocarrier has been tested in vitro with A549 cells, that are known to express nitroreductase, to demonstrate its effectiveness as drug carrier for doxorubicin release, showing great potential for the treatment of hypoxic tumors., We thank the Spanish Government for grants PID2021-126304OB-C41, PID2021-126304OB-C42, and PID2021-126304OB-C43, funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of making Europe, EU. We also acknowledge the Generalitat Valenciana (Conselleria de Educacion, Universidades y Empleo) for grants CIAICO/2022/146 and CIPROM/2021/007. SCSIE (Universidad de Valencia) is gratefully acknowledged for all the equipment employed. NMR spectra were registered at the U26 facility of ICTS "NAMBIOSIS" at the Universitat de Valencia.r C41, PID2021-126304OB-C42, and PID2021-126304OB-C43, funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of making Europe, EU. We also acknowledge the Generalitat Valenciana (Conselleria de Educacio<acute accent>n, Universidades y Empleo) for grants CIAICO/2022/146 and CIPROM/2021/007. SCSIE (Universidad de Valencia) is gratefully acknowledged for all the equipment employed. NMR spectra were registered at the U26 facility of ICTS "NAMBIOSIS" at the Universitat de Vale`ncia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Smart Nanoparticles for Enhanced Melanoma Therapy: From Controlled Drug Release to Self-Propelled Nanomotors

  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
[ES] La presente tesis doctoral, titulada "Nanopartículas inteligentes para una terapia mejorada contra el melanoma: desde la liberación controlada de fármacos a los nanomotores autopropulsados", se centra en el desarrollo de estrategias terapéuticas innovadoras frente al melanoma mediante nanopartículas inteligentes. En concreto, aborda la síntesis, caracterización y evaluación de nanodispositivos para la liberación controlada de fármacos. Estos sistemas buscan superar barreras características del melanoma, como la evasión inmunitaria, la matriz extracelular tumoral y la degradación prematura de los fármacos, reduciendo los efectos adversos sobre tejidos sanos. El primer capítulo presenta una introducción al cáncer y, especialmente, al melanoma, describiendo sus principales características biológicas, mecanismos de metástasis y evasión inmune. Asimismo, revisa la evolución de las estrategias terapéuticas y las limitaciones que condicionan su eficacia. Posteriormente, se introduce la nanotecnología aplicada a la medicina y sus principales aplicaciones oncológicas. Finalmente, se analizan los sistemas de liberación controlada de fármacos, las profármacos y los estímulos capaces de desencadenar su activación, con especial atención a las nanoestrellas de oro y a las nanopartículas mesoporosas de sílice como plataformas prometedoras para el tratamiento del melanoma. El capítulo segundo se exponen los objetivos de la tesis. El tercer capítulo describe una plataforma nanoterapéutica bioortogonal basada en nanoestrellas de oro para la fotoactivación controlada de profármacos de doxorrubicina mediante luz infrarroja cercana (NIR). Se desarrollaron dos estrategias complementarias: una prodroga de doxorrubicina inactivada mediante grupos 2-nitrobencilo y la misma molécula anclada covalentemente a la superficie de las nanoestrellas. La irradiación NIR induce la liberación controlada de la doxorrubicina activa. Ambas formulaciones mostraron elevada estabilidad en condiciones fisiológicas y activación exclusivamente tras irradiación. Además, se demostró la activación intracelular del profármaco en células de melanoma y cáncer de cuello uterino minimizando los efectos fototérmicos. Los estudios in vitro e in vivo en modelos murinos de melanoma evidenciaron una liberación eficiente del fármaco, una inhibición significativa del crecimiento tumoral y una actividad terapéutica selectiva únicamente bajo irradiación NIR. El cuarto capítulo se centra en el desarrollo de nanomotores autopropulsados para mejorar la distribución de fármacos en regiones profundas del tumor. El sistema se basa en nanopartículas Janus de platino funcionalizadas con lactato oxidasa y cargadas con doxorrubicina. Estas aprovechan el lactato del microambiente tumoral como combustible endógeno, proporcionando propulsión autónoma y depleción metabólica. Los nanomotores mostraron movimiento autónomo y liberación específica del fármaco en condiciones fisiológicas. En células de melanoma produjeron una marcada reducción de la viabilidad celular a bajas concentraciones, mientras que en esferoides tumorales alcanzaron una penetración intratumoral superior a la de sistemas pasivos. Los estudios in vivo demostraron una reducción significativa del tamaño tumoral y un aumento de la infiltración de linfocitos CD8+, sugiriendo una disminución de la evasión inmunitaria asociada al metabolismo del lactato. Finalmente, los capítulos quinto y sexto recogen la discusión general, las perspectivas futuras y las conclusiones. En conjunto, los resultados demuestran la versatilidad de las nanoestrellas plasmónicas y de los nanomotores impulsados por metabolitos como plataformas para terapias antitumorales innovadoras. Estas estrategias combinan activación controlada de profármacos, propulsión autónoma y remodelación del microambiente tumoral para mejorar la administración de fármacos frente al melanoma y otros tumores accesibles., [EN] The present doctoral thesis, entitled "Smart nanoparticles for improved melanoma therapy: from controlled drug release to self-propelled nanomotors", focuses on the development of innovative therapeutic strategies against melanoma through the use of smart nanoparticles. Specifically, it addresses the synthesis, characterization, and evaluation of nanodevices for controlled drug release. These systems are designed to overcome key barriers associated with melanoma, such as immune evasion, the tumor extracellular matrix, and premature drug degradation, while reducing adverse effects on healthy tissues. The first chapter provides an introduction to cancer, and especially to melanoma, describing its main biological features, mechanisms of metastasis, and immune evasion. It also reviews the evolution of therapeutic strategies and the limitations that affect their efficacy. Subsequently, the application of nanotechnology in medicine and its main oncological applications are introduced. Finally, controlled drug delivery systems, prodrugs, and the stimuli capable of triggering their activation are analyzed, with special attention to gold nanostars and mesoporous silica nanoparticles as promising platforms for melanoma treatment. The second chapter presents the objectives of the thesis. The third chapter describes a bioorthogonal nanotherapeutic platform based on gold nanostars for the controlled photoactivation of doxorubicin prodrugs using near-infrared (NIR) light. Two complementary strategies were developed: a doxorubicin prodrug inactivated by 2-nitrobenzyl groups and the same molecule covalently anchored to the surface of the nanostars. NIR irradiation induces the controlled release of active doxorubicin. Both formulations showed high stability under physiological conditions and were activated only upon irradiation. In addition, intracellular activation of the prodrug was demonstrated in melanoma and cervical cancer cells, minimizing photothermal effects. In vitro and in vivo studies in murine melanoma models showed efficient drug release, significant inhibition of tumor growth, and selective therapeutic activity only under NIR irradiation. The fourth chapter focuses on the development of self-propelled nanomotors to improve drug distribution in deep tumor regions. The system is based on platinum Janus nanoparticles functionalized with lactate oxidase and loaded with doxorubicin. These nanoparticles exploit lactate from the tumor microenvironment as an endogenous fuel, providing autonomous propulsion and metabolic depletion. The nanomotors showed self-propulsion and specific drug release under physiological conditions. In melanoma cells, they produced a marked reduction in cell viability at low concentrations, while in tumor spheroids they achieved greater intratumoral penetration than passive systems. In vivo studies demonstrated a significant reduction in tumor size and an increase in CD8+ lymphocyte infiltration, suggesting a decrease in immune evasion associated with lactate metabolism. Finally, the fifth and sixth chapters present the general discussion, future perspectives, and conclusions. Overall, the results demonstrate the versatility of plasmonic nanostars and metabolite-driven nanomotors as platforms for innovative anticancer therapies. These strategies combine controlled prodrug activation, autonomous propulsion, and remodeling of the tumor microenvironment to improve drug delivery against melanoma and other accessible tumors., [CA] La present tesi doctoral, titulada "Nanopartícules intel·ligents per a una teràpia millorada contra el melanoma: des de l'alliberament controlat de fàrmacs fins als nanomotors autopropulsats", se centra en el desenvolupament d'estratègies terapèutiques innovadores contra el melanoma mitjançant l'ús de nanopartícules intel·ligents. En concret, aborda la síntesi, la caracterització i l'avaluació de nanodispositius per a l'alliberament controlat de fàrmacs. Aquests sistemes busquen superar barreres característiques del melanoma, com ara l'evasió immunitària, la matriu extracel·lular tumoral i la degradació prematura dels fàrmacs, reduint els efectes adversos sobre els teixits sans. El primer capítol presenta una introducció al càncer i, especialment, al melanoma, descrivint-ne les principals característiques biològiques, els mecanismes de metàstasi i l'evasió immune. Així mateix, revisa l'evolució de les estratègies terapèutiques i les limitacions que en condicionen l'eficàcia. Posteriorment, s'introdueix la nanotecnologia aplicada a la medicina i les seues principals aplicacions oncològiques. Finalment, s'analitzen els sistemes d'alliberament controlat de fàrmacs, els profàrmacs i els estímuls capaços de desencadenar-ne l'activació, amb una atenció especial a les nanoestrelles d'or i a les nanopartícules mesoporoses de sílice com a plataformes prometedores per al tractament del melanoma. El segon capítol exposa els objectius de la tesi. El tercer capítol descriu una plataforma nanoterapèutica bioortogonal basada en nanoestrelles d'or per a la fotoactivació controlada de profàrmacs de doxorubicina mitjançant llum infraroja pròxima (NIR). Es van desenvolupar dues estratègies complementàries: un profàrmac de doxorubicina inactivat mitjançant grups 2-nitrobenzil i la mateixa molècula ancorada covalentment a la superfície de les nanoestrelles. La irradiació NIR indueix l'alliberament controlat de la doxorubicina activa. Ambdues formulacions van mostrar una elevada estabilitat en condicions fisiològiques i una activació exclusivament després de la irradiació. A més, es va demostrar l'activació intracel·lular del profàrmac en cèl·lules de melanoma i de càncer de coll uterí, minimitzant els efectes fototèrmics. Els estudis in vitro i in vivo en models murins de melanoma van evidenciar un alliberament eficient del fàrmac, una inhibició significativa del creixement tumoral i una activitat terapèutica selectiva únicament sota irradiació NIR. El quart capítol se centra en el desenvolupament de nanomotors autopropulsats per a millorar la distribució de fàrmacs en regions profundes del tumor. El sistema es basa en nanopartícules Janus de platí funcionalitzades amb lactat oxidasa i carregades amb doxorubicina. Aquestes aprofiten el lactat del microambient tumoral com a combustible endogen, proporcionant propulsió autònoma i depleció metabòlica. Els nanomotors van mostrar moviment autònom i alliberament específic del fàrmac en condicions fisiològiques. En cèl·lules de melanoma van produir una reducció marcada de la viabilitat cel·lular a baixes concentracions, mentre que en esferoides tumorals van assolir una penetració intratumoral superior a la dels sistemes passius. Els estudis in vivo van demostrar una reducció significativa de la mida tumoral i un augment de la infiltració de limfòcits CD8+, la qual cosa suggereix una disminució de l'evasió immunitària associada al metabolisme del lactat. Finalment, els capítols cinqué i sisé recullen la discussió general, les perspectives futures i les conclusions. En conjunt, els resultats demostren la versatilitat de les nanoestrelles plasmòniques i dels nanomotors impulsats per metabolits com a plataformes per a teràpies antitumorals innovadores. Aquestes estratègies combinen activació controlada de profàrmacs, propulsió autònoma i remodelació del microambient tumoral per a millorar l'administració de fàrmacs davant del melanoma i altres tumors accessibles., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22 and PID2024-155683OB-C41, funded by MCIN/AEI/10.13039/501100011033 and by the European Regional Development Fund (ERDF) – A way of doing Europe; by the Generalitat Valenciana (Project PROMETEO CIPROM/2021/007); by Project MFA/2022/049 from the Advanced Materials programme, funded by the European Union NextGenerationEU (PRTR-C17.I1); and by the Generalitat Valenciana and the European Research Council (ERC) via Advanced Grant 101052997 (EDISON). This research was also supported by CIBER – Consorcio Centro de Investigación Biomédica en Red – (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. J.J.E.-M. thanks the AECC Scientific Foundation, and especially the AECC Council of Valencia, for their PhD grant (PRDVA21651ESTE). P.D. thanks the AECC Scientific Foundation for their postdoctoral grant (INVES246470DIEZ). O.F.S. acknowledges the support from the Provincial Council of Gipuzkoa under the Fellows Gipuzkoa programme. F.J.H. thanks MIU for his FPU grant (FPU20/06021). V.S.-A. thanks MIU for his FPI grant (PRE2022-103714). A.G-F. and P.D. thank the Instituto de Salud Carlos III and the European Social Fund for their "Miguel Servet" contracts (CP25/00067 and CP24/00043). The authors thank the UPV Electron Microscopy Service and the CIPF Confocal and Electron Microscopy Services for their technical support. The U26 NMR: Biomedical Applications II platform from NANBIOSIS (ICTS "NANBIOSIS", Research Infrastructures & Services of CIBER-BBN) is also gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparing organic and metallo-organic hydrazone molecular cages as potential carriers for doxorubicin delivery

  • Montà-González, Giovanni|||0000-0002-0739-9937
  • Bastante-Rodríguez, David
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Lusby, Paul J.
[EN] Molecular cages are three-dimensional supramolecular structures that completely wrap guest molecules by encapsulation. We describe a rare comparative study between a metallo-organic cage and a fully organic analogous system, obtained by hydrazone bond formation self-assembly. Both cages are able to encapsulate the anticancer drug doxorubicin, with the organic cage forming a 1 : 1 inclusion complex with mu M affinity, whereas the metallo-organic host experiences disassembly by interaction with the drug. Stability experiments reveal that the ligands of the metallo-organic cage are displaced in buffer at neutral, acidic, and basic pH, while the organic cage only disassembles under acidic conditions. Notably, the organic cage also shows minimal cell toxicity, even at high doses, whilst the doxorubicin-cage complex shows in vitro anti-cancer activity. Collectively, these results show that the attributes of the pure organic molecular cage are suitable for the future challenges of in vivo drug delivery using molecular cages., V. M.-C. acknowledges the financial support from project CIDEGENT/2020/031 funded by the Generalitat Valenciana, project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/ 501100011033, and project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R. M.-M. acknowledges the financial support from project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033 and FEDER A way to make Europe. G. M.-G. acknowledges the financial support from the mobility grant CIBEFP/2022/43 funded by the Generalitat Valenciana. D. B.-R. acknowledges the financial support from fellowship CIACIF/2022/174 funded by the Generalitat Valenciana. The authors thank Servei Central d'Instrumentacio Científica (SCIC) at Universitat Jaume I, and mass spectrometry, proteomics laboratory member of Proteored, and single crystal X-ray diffraction facilities of SCSIE at Universitat de Valencia. NMR spectra were registered at the U26 facility of ICTS NANBIOSIS . This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Development of Functional Hybrid Materials for Advanced Antimicrobial Applications

  • Medaglia, Serena|||0000-0003-3537-9842
[ES] Las infecciones microbianas asociadas a biopelículas y el aumento de la resistencia a los antimicrobianos representan un desafío crítico, tanto en entornos clínicos como industriales. En este contexto, esta tesis doctoral, titulada "Desarrollo de materiales híbridos funcionales para aplicaciones antimicrobianas avanzadas", explora nuevas estrategias para la prevención y erradicación de biopelículas, mediante el uso de materiales funcionalizados con compuestos antimicrobianos naturales. El primer capítulo se centra en el desarrollo de superficies de acero inoxidable modificadas con un recubrimiento antimicrobiano basado en vainillina, anclado a una capa intermedia de sílice. Las pruebas realizadas sobre Staphylococcus epidermidis, uno de los principales patógenos responsables de infecciones nosocomiales, demostraron una reducción del 100% en la viabilidad bacteriana y una disminución del 75% en la formación de biopelículas, en comparación con superficies no tratadas. El segundo capítulo presenta un nuevo enfoque para la prevención de infecciones asociadas a implantes, ya que las infecciones postquirúrgicas en ortopedia siguen siendo un grave problema clínico. En este estudio, se funcionalizaron materiales regenerativos basados en fosfato de calcio (CaP) con vainillina (CaP-Vainillina), con el fin de combinar sus propiedades regenerativas, con una acción antimicrobiana prolongada. La letalidad promedio sobre S. epidermidis en biopelícula, cuando se trató con CaP-Vanillin, fue del 98,9% y superior al 99,9% en concentraciones de 50 mg/mL y 100 mg/mL, respectivamente, en comparación con el CaP. Los estudios in vivo en modelos animales confirmaron que el uso de estos biomateriales no interfiere con la osteointegración, lo que los convierte en candidatos prometedores para aplicaciones clínicas. En el tercer capítulo, se abordan las limitaciones asociadas a diversos compuestos naturales mediante la aplicación de la nanotecnología, utilizada como herramienta para mejorar la eficacia y funcionalidad de estos agentes naturales. Este capítulo presenta dos artículos de investigación, que describen el desarrollo de nanodispositivos avanzados. El primer artículo explora una tecnología prometedora para la industria alimentaria, donde la contaminación por biopelículas bacterianas representa un riesgo grave para la seguridad alimentaria y provoca importantes costes económicos. Se diseñó un sistema basado en nanopartículas de tipo Janus, formado por una combinación de nanopartículas de platino con sílice mesoporosa funcionalizada con vainillina. Estos nanosistemas muestran movimiento autónomo en presencia de peróxido de hidrógeno (H¿O¿) y, con ello, una alta capacidad para penetrar biopelículas de Staphylococcus aureus y eliminar eficazmente las células patógenas, abriendo nuevas vías para soluciones de desinfección industrial. El segundo artículo del tercer capítulo investiga una estrategia innovadora basada en la Terapia Fotodinámica Antimicrobiana (aPDT), que aprovecha la acción combinada de fotosensibilizadores y luz a longitudes de onda específicas para generar especies reactivas de oxígeno e inducir la muerte bacteriana. Se diseñó un sistema basado en nanopartículas de sílice mesoporosa cargadas con curcumina y funcionalizadas con polimixina B (actuando como puerta molecular). Los resultados mostraron una reducción significativa en la viabilidad bacteriana y hasta un 99% de inhibición en la formación de biopelículas. Así, esta tesis doctoral demuestra el potencial de las superficies funcionalizadas, los nanomateriales motorizados y la Terapia Fotodinámica como estrategias avanzadas y eficaces para combatir infecciones por biopelículas y la resistencia antimicrobiana. Las aplicaciones abarcan desde el ámbito biomédico hasta la seguridad alimentaria, proponiendo nuevas soluciones para el control de infecciones y la reducción del uso de antibióticos o biocidas., [CA] Les infeccions microbianes associades a biofilms i l'augment de la resistència als antimicrobians representen un desafiament crític tant en entorns clínics com industrials. En aquest context, aquesta tesi doctoral, titulada "Desenvolupament de materials híbrids funcionals per a aplicacions antimicrobianes avançades", explora noves estratègies per a la prevenció i eradicació de biofilms mitjançant l'ús de materials funcionalitzats amb compostos antimicrobians naturals. El primer capítol se centra en el desenvolupament de superfícies d'acer inoxidable modificades amb un recobriment antimicrobià a base de vainillina, ancorat a una capa intermèdia de sílice. Les proves realitzades sobre Staphylococcus epidermidis, un dels principals patògens responsables d'infeccions nosocomials, van demostrar una reducció del 100% en la viabilitat bacteriana i una disminució del 75% en la formació de biofilms en comparació amb superfícies no tractades. El segon capítol presenta un nou enfocament per a la prevenció d'infeccions associades a implants, ja que les infeccions postquirúrgiques en ortopèdia continuen sent un problema clínic greu. En aquest estudi, es van funcionalitzar materials regeneratius a base de fosfat de calci (CaP) amb vainillina (CaP-Vanillin), amb l'objectiu de combinar les seues propietats regeneratives amb una acció antimicrobiana prolongada. La letalitat mitjana sobre S. epidermidis en biofilm, quan es tractava amb CaP-Vainillina, fou del 98,9% i superior al 99,9% a concentracions de 50 mg/mL i 100 mg/mL, respectivament, en comparació amb el CaP. Els estudis in vivo en models animals van confirmar que l'ús d'aquests biomaterials no interfereix amb l'osteointegració, la qual cosa els converteix en candidats prometedors per a aplicacions clíniques. Al tercer capítol, s'aborden les limitacions associades a diversos compostos naturals mitjançant l'aplicació de la nanotecnologia, utilitzada com a eina per a millorar l'eficàcia i funcionalitat d'aquests agents naturals. Aquest capítol presenta dos articles d'investigació que descriuen el desenvolupament de nanodispositius avançats. El primer article explora una tecnologia prometedora per a la indústria alimentària, on la contaminació per biofilms bacterians representa un risc greu per a la seguretat alimentària i provoca importants costos econòmics. Es va dissenyar un sistema basat en nanopartícules de tipus Janus, compost per una combinació de nanopartícules de platí amb sílice mesoporosa funcionalitzada amb vainillina. Aquests nanosistemes mostren moviment autònom en presència de peròxid d'hidrogen (H¿O¿) i, amb això, una gran capacitat per a penetrar biofilms de Staphylococcus aureus i eliminar eficaçment les cèl·lules patògenes, obrint noves vies per a solucions de desinfecció industrial. El segon article del tercer capítol investiga una estratègia innovadora basada en la Teràpia Fotodinàmica Antimicrobiana (aPDT), que aprofita l'acció combinada de fotosensibilitzadors i llum a longituds d'ona específiques per a generar espècies reactives d'oxigen i induir la mort bacteriana. Es va dissenyar un sistema basat en nanopartícules de sílice mesoporosa carregades amb curcumina i funcionalitzades amb polimixina B (actuant com a porta molecular). Els resultats van mostrar una reducció significativa en la viabilitat bacteriana i fins a un 99% d'inhibició en la formació de biofilms. Així, aquesta tesi doctoral demostra el potencial de les superfícies funcionalitzades, els nanomaterials motoritzats i la Teràpia Fotodinàmica com a estratègies avançades i eficaces per a combatre infeccions per biofilms i la resistència antimicrobiana. Les aplicacions abasten des del sector biomèdic fins a la seguretat alimentària, proposant noves solucions per al control d'infeccions i la reducció de l'ús d'antibiòtics o biocides., [EN] Microbial biofilm infections and increasing antimicrobial resistance represent a critical challenge in both clinical and industrial settings. In this context, this doctoral thesis, entitled "Development of Functional Hybrid Materials for Advanced Antimicrobial Applications", explores new strategies for biofilm prevention and eradication through the use of functionalized materials with natural antimicrobial compounds. The first chapter focuses on the development of stainless steel surfaces modified with an antimicrobial coating based on vanillin, anchored to an intermediate silica layer. The tests performed on Staphylococcus epidermidis, one of the main pathogens responsible for nosocomial infections, showed a 100% reduction in bacterial viability and a 75% decrease in biofilm formation, compared to untreated surfaces. The second chapter presents a new approach for preventing infections associated with implants, as post-surgical infections in orthopedics remain a serious clinical problem. In this study, regenerative materials based on calcium phosphate (CaP) were functionalized with vanillin (CaP-Vanillin) in order to combine their regenerative properties with prolonged antimicrobial action. The average lethality on S. epidermidis in biofilm, when treated with CaP-Vanillin, was 98.9% and over 99.9% at concentrations of 50 mg/mL and 100 mg/mL, respectively, compared to CaP. In vivo studies in animal models confirmed that the use of these biomaterials does not interfere with osteointegration, making them promising candidates for clinical applications. In the third chapter, the limitations associated with various natural compounds are addressed through the application of nanotechnology, used as a tool to enhance the efficacy and functionality of these natural agents. Two research articles are presented in this chapter, describing the development of advanced nanodevices. The first article explores a promising technology for the food industry, where bacterial biofilm contamination poses a serious risk to food safety and results in significant economic costs. A system based on Janus nanoparticles was designed, consisting of a combination of platinum nanoparticles with vanillin-functionalized mesoporous silica. These nanosystems exhibit autonomous movement in the presence of hydrogen peroxide (H¿O¿) and, with that, show a high capacity to penetrate Staphylococcus aureus biofilms and effectively eliminate pathogenic cells, paving the way for new industrial disinfection solutions. The second article of the third chapter investigates an innovative strategy based on Antimicrobial Photodynamic Therapy (aPDT), which exploits the combined action of photosensitizers and light at specific wavelengths to generate reactive oxygen species and induce bacterial death. A system based on mesoporous silica nanoparticles loaded with curcumin and functionalized with polymyxin B (acting as a molecular gate) was designed. The results showed a significant reduction in bacterial viability and up to 99% inhibition in biofilm formation. Thus, this doctoral thesis demonstrates the potential of functionalized surfaces, motorized nanomaterials, and Photodynamic Therapy as advanced and effective strategies to combat biofilm infections and antimicrobial resistance. The applications range from biomedical sectors to food safety, suggesting new approaches for infection control and the reduction of antibiotic or biocide use., The Spanish Government (projects PID2021-126304OB-C41, PID2021-128141OB-C22 and TED2021-132114B-I00, MCUI/FEDER, EU and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación) and the Generalitat Valenciana (CIPROM/2021/007) funded this research. This work was also supported by the European Research Council (ERC) via Advanced Grant (101052997, EDISON). This study formed part of the Advanced Materials program (MFA/2022/053) and the AGROALNEXT program (AGROALNEXT/2022/032), supported by MCIN with funding from the European Union NextGenerationEU (PRTR-C17.I1) and by Generalitat Valenciana. S.M. thanks the Generalitat Valenciana for her Grisolía fellowship (GRISOLIAP/2018/149). Á.M.-A. thanks the Universitat Politècnica de Valencia (UPV) for her Ph.D. grant (DOCEMPR22). F.J.H thanks Ministerio de Universidades (MIU, Spanish Government) for his FPU grant (FPU20/06021). M.R.-T. thanks MIU for his FPU grant (FPU21/03142). A.B. thanks the MIU for her Beatriz Galindo contract (BG20/00020). P.D. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support “Sara Borrell” (CD20/00120) and “Miguel Servet” (CP24/00043).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chemical Strategies for the Detection and Elimination of Senescent Cells

  • García-Fleitas, Jessie
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Cellular senescence can be defined as an irreversible stopping of cell proliferation that arises in response to various stress signals. Cellular senescence is involved in diverse physiological and pathological processes in different tissues, exerting effects on processes as differentiated as embryogenesis, tissue repair and remodeling, cancer, aging, and tissue fibrosis. In addition, the development of some pathologies, aging, cancer, and other age-related diseases has been related to senescent cell accumulation. Due to the complexity of the senescence phenotype, targeting senescent cells is not trivial, is challenging, and is especially relevant for in vivo detection in age-related diseases and tissue samples. Despite the elimination of senescent cells (senolysis) using specific drugs (senolytics) that have been shown to be effective in numerous preclinical disease models, the clinical translation is still limited due to the off-target effects of current senolytics and associated toxicities. Therefore, the development of new chemical strategies aimed at detecting and eliminating senescent cells for the prevention and selective treatment of senescence-associated diseases is of great interest. Such strategies not only will contribute to a deeper understanding of this rapidly evolving field but also will delineate and inspire new possibilities for future research.In this Account, we report our recent research in the development of new chemical approaches for the detection and elimination of senescent cells based on new probes, nanoparticles, and prodrugs. The designed systems take advantage of the over-representation in senescent cells of certain biomarkers such as ß-galactosidase and lipofuscin. One- and two-photon probes, for higher tissue penetration, have been developed. Moreover, we also present a renal clearable fluorogenic probe for the in vivo detection of the ß-galactosidase activity, allowing for correlation with the senescent burden in living animals. Moreover, as an alternative to molecular-based probes, we also developed nanoparticles for senescence detection. Besides, we describe advances in new therapeutic agents to selectively eradicate senescent cells using ß-galactosidase activity-sensitive gated nanoparticles loaded with cytotoxic or senolytic agents or new prodrugs aiming to increase the selectivity and reduction of off-target toxicities of current drugs. Moreover, new advances therapies have been applied in vitro and in vivo. Studies with the probes, nanoparticles, and prodrugs have been applied in several in vitro and in vivo models of cancer, fibrosis, aging, and drug-induced cardiotoxicity in which senescence plays an important role. We discuss the benefits of these chemical strategies toward the development of more specific and sophisticated probes, nanoparticles, and prodrugs targeting senescent cells., This work was supported by the European Research Council (ERC) via an Advanced Grant (101052997, EDISON). The authors are also grateful for project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033 and by the European Regional Development Fund - A way of doing Europe. The authors also thank the Generalitat Valenciana (CIPROM/2021/007). This research was supported by CIBER-Consorcio Centro de Investigación Biomédica en Red (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. J.G.-F. is grateful for her predoctoral Grisolia grant from the Genelalitat Valenciana (GRISOLIAP/2021/ 122). A.B. thanks the MCIN for her BG20/00020 contract. V.M.-C. thanks the Generalitat Valenciana (CIDEGENT/2020/031).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Super Hydrophobic Pectin-Anthocyanin Colorimetric Sensor to Indicate Freshness in Bovine Meat

  • Cruces, F
  • García, MG
  • Poyatos-Racionero, Elisa
  • Ochoa, NA
  • Vivancos, José-Luis|||0000-0002-8524-5466
  • Fuentes López, Ana|||0000-0002-4144-2396
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] In this work, an innovative three-layer sensor was developed in a fully sustainable design. For that purpose, pectin and anthocyanins from Morus nigra and Prosopis alba were used. Furthermore, mixtures of beeswax and colophony as hydrophobic layers were used to prevent the moisture from affecting the sensor work. The ratio of beeswax/colophony (B/C) was studied to optimize the moisture barrier. The response of colorimetric sensors pectin-Morus nigra (PMN) and pectin-Prosopis alba (PPA) in vapors of simulant solutions was recorded. Furthermore, physicochemical and microbiological tests on fresh bovine meat were carried out, and volatile compound content (VC) was correlated with color changes in PMN and PPA sensors. The results depicted that the optimal ratio in the waterproof layer was B/C: 70/30 (BC3) showing the highest water contact angle of 112 degrees and minimal water vapor absorption value of 2.4%. In addition, the light transmittance of the BC3 layer allows to perceive the color of the sensor without alteration. The outcomes of the simulation test showed differences in color values of 26 and 31 to PMN and PPA, respectively, highlighting the ability of both sensors to allow the detection of quality changes in packaged bovine meat. This research paves the way for the development of sustainable and environmentally friendly colorimetric sensors with diverse applications., The research leading to these results received funding from the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (GRANT: PID2021-126304OB-C41), the GVA (GRANT: CIPROM/2021/007), CONICET-Argentina (GRANT: PIP 559CO), and UNSL Argentina (GRANT: PROICO 2-2420). DAS:The authors confirm that the data supporting the findings of this study are available within the article.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Sistemas optoelectrónicos para terapias fototérmicas dirigidas al cáncer de piel y optogenética en la regeneración de tejido nervioso

  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
[ES] Esta tesis doctoral se enfoca en la creación y validación de sistemas optoelectrónicos para aplicaciones biomédicas, en concreto para la terapia fototérmica contra el cáncer de piel y la optogenética para la regeneración de tejido nervioso. En su transcurso, se ha desarrollado un conjunto de herramientas y dispositivos que abarcan desde la experimentación sobre cultivos celulares hasta modelos computacionales que simulan el tratamiento. Para la terapia fototérmica, se ha diseñado y construido un equipo de experimentación in vitro validado sobre cultivos celulares. Este dispositivo, equipado con funcionalidades para controlar la potencia del láser, gestionar los tiempos de irradiación, realizar un posicionamiento automático de varias muestras bajo el haz, y monitorizar la evolución de la temperatura, se presenta como una herramienta altamente beneficiosa para la investigación en esta área. Después, se exploró la simulación mediante el Método de Elementos Finitos para analizar el comportamiento de las nanopartículas y sus suspensiones en agua, arrojando luz sobre sus potenciales aplicaciones en terapias fototérmicas y campos relacionados. Gracias al aprendizaje obtenido en los primeros pasos de este estudio, se logró el desarrollo de dos nuevos equipos que habilitan la realización de experimentos in vivo. Además, se ha implementado un modelo computacional diseñado para investigar el impacto de la terapia fototérmica en tejido biológico. Por último, se desarrolló un dispositivo optoelectrónico de reducidas dimensiones y alta potencia para la estimulación optogenética de neuronas modificadas genéticamente, con el objetivo de observar el transitorio de la estimulación y así entender en mayor medida las posibilidades que ofrece la optogenética en el campo de la regeneración de tejidos., [CA] Aquesta tesi doctoral es centra en la creació i validació de sistemes optoelectrònics per a aplicacions biomèdiques, específicament per a la teràpia fototèrmica contra el càncer de pell i l'optogenètica per a la regeneració del teixit nerviós. Durant el seu desenvolupament, s'han dut a terme un conjunt d'eines i dispositius, des de l'experimentació en cultius cel·lulars fins a models computacionals que simulen el tractament. Per a la teràpia fototèrmica, s'ha dissenyat i construït un dispositiu de experimentació in vitro validat en cultius cel·lulars. Aquest dispositiu, equipat amb funcionalitats per controlar la potència del làser, gestionar els temps d'irradiació, realitzar un posicionament automàtic de diverses mostres sota el feix i monitoritzar l'evolució de la temperatura, es presenta com una eina altament beneficiosa per a la recerca en aquest àmbit. A continuació, s'ha explorat la simulació mitjançant el Mètode d'Elements Finits per analitzar el comportament de les nanopartícules i les seves suspensions en aigua, aportant llum a les seves possibles aplicacions en teràpies fototèrmiques i camps relacionats. Gràcies al coneixement adquirit en les primeres etapes d'aquest estudi, s'ha aconseguit el desenvolupament de dos nous dispositius que possibiliten realitzar experiments in vivo. A més, s'ha implementat un model computacional dissenyat per investigar l'impacte de la teràpia fototèrmica en teixit biològic. Finalment, s'ha desenvolupat un dispositiu optoelectrònic de reduïdes dimensions i alta potència per a l'estimulació optogenètica de neurones modificades genèticament, amb l'objectiu d'observar la estimulació transitoria i comprendre millor les possibilitats que ofereix l'optogenètica en el camp de la regeneració de teixits., [EN] This doctoral thesis focuses on the creation and validation of optoelectronic systems for biomedical applications, specifically for photothermal therapy against skin cancer and optogenetics for nerve tissue regeneration. During its course, a set of tools and devices has been developed, ranging from experimentation on cell cultures to computational models simulating the treatment. For photothermal therapy, an in vitro device has been designed and constructed for experimentation in cell cultures. This device, equipped with functionalities to control laser power, manage irradiation times, perform automatic positioning of multiple samples under the beam, and monitor temperature evolution, emerges as a highly beneficial tool for research in this area. Next, simulation using the Finite Element Method was explored to analyze the behavior of nanoparticles and their suspensions in water, shedding light on their potential applications in photothermal therapies and related fields. Thanks to the knowledge gained in the early stages of this study, the development of two new devices enabling in vivo experiments was achieved. Furthermore, a computational model designed to investigate the impact of photothermal therapy on biological tissue has been implemented. Finally, a compact, high-power optoelectronic device was developed for the optogenetic stimulation of genetically modified neurons, with the aim of observing the stimulation transient and gaining a better understanding of the possibilities that optogenetics offers in the field of tissue regeneration., El material y las instalaciones utilizados en el desarrollo de este trabajo fueron financiados por las ayudas PID2021-126304OB-C44 y PID2021-124359OB-I00 de MCIN/AEI/10.13039/5011000110-33, el programa H2020 FetOpen con el proyecto número 964562, la ayuda de la Conselleria de Educación, Investigación, Cultura y Deporte de la Generalitat Valenciana CIPROM/2021/007 y el proyecto PROMETEO 2018/024, la Fundación Social Europea ACIF/2019/120, y el Ministerio de Ciencia, Innovación y Universidades con las becas doctorales FPU17/03239 y FPU17/03800. El trabajo ha recibido también financiación de la Agencia Estatal de Investigación con los proyectos números RTI2018-100910-B-C41, RTI2018-100910-B-C43-AR y PID2021-126304OB-C41, el Instituto de Salud Carlos III - CIBER-BBN: Safe N Medtech and Smart-4-Fabry Projects (asociado a los programas europeos del marco H2020 (H2020/2014-2020) con la ayuda número 814607) y el Ministerio de Ciencia e Innovación con las beca predoctorales FPU17/03800 y FPU17/03239
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Molecular cages: emerging applications in diverse fields

  • Ortiz-Gómez, Eduardo|||0009-0005-5778-9158
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Martí-Centelles, Vicente|||0000-0002-9142-9392
[EN] Molecular cages are readily adaptable supramolecular structures with outstanding potential for multiple purposes. Cages have well-defined cavities that enable precise guest encapsulation, offering unique opportunities in sensing, catalysis, environmental and biological applications, among others. Recent advances in the field have demonstrated how the structural versatility of molecular cages - including all-organic and metal-organic architectures - allows the design of systems with tailored functionality. Innovative uses span from simple host-guest applications for the selective encapsulation of chemical species, to more sophisticated approaches aiming to mimic biological systems. This review gives a general overview of the field, focusing on the advances in the last 3 years, and emphasizing how the design of molecular cages to achieve specific functionalities is opening frontiers in innovative applications., V.M.-C. acknowledges the financial support from projects ESGENT/2024/001 and CIDEGENT/2020/031 both funded by the Generalitat Valenciana, Project PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/501100011033, and Project CNS2023-144879 funded by MICIU/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. R.M.-M. acknowledges the financial support from Project PROMETEO CIPROM/2021/007 from the Generalitat Valenciana and project PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/501100011033/ and FEDER A way to make Europe. This research was supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. E.O.-G. is grateful to the Generalitat Valenciana for Grisolia grant (CIGRIS/2021/128).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Metabolomic study for the identification of symptomatic carotid plaque biomarkers

  • Botello-Marabotto, Marina Dolores
  • Plana Andani, Emma
  • Medina, Pilar
  • Miralles, Manuel
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Carotid artery stenosis is mainly produced due to the progressive accumulation of atherosclerotic plaque in the vascular wall. The atherosclerotic plaque is characterized by the accumulation of lipids, low density proteins, expression of chemokines and adhesion molecules, and migration of monocytes and lymphocytes into the plaque. Its rupture can produce stroke, but embolic propensity depends principally on the composition and vulnerability of plaque rather than the severity of stenosis. It is important, then, to ascertain which patients with carotid artery stenosis have a greater risk of developing neurological symptomatology. Here, we present a metabolomic study by using nuclear magnetic resonance (NMR) spectroscopy in atheroma plaque and serum samples from patients with recently symptomatic and asymptomatic carotid stenosis to search for metabolites that could be used as biomarkers associated with plaque vulnerability and subsequent risk of rupture. Thirty-eight atheromatous plaque samples (24 asymptomatic patients and 14 symptomatic) and 70 serum samples (43 asymptomatic and 27 symptomatic) were studied by NMR spectroscopy. The data were analysed using multivariate statistics (PLS-DA) to determine a model to discriminate between symptomatic and asymptomatic samples (atheroma plaques and sera). The calculated PLS-DA models showed a 100 % sensitivity and a 96.6 % specificity for the cross validation to discriminate between symptomatic and asymptomatic plaques, and 88.37% sensitivity and 77.78 % specificity when serum samples were analysed. According to the results of our multivariate and univariate analysis, the most discriminative metabolites for plaque vulnerability were threonine in serum samples, and glutamate in plaque samples. Also, an analysis of the main metabolic pathways involved in plaque vulnerability revealed that D-glutamine and D-glutamate metabolism, and phenylalanine, tyrosine, and tryptophan biosynthesis were the most affected pathways in plaque and serum, respectively., M. Botello-Marabotto acknowledges Generalitat Valenciana and the Spanish Government for her PhD grants ACIF/2020 and FPU 2020, respectively. Andrea Bernardos acknowledges her "Beatriz Galindo" contract from the MCIN (BG20/00020). This project has received the following funding: Instituto de Salud Carlos III (ISCIII) (PI20/01171 and PI20/00075) co-funded by the European Union (ERDF, "A way to make Europe") , project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund - A way of doing Europe and Generalitat Valenciana (project CIPROM/2021/007). La Fe Biobank (Hospital Universitario y Politecnico La Fe) is acknowledged for the storage and management of tissue samples (PT17/0015/0043). CIBER -Consorcio Centro de Investigacion Biomedica en Red- (CB07/01/2012), Ministerio de Ciencia e Innovacion and U26 NMR: Biomedical Applications II platform from Nanbiosis (Research Infrastructures & Services of CIBER-BBN) are also gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Non-invasive biomarkers for mild cognitive impairment and Alzheimer&apos, s disease

  • Botello-Marabotto, Marina Dolores
  • Calero, Miguel
  • Pastor, Ana B.
  • Medina, Miguel
  • Martínez-Bisbal, M.Carmen|||0000-0002-8526-4413
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Alzheimer's disease is the most common type of dementia in the elderly. It is a progressive degenerative disorder that may begin to develop up to 15 years before clinical symptoms appear. The identification of early biomarkers is crucial to enable a prompt diagnosis and to start effective interventions. In this work, we conducted a metabolomic study using proton Nuclear Magnetic Resonance (1H NMR) spectroscopy in serum samples from patients with neuropathologically confirmed Alzheimer's disease (AD, n = 51), mild cognitive impairment (MCI, n = 27), and cognitively healthy controls (HC, n = 50) to search for metabolites that could be used as biomarkers. Patients and controls underwent yearly clinical follow-ups for up to six years. MCI group included samples from three subgroups of subjects with different disease progression rates. The first subgroup included subjects that remained clinically stable at the MCI stage during the period of study (stable MCI, S-MCI, n = 9). The second subgroup accounted for subjects which were diagnosed with MCI at the moment of blood extraction, but progressed to clinical dementia in subsequent years (MCI-to-dementia, MCI-D, n = 14). The last subgroup was composed of subjects that had been diagnosed as dementia for the first time at the moment of sample collection (incipient dementia, Incp-D, n = 4). Partial Least Square Discriminant Analysis (PLS-DA) models were developed. Three models were obtained, one to discriminate between AD and HC samples with high sensitivity (93.75%) and specificity (94.75%), another model to discriminate between AD and MCI samples (100% sensitivity and 82.35% specificity), and a last model to discriminate HC and MCI with lower sensitivity and specificity (67% and 50%). Differences within the MCI group were further studied in an attempt to determine those MCI subjects that could develop AD-type dementia in the future. The relative concentration of metabolites, and metabolic pathways were studied. Alterations in the pathways of alanine, aspartate and glutamate metabolism, pantothenate and CoA biosynthesis, and beta-alanine metabolism, were found when HC and MCI- D patients were compared. In contrast, no pathway was found disturbed in the comparison of S-MCI with HC groups. These results highlight the potential of 1H NMR metabolomics to support the diagnosis of dementia in a less invasive way, and set a starting point for the study of potential biomarkers to identify MCI or HC subjects at risk of developing AD in the future., Authors acknowledge the Spanish Government MICINN (PID2019-110401RB-100) , ISCIII (COHORTES CIBERBBN-CIBERNED) , and Queen Sofia Foundation. This research was supported by project PID2021-126304OB-C41 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. This study was also supported by Generalitat Valenciana (CIPROM/2021/007) . M. Botello-Marabotto acknowledges Generalitat Valenciana for her PhD grant (ACIF/2020) and Spanish Government for her PhD grant (FPU 2020) .
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Cellular senescence promotes progenitor cell expansion during axolotl limb regeneration

  • Yu, Qinghao
  • Walters, Hannah E.
  • Pasquini, Giovanni
  • Singh, Sumeet Pal
  • Lachnit, Martina
  • Oliveira, Catarina R.
  • León-Periñán, Daniel
  • Petzold, Andreas
  • Kesavan, Preethi
  • Adrados, Cristina Subiran
  • Garteizgogeascoa, Ines
  • Knapp, Dunja
  • Wagner, Anne
  • Alfonso, María
  • Bernardos Bau, Andrea|||0000-0002-3842-5771
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Axolotl limb regeneration is accompanied by the transient induction of cellular senescence within the blastema, the structure that nucleates regeneration. The precise role of this blastemal senescent cell (bSC) population, however, remains unknown. Here, through a combination of gain-and loss-of-function assays, we elucidate the functions and molecular features of cellular senescence in vivo. We demonstrate that cellular senescence plays a positive role during axolotl regeneration by creating a pro-proliferative niche that supports progenitor cell expansion and blastema outgrowth. Senescent cells impact their microenvironment via Wnt pathway modulation. Further, we identify a link between Wnt signaling and senescence induction and propose that bSC-derived Wnt signals facilitate the proliferation of neighboring cells in part by preventing their induction into senescence. This work defines the roles of cellular senescence in the regeneration of complex structures., We thank TUD-CMCB Flow Cytometry and Light Microscopy Facilities for cell sorting and imaging support; DRESDEN-concept genome center for RNA sequencing; MPI-CBG Computing Facility for image processing advice; Phillip Gates for technical support; Daniel Munoz Espin for nanoparticle advice; Gabriel Waksman for institutional support; Beate Gruhl, Anja Wagner, and Dominic Kruger for animal care; and all members of the Yun lab for advice and comments on the manuscript. This work was supported by an Alexander von Humboldt postdoctoral fellowship to H.E.W., a DAAD MSc scholarship (57507833) to D.L.-P., MISU-PROL funding from the FNRS (40005588) and Fondation Jaumotte-Demoulin funds to S.P.S., a CRTD E.V. scholarship to C.S.A., a DAAD Scholarship to K.E.T., CRTD-FSJ program funds to A.M.G., DFG (BU 2974/3-2 and EXC-2151-390873048) and Volkswagen Foundation Freigeist (A110720) grants to V.B., MCIU/AEI/FEDER, EU (PID2021-126304OB-C41 and PID2021-128141OB-C22) and Generatitat Valenciana (CIPROM/2021/007) grants to R.M.-M., and DFG (22137416, 450807335, and 497658823) grants and TUD and CRTD funds to M.H.Y.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer

  • Marcelo, Goncalo A.
  • Montpeyó, David
  • Galhano, Joana
  • Capelo-Martínez, José Luis
  • Lorenzo, Julia
  • Lodeiro, Carlos
  • Oliveira, Elisabete
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] The need for non-invasive therapies capable of conserving drug efficiency and stability while having specific targetability against colorectal cancer (CRC), has made nanoparticles preferable vehicles and principal building blocks for the development of complex and multi-action anti-tumoral approaches. For that purpose, we herein report the production of a combinatory anti-tumoral nanotherapy using the production of a new targeting towards CRC lines. To do so, Magneto-fluorescent NANO3 nanoparticles were used as nanocarriers for a combination of the drugs doxorubicin (DOX) and ofloxacin (OFLO). NANO3 nanoparticles' surface was modified with two different targeting agents, a newly synthesized (anti-CA IX acetazolamide derivative (AZM-SH)) and a commercially available (anti-epidermal growth factor receptor (EGFR), Cetuximab). The cytotoxicity revealed that only DOX-containing nanosystems showed significant and even competitive cytotoxicity when compared to that of free DOX. Interestingly, surface modification with AZM-SH promoted an increased cellular uptake in the HCT116 cell line, surpassing even those functionalized with Cetuximab. The results show that the new target has high potential to be used as a nanotherapy agent for CRC cells, surpassing commercial targets. As a proof-of-concept, an oral administration form of NANO3 systems was successfully combined with Eudragit (R) enteric coating and studied under extreme conditions., This work received financial support from PT national funds (FCT/MCTES, Fundacao para a Ciencia e Tecnologia and Ministerio da Ciencia, Tecnologia e Ensino Superior) through the projects UIDB/50006/2020 and UIDP/50006/2020. G.M. acknowledges the financial support by the Associate Laboratory Research Unit for Green Chemistry-Clean Processes and Technologies-LAQV, which is financed by national funds from FCT/MEC (UID/QUI/50006/2013) and co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007265), as well as the Scientific Society PROTEOMASS (Portugal) for funding support (General Funding Grant). G.M. and J.G. thank FCT/MEC (Portugal) for their doctoral grant PD/BD/142865/2018 and 2022.09495.BD, respectively. E.O. thanks FCT (Fundacao para a Ciencia e Tecnologia) for funding through the Scientific Employment Stimulus-Individual Call (Ref. CEECIND/00648/2017). J.L. acknowledges the funding received from the Ministerio de Ciencia, Innovacion y Universidades, Spain, grant PID2021-127983OB-C22 funded by MCIN/AEI/10.13039/501100011033. RMM acknowledges the funding received from project PID2021-126304OB-C41 funded by MCIN/AEI /10.13039/501100011033/ and by European Regional Development Fund-A way of doing Europe and Generalitat Valenciana (CIPROM/2021/007).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bioorthogonal Photoactivation of 2-Nitrobenzyl Caged Doxorubicin Anticancer Prodrugs on Gold Nanostars

  • Esteve-Moreno, Juan José|||0000-0002-1259-7663
  • Escudero-Noguera, Andrea|||0000-0003-2670-6127
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Hernández-Montoto, Andy|||0000-0001-5623-9836
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Ferreira Silvestre, Óscar
  • Gorbe, Mónica
  • Garrido, Eva
  • Renero-Lecuna, Carlos
  • Langer, Judith
  • Alfonso, María
  • Ibañez, J.
  • Roberto Cao Milán
  • Liz-Marzán, Luis M.
[EN] Bioorthogonal chemistry that can be controlled through near-infrared (NIR) light is a promising route to therapeutics. This study proposes a method to intracellularly photoactivate prodrugs using plasmonic gold nanostars (AuNSt) and NIR irradiation. Two strategies are followed. On one hand, doxorubicin (Dox) masked with a 2-nitrobenzyl carbamate (proDox1) is used as a photoactivatable prodrug. In the second strategy, a photolabile Dox prodrug (proDox2) obtained by modification of Dox with 2-nitrobenzyl diol bearing a disulfide is attached to the AuNSt surface. Under NIR irradiation AuNSt induce local electromagnetic field enhancement, leading to photocleavage of the 2-nitrobenzyl moiety in both proDox1 and proDox2, and subsequent Dox release. Near field enhancement by excitation of surface plasmons in AuNSt is sufficient to record the surface-enhanced Raman scattering (SERS) spectra of proDox1 and proDox2. The therapeutic potential of this bioorthogonal photoactivation strategy is confirmed in vitro and in vivo using a mouse model of human melanoma. NIR-activated AuNSt induce in vivo the intracellular release of Dox and subsequent cancer cell death, thus reducing tumor growth at low irradiation power density to avoid undesired photothermal effects. These results demonstrate that AuNSt are suitable platforms for NIR light-triggered drug delivery in cancer therapy., This research was supported by project PID2021-126304OB-C41 and PID2021-128141OB-C22 funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund-A way of doing Europe. The work was also supported by Generalitat Valenciana (CIPROM/2021/007). This study was also supported by the ERC Advanced Grant Edison (101052997). This research was supported by CIBER-Consorcio Centro de Investigacion Biomedica en Red-(CB06/01/2012), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion. J. J. E-M. thanks the financial support from FC AECC and especially to the AECC Council of Valencia for the trust placed (PRDVA21651ESTE). O.F.S. acknowledges the support from the Provincial Council of Gipuzkoa under the program Fellows Gipuzkoa. The authors thank the UPV electron microscopy and CIPF confocal and electron microscopy services for technical support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chemical Communication between Giant Vesicles and Gated Nanoparticles for Strip-Based Sensing

  • Ventura-Cobos, Jordi|||0000-0001-8475-9820
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Llopis-Lorente, Antoni|||0000-0002-6987-9506
  • Climent Terol, Estela
[EN] Inspired by nature, the development of artificial micro/nanosystems capable of communicating has become an emergent topic in nanotechnology, synthetic biology, and related areas. However, the demonstration of actual applications still has to come. Here, we demonstrate how chemical communication between micro- and nanoparticles can be used for the design of sensing systems. To realize this, we synergistically combine two different types of particles: i.e., giant unilamellar vesicles (GUVs) as senders and gated mesoporous nanoparticles as receivers. The use of engineered GUVs allows the detection of analytes based on responsive membranes, while the use of gated nanoparticles allows a straightforward application on test strips with smartphone-based detection. In addition, we demonstrate that the combined communication system exhibits signal amplification and its application in real samples employing the bacterial toxin ¿-hemolysin as target analyte. Altogether, our report presents a new route for engineering sensing systems based on the combination of communicative micro/nanoparticles., The authors would like to acknowledge the support from ERC Advanced Grant Edison (101052997); the Spanish Ministry of Science and Innovation, AEI, and FEDER-EU (project PID2021-126304OB-C41), and the GVA (Project CIPROM/2021/007). A.L.-L. thanks the Spanish Government for his "Ramon y Cajal" Fellowship (RYC2021-034728-I), funded by MCIN/AEI/10.13039/501100011033 and by the European Union "NextGenerationEU" / "PRTR". A.L-L. also thanks the UPV for funding (Ayuda para potenciar la investigacion postdoctoral de la UPV (PAID-PD-22), Ayuda a Primeros Proyectos de Investigacion (PAID-06-22), Vicerrectorado de Investigacion de la Universitat Politecnica de Valencia (UPV)). E.C. thanks the Instituto de Salud Carlos III for her Miguel Servet Fellowship (CP23/00086).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Renal Clearable Probe for In Vivo Monoamine Oxidase (MAO) Detection

  • Domínguez-Rodríguez, Marcia|||0000-0002-0635-0699
  • Azorín-Soriano, David
  • García-Fleitas, Jessie
  • Soriano-Teruel, Paula
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Lerida-Viso, Araceli
  • Soler-Beatty, Jennifer
  • Rodrigo-Martínez, Paula
  • Pau Arroyo Máñez
  • Rojas-Vázquez, Sara
  • Fariñas, Isabel
  • Blandez, Juan F.
[EN] Hyperactivation of monoamine oxidase enzymes (MAO) is associated with uncontrolled production of neurotoxic compounds such as reactive oxygen species, whose accumulation is linked to neurodegenerative, chronic, and age-related diseases. Although chromo-fluorogenic probes for detecting and quantifying MAO activity have been reported, non-invasive methods for monitoring MAO overexpression in vivo remain elusive. Here, we report a renal-clearable fluorogenic probe based on the cyanine-7 fluorophore (Cy7-MAO) for in vivo detection of MAO overexpression through a simple measurement of the fluorescence in urine. The probe incorporates sulfonic acid moieties for renal clearance and a propylamino group as a MAO substrate. Upon administration, Cy7-MAO is hydrolysed at the site by MAO, releasing a highly emissive Cy7 fluorophore, which is excreted in urine and quantified by fluorescence. Cy7-MAO is validated in vitro using HepG2 liver human cells, which express elevated MAO levels. We further demonstrate the in vivo applicability of Cy7-MAO for MAO activity monitoring in aged mice, which show significantly higher urine fluorescence than young mice, consistent with an elevated MAO activity in older animals. These findings support Cy7-MAO as a tool for longitudinal assessment of MAO activity in vivo, providing a novel approach to study MAO-related pathologies., This research was supported by projects PID2021-126304OB-C41, PID2021-128141OB-C22, and PID2024-155683OB-C41, funded by MCIN/AEI/10.13039/501100011033/and by European Regional Development Fund A way of doing Europe, and CIPROM/2021/007, funded by Generalitat Valenciana (GVA), to R. M-M., and PID2020-117937GB-I00 to I.F. The authors acknowledge the financial support from the FEDER found of the European Union (IDIFEDER/2021/044). This research also wassupported by CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB06/01/2012 and CB06/05/0086), Instituto de Salud Carlos III, MCIN. This study was also supported by the project PAID06-24 funded by Universitat Politècnica de València. J. F. B. thanks the support from the la Caixa Foundation (ID 100010434) under the fellowship code LCF/BQ/PR24/12050022. D. A. -S. thanks his predoctoral fellowship CIACIF from GVA (CIACIF/2022/132). J. G. -F. thanks his predoctoral fellowship GRISOLIA from GVA (GRISOLIAP/2021/122) A.G-F. thanks the Instituto de Salud Carlos III and the European Social Fund for financial support Miguel Servet (CP25/00067).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

BODIPY doping of covalent organic frameworks-based nanomaterials: A novel strategy towards biomedical applications

  • Suárez-Bas, Fátima
  • Martínez-Fernández, Marcos
  • Prieto-Castañeda, Alejandro
  • García-Fernández, Alba
  • Martínez, José I.
  • Ramos, María Mar
  • Ortiz, María J.
  • Martínez-Máñez, Ramón
  • Segura, José L.
[EN] Covalent organic Frameworks (COFs) are a class of crystalline macromolecular materials build-up by monomers with specific symmetries or functionalities. There are important limitations in the synthesis of highly ordered COFs, such as the shape and packing of the building blocks. Thus, the presence of fluorine atoms that lie perpendicular to the bisecting plane of BODIPY derivatives together with the presence of four bulky methyl groups could hinder the crystallization process in COF synthesis. For that reason, BODIPY-based COFs are rarely incorporated to COF networks. In this work, following the mixed linker strategy, a pre-synthetic method to dope COF structures with BODIPY units was developed. The materials have been processed into fluorescent Covalent Organic Nanosheets (CONs) with defined particle-size distributions around 100 nm, suitable for cellular biomedical applications. The viability of the CONs was evaluated using Sk-Mel-103 cells, demonstrating the internalization showing 100% cell viability. We envisage that this work could accelerate the discovery of new COF-based materials for biomedical sciences., This work was financially supported by Spanish MICINN (PID2019- 106268GB-C33, TED2021-129886B-C43, PID2020-114755GB-C32, PID2020-113142RB-C21 and PLEC2021-007906), as well as by project PID2021-126304OB-C41 via MCIN/AEI/10.13039/501100011033/, by European Regional Development Fund - A way of doing Europe and by the Generalitat Valenciana (CIPROM/2021/007). J.I.M. also acknowledges funding from EU via the European Graphene Flagship (Grant Graphene Core3 881603) and Comunidad de Madrid (Grants S2018/NMT-4367 and Y2020/NMT-6469)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Aptamer-capped nanoporous anodic alumina for SARS-CoV-2 spike protein detection

  • Caballos, Isabel
  • Aranda, María Nieves
  • López-Palacios, Alba
  • Pla, Luis
  • Santiago-Felipe, Sara
  • Hernández-Montoto, Andy
  • Tormo-Mas, María Ángeles
  • Pemán, Javier
  • Gómez-Ruiz, María Dolores
  • Calabuig, Eva
  • Sánchez-Sendra, Beatriz
  • Francés-Gómez, Clara
  • Geller, Ron
  • Aznar, Elena
  • Martínez-Máñez, Ramón
The COVID-19 pandemic, which began in 2019, has highlighted the importance of testing and tracking infected individuals as a means of mitigating the spread of the virus. In this context, the development of sensitive and rapid methods for the detection of SARS-CoV-2, the virus responsible for COVID-19, is crucial. Herein, a biosensor based on oligonucleotide-gated nanomaterials for the specific detection of SARS-CoV-2 spike protein is presented. The sensing system consists of a nanoporous anodic alumina disk loaded with the fluorescent indicator rhodamine B and capped with a DNA aptamer that selectively binds the SARS-CoV-2 spike protein. The system is initially evaluated using pseudotype virus systems based on vesicular stomatitis virus carrying different SARS-CoV-2 S-proteins on their surface. When the pseudotype virus is present, the cap of the solid is selectively removed, triggering the release of the dye from the pore voids to the medium. The nanodevice demonstrated its ability to detect pseudotype virus concentrations as low as 7.5·103 PFU mL. In addition, the nanodevice is tested on nasopharyngeal samples from individuals suspected of having COVID-19., This study was supported by the Spanish Government (projects PID2021-126304OB-C41, and PID2021-122875OB-100 (MCUI/AEI/FEDER, UE)), the Generalitat Valenciana (project no.2 RD 180/2020, CIPROM/2021/007), Supera COVID-19 Fund (DIACOVID project), the Universitat Politècnica de València−Instituto de Investigación Sanitaria La Fe (IIS-LaFe) (SARS-COV-2-SEEKER and VISION-COV projects), and by the European Commission –NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) to Ron Geller. The project leading to this application has received funding from the European Union's Horizon EUROPE research and innovation programme under grant agreement No 101093042. Isabel Caballos thanks the Instituto de Salud Carlos III for her predoctoral fellowship (IFI21/00008). Alba López-Palacios thanks the Ministerio de Universidades for her predoctoral grant (FPU20/05297). Ron Geller holds a Ramon y Cajal fellowship from the Spanish Ministerio de Economía y Competitividad (RYC-2015-17517)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer

  • Marcelo, Gonçalo A.|||0000-0003-1248-085X
  • Montpeyó, David|||0000-0002-0327-2015
  • Galhano, Joana|||0000-0002-7149-1682
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Capelo-Martínez, José Luis|||0000-0001-6276-8507
  • Lorenzo Rivera, Julia|||0000-0001-5659-6008
  • Lodeiro, Carlos|||0000-0001-5582-5446
  • Oliveira, Elisabete|||0000-0002-8339-4820
The need for non-invasive therapies capable of conserving drug efficiency and stability while having specific targetability against colorectal cancer (CRC), has made nanoparticles preferable vehicles and principal building blocks for the development of complex and multi-action anti-tumoral approaches. For that purpose, we herein report the production of a combinatory anti-tumoral nanotherapy using the production of a new targeting towards CRC lines. To do so, Magneto-fluorescent NANO3 nanoparticles were used as nanocarriers for a combination of the drugs doxorubicin (DOX) and ofloxacin (OFLO). NANO3 nanoparticles' surface was modified with two different targeting agents, a newly synthesized (anti-CA IX acetazolamide derivative (AZM-SH)) and a commercially available (anti-epidermal growth factor receptor (EGFR), Cetuximab). The cytotoxicity revealed that only DOX-containing nanosystems showed significant and even competitive cytotoxicity when compared to that of free DOX. Interestingly, surface modification with AZM-SH promoted an increased cellular uptake in the HCT116 cell line, surpassing even those functionalized with Cetuximab. The results show that the new target has high potential to be used as a nanotherapy agent for CRC cells, surpassing commercial targets. As a proof-of-concept, an oral administration form of NANO3 systems was successfully combined with Eudragit ® enteric coating and studied under extreme conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles

  • Barguilla, Irene|||0000-0003-1081-4457
  • Candela-Noguera, Vicente|||0000-0001-5310-8443
  • Oliver, Patrick
  • Annangi, Balasubramanyam|||0000-0002-1479-138X
  • Díez, Paula
  • Aznar, Elena|||0000-0003-0361-3876
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
  • Marcos, Ricard|||0000-0001-7891-357X
  • Hernández, Alba|||0000-0001-6938-1233
  • Marcos Martínez, Maria Dolores|||0000-0001-7079-8589
Mesoporous silica nanoparticles (MSNs) are amongst the most used nanoparticles in biomedicine. However, the potentially toxic effects of MSNs have not yet been fully evaluated, being a controversial matter in research. In this study, bare MSNs, PEGylated MSNs (MSNs-PEG), and galacto-oligosaccharide-functionalized MSNs (MSNs-GAL) are synthesized and characterized to assess their genotoxicity and transforming ability on human lung epithelial BEAS-2B cells in short- (48 h) and long-term (8 weeks) exposure scenarios. Initial short-term treatments show a dose-dependent increase in genotoxicity for MSNs-PEG-treated cells but not oxidative DNA damage for MSNs, MSNs-PEG, or for MSNs-GAL. In addition, after 8 weeks of continuous exposure, neither induced genotoxic nor oxidative DNA is observed. Nevertheless, long-term treatment with MSNs-PEG and MSNs-GAL, but not bare MSNs, induces cell transformation features, as evidenced by the cell's enhanced ability to grow independently of anchorage, to migrate, and to invade. Further, the secretome from cells treated with MSNs and MSNs-GAL, but not MSNs-PEG, shows certain tumor-promoting abilities, increasing the number and size of HeLa cell colonies formed in the indirect soft-agar assay. These results show that MSNs, specifically the functionalized ones, provoke some measurable adverse effects linked to tumorigenesis. These effects are in the order of other nanomaterials, such as carbon nanotubes or cerium dioxide nanoparticles, but they are lower than those provoked by some approved drugs, such as doxorubicin or dexamethasone.